Chr	Start	End	Ref	Alt	Func.refGene	Gene.refGene	GeneDetail.refGene	ExonicFunc.refGene	AAChange.refGene	pLi.refGene	pRec.refGene	pNull.refGene	Disease_description.refGene	P(HI).refGene	P(rec).refGene	RVIS.refGene	RVIS_percentile.refGene	GDI.refGene	GDI-Phred.refGene	SIFT_score	SIFT_converted_rankscore	SIFT_pred	Polyphen2_HDIV_score	Polyphen2_HDIV_rankscore	Polyphen2_HDIV_pred	Polyphen2_HVAR_score	Polyphen2_HVAR_rankscore	Polyphen2_HVAR_pred	LRT_score	LRT_converted_rankscore	LRT_pred	MutationTaster_score	MutationTaster_converted_rankscore	MutationTaster_pred	MutationAssessor_score	MutationAssessor_score_rankscore	MutationAssessor_pred	FATHMM_score	FATHMM_converted_rankscore	FATHMM_pred	PROVEAN_score	PROVEAN_converted_rankscore	PROVEAN_pred	VEST3_score	VEST3_rankscore	MetaSVM_score	MetaSVM_rankscore	MetaSVM_pred	MetaLR_score	MetaLR_rankscore	MetaLR_pred	M-CAP_score	M-CAP_rankscore	M-CAP_pred	CADD_raw	CADD_raw_rankscore	CADD_phred	DANN_score	DANN_rankscore	fathmm-MKL_coding_score	fathmm-MKL_coding_rankscore	fathmm-MKL_coding_pred	Eigen_coding_or_noncoding	Eigen-raw	Eigen-PC-raw	GenoCanyon_score	GenoCanyon_score_rankscore	integrated_fitCons_score	integrated_fitCons_score_rankscore	integrated_confidence_value	GERP++_RS	GERP++_RS_rankscore	phyloP100way_vertebrate	phyloP100way_vertebrate_rankscore	phyloP20way_mammalian	phyloP20way_mammalian_rankscore	phastCons100way_vertebrate	phastCons100way_vertebrate_rankscore	phastCons20way_mammalian	phastCons20way_mammalian_rankscore	SiPhy_29way_logOdds	SiPhy_29way_logOdds_rankscore	Interpro_domain	GTEx_V6_gene	GTEx_V6_tissue	Otherinfo
chr1	1560911	1560911	C	A	intronic	MIB2	.	.	.	0.000158543	0.998420185	0.001421272	.	0.17639	0.12919	-0.033100763	50.56027365	2011.5952	8.25644	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	64	78	chr1	1560911	chr1:1560911	C	A	64	PASS	AN=2;DP=78	GT	0/1
chr1	1560943	1560943	C	T	exonic	MIB2	.	synonymous SNV	MIB2:NM_001170688:exon7:c.C1032T:p.G344G,MIB2:NM_001170689:exon7:c.C687T:p.G229G,MIB2:NM_001170686:exon8:c.C1215T:p.G405G,MIB2:NM_001170687:exon8:c.C1185T:p.G395G,MIB2:NM_080875:exon8:c.C1227T:p.G409G	0.000158543	0.998420185	0.001421272	.	0.17639	0.12919	-0.033100763	50.56027365	2011.5952	8.25644	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	35	chr1	1560943	chr1:1560943	C	T	.	PASS	AN=0;DP=35	GT	0/1
chr1	1843597	1843597	T	-	intergenic	GNB1;CALML6	dist=21041;dist=2669	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	44	25	chr1	1843596	chr1:1843596	CT	C	44	PASS	AN=2;DP=25	GT	0/1
chr1	1920313	1920313	G	A	intronic	CFAP74	.	.	.	.	.	.	.	0.12614	0.09843	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	311	chr1	1920313	chr1:1920313	G	A	.	PASS	AN=0;DP=311	GT	0/1
chr1	11008497	11008497	G	C	exonic	C1orf127	.	synonymous SNV	C1orf127:NM_001170754:exon12:c.C1695G:p.G565G	1.33E-05	0.955388217	0.044598438	.	0.1648	.	0.986521626	90.48124558	1056.79352	6.24152	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	62	19	chr1	11008497	chr1:11008497	G	C	62	PASS	AN=2;DP=19	GT	0/1
chr1	16451783	16451783	C	T	exonic	EPHA2	.	nonsynonymous SNV	EPHA2:NM_001329090:exon16:c.G2696A:p.G899D,EPHA2:NM_004431:exon17:c.G2858A:p.G953D	0.738294173	0.261704958	8.69E-07	DISEASE: Cataract 6, multiple types (CTRCT6) [MIM:116600]: An opacification of the crystalline lens of the eye that frequently results in visual impairment or blindness. Opacities vary in morphology, are often confined to a portion of the lens, and may be static or progressive. CTRCT6 includes posterior polar and age- related cortical cataracts, among others. Posterior polar cataract is a subcapsular opacity, usually disk-shaped, located at the back of the lens. Age-related cortical cataract is a developmental punctate opacity restricted to the cortex. The cataract is white or cerulean, increases in number with age, but rarely affects vision. {ECO:0000269|PubMed:19005574, ECO:0000269|PubMed:19306328, ECO:0000269|PubMed:19649315}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Note=Overexpressed in several cancer types and promotes malignancy. {ECO:0000269|PubMed:19573808}.; 	0.5483	0.28861	-0.628385276	16.82000472	391.87029	4.16611	0.0	0.912	D	1.0	0.899	D	1.0	0.971	D	0.000	0.537	D	1	0.810	D	3.755	0.952	H	-0.23	0.667	T	-5.37	0.849	D	0.683	0.690	0.362	0.885	D	0.573	0.846	D	0.317	0.914	D	7.186	0.945	34	0.998	0.929	0.984	0.818	D	c	0.882	0.802	1.000	0.747	0.672	0.522	0	4.88	0.630	7.818	0.846	0.785	0.317	1.000	0.715	0.958	0.437	17.007	0.862	Sterile alpha motif domain|Sterile alpha motif/pointed domain	.	.	0.5	.	81	chr1	16451783	chr1:16451783	C	T	.	PASS	AN=0;DP=81	GT	0/1
chr1	20972061	20972061	G	A	exonic	PINK1	.	nonsynonymous SNV	PINK1:NM_032409:exon5:c.G968A:p.C323Y	4.08E-07	0.587542005	0.412457586	DISEASE: Parkinson disease 6 (PARK6) [MIM:605909]: A neurodegenerative disorder characterized by parkinsonian signs such as rigidity, resting tremor and bradykinesia. A subset of patients manifest additional symptoms including hyperreflexia, autonomic instability, dementia and psychiatric disturbances. Symptoms show diurnal fluctuation and can improve after sleep. {ECO:0000269|PubMed:15087508, ECO:0000269|PubMed:15349860, ECO:0000269|PubMed:15349870, ECO:0000269|PubMed:15505171, ECO:0000269|PubMed:15596610, ECO:0000269|PubMed:15955953, ECO:0000269|PubMed:15970950, ECO:0000269|PubMed:16009891, ECO:0000269|PubMed:16207217, ECO:0000269|PubMed:16257123, ECO:0000269|PubMed:16401616, ECO:0000269|PubMed:16482571, ECO:0000269|PubMed:16632486, ECO:0000269|PubMed:16966503, ECO:0000269|PubMed:17030667, ECO:0000269|PubMed:18286320, ECO:0000269|PubMed:22956510}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.14291	0.17629	-0.462894052	23.62585515	2907.56994	10.22981	0.223	0.187	T	0.007	0.161	B	0.006	0.166	B	0.000	0.497	D	1.000	0.489	D	1.095	0.275	L	-0.75	0.733	T	-2.62	0.563	D	0.761	0.755	-0.748	0.581	T	0.267	0.639	T	0.049	0.639	D	1.859	0.284	15.34	0.838	0.144	0.935	0.582	D	c	-0.147	0.067	0.986	0.310	0.707	0.730	0	5.8	0.921	2.416	0.441	1.032	0.654	0.998	0.411	0.999	0.750	15.563	0.759	Protein kinase domain|Protein kinase-like domain	.	.	0.5	.	66	chr1	20972061	chr1:20972061	G	A	.	PASS	AN=0;DP=66	GT	0/1
chr1	24120833	24120833	C	-	intronic	LYPLA2	.	.	.	0.979519145	0.020463866	1.70E-05	.	0.20635	0.10011	-0.295622497	32.61972163	4.69509	0.16866	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	57	49	chr1	24120832	chr1:24120832	AC	A	57	PASS	AN=2;DP=49	GT	0/1
chr1	26510343	26510343	C	T	intronic	CNKSR1	.	.	.	3.79E-16	0.136331853	0.863668147	.	0.16583	0.10675	0.516238257	80.33734371	811.05923	5.60139	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	67	chr1	26510343	chr1:26510343	C	T	.	PASS	AN=0;DP=67	GT	0/1
chr1	37958245	37958245	T	-	UTR3	MEAF6	NM_022756:c.*1455delA;NM_001270876:c.*1125delA;NM_001270875:c.*1455delA	.	.	0.730388139	0.269048652	0.000563209	DISEASE: Note=A chromosomal aberration involving MEAF6 may be a cause of endometrial stromal tumors. Translocation t(1;6)(p34;p21) with PHF1. {ECO:0000269|PubMed:22761769}.; 	0.18507	0.10264	-0.09720619	46.20193442	5.77712	0.21811	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	61	110	chr1	37958244	chr1:37958244	GT	G	61	PASS	AN=2;DP=110	GT	0/1
chr1	38304425	38304425	C	T	exonic	MTF1	.	synonymous SNV	MTF1:NM_005955:exon4:c.G651A:p.L217L	0.991394717	0.0086052	8.29E-08	.	0.88579	0.09665	7.61E-05	53.98089172	88.53093	2.01737	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	95	chr1	38304425	chr1:38304425	C	T	.	PASS	AN=0;DP=95	GT	0/1
chr1	43888419	43888419	C	G	intronic	SZT2	.	.	.	1.52E-07	0.999999848	4.70E-20	.	.	0.09202	.	.	2151.43823	8.5294	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	117	695	chr1	43888419	chr1:43888419	C	G	117	PASS	AN=2;DP=695	GT	0/1
chr1	43888432	43888432	C	G	intronic	SZT2	.	.	.	1.52E-07	0.999999848	4.70E-20	.	.	0.09202	.	.	2151.43823	8.5294	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	81	607	chr1	43888432	chr1:43888432	C	G	81	PASS	AN=2;DP=607	GT	0/1
chr1	45981386	45981386	T	A	exonic	PRDX1	.	nonsynonymous SNV	PRDX1:NM_001202431:exon3:c.A200T:p.K67M,PRDX1:NM_002574:exon3:c.A200T:p.K67M,PRDX1:NM_181696:exon3:c.A200T:p.K67M,PRDX1:NM_181697:exon3:c.A200T:p.K67M	1.44E-07	0.06218816	0.937811696	.	0.84286	0.73165	-0.251530012	35.42108988	22.33675	0.75	0.001	0.784	D	0.391	0.328	B	0.393	0.425	B	0.000	0.843	D	1.000	0.810	D	3.55	0.934	H	1.35	0.346	T	-3.33	0.671	D	0.471	0.522	-0.700	0.605	T	0.186	0.536	T	0.028	0.507	D	5.765	0.788	27.0	0.994	0.636	0.906	0.517	D	c	0.413	0.472	1.000	0.747	0.672	0.522	0	5.9	0.949	2.323	0.432	1.056	0.757	1.000	0.715	1.000	0.888	11.373	0.488	Alkyl hydroperoxide reductase subunit C/ Thiol specific antioxidant|Thioredoxin-like fold	.	.	0.5	.	43	chr1	45981386	chr1:45981386	T	A	.	PASS	AN=0;DP=43	GT	0/1
chr1	45981387	45981387	T	A	exonic	PRDX1	.	stopgain	PRDX1:NM_001202431:exon3:c.A199T:p.K67X,PRDX1:NM_002574:exon3:c.A199T:p.K67X,PRDX1:NM_181696:exon3:c.A199T:p.K67X,PRDX1:NM_181697:exon3:c.A199T:p.K67X	1.44E-07	0.06218816	0.937811696	.	0.84286	0.73165	-0.251530012	35.42108988	22.33675	0.75	.	.	.	.	.	.	.	.	.	0.000	0.843	D	1	0.810	A	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	11.475	0.975	37	0.995	0.669	0.901	0.507	D	c	0.868	0.758	1.000	0.747	0.672	0.522	0	5.9	0.949	3.821	0.552	1.056	0.757	1.000	0.715	1.000	0.888	16.325	0.827	Alkyl hydroperoxide reductase subunit C/ Thiol specific antioxidant|Thioredoxin-like fold	.	.	0.5	.	43	chr1	45981387	chr1:45981387	T	A	.	PASS	AN=0;DP=43	GT	0/1
chr1	49201967	49201967	T	-	exonic	BEND5	.	frameshift deletion	BEND5:NM_001349793:exon4:c.545delA:p.K182Rfs*14,BEND5:NM_001302082:exon5:c.545delA:p.K182Rfs*14,BEND5:NM_024603:exon5:c.1052delA:p.K351Rfs*14,BEND5:NM_001349794:exon6:c.545delA:p.K182Rfs*14,BEND5:NM_001349795:exon7:c.797delA:p.K266Rfs*14	0.114990689	0.857716612	0.027292699	.	0.62579	0.11262	-0.271755481	34.31823543	38.21221	1.13413	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	44	51	chr1	49201966	chr1:49201966	CT	C	44	PASS	AN=2;DP=51	GT	0/1
chr1	50666911	50666911	G	A	UTR3	ELAVL4	NM_001324208:c.*61G>A;NM_001144777:c.*61G>A;NM_001144776:c.*61G>A;NM_001144775:c.*61G>A;NM_021952:c.*61G>A;NM_001324212:c.*61G>A;NM_001324209:c.*61G>A;NM_001144774:c.*61G>A;NM_001324214:c.*61G>A;NM_001324213:c.*61G>A;NM_001294348:c.*61G>A;NM_001324215:c.*61G>A	.	.	0.976912762	0.023064415	2.28E-05	.	0.68875	0.15149	-0.095386216	46.48502005	19.6708	0.67387	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	44	chr1	50666911	chr1:50666911	G	A	.	PASS	AN=0;DP=44	GT	0/1
chr1	55129405	55129405	G	T	ncRNA_intronic	MROH7-TTC4	.	.	.	.	.	.	.	.	.	.	.	6.75121	0.24928	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	57	chr1	55129405	chr1:55129405	G	T	.	PASS	AN=0;DP=57	GT	0/1
chr1	55277556	55277556	G	A	exonic	LEXM	.	synonymous SNV	LEXM:NM_001110533:exon5:c.G570A:p.E190E,LEXM:NM_152607:exon5:c.G570A:p.E190E	.	.	.	.	0.07116	0.08588	1.798708763	96.91554612	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	57	chr1	55277556	chr1:55277556	G	A	.	PASS	AN=0;DP=57	GT	0/1
chr1	92457938	92457938	T	-	intronic	BRDT	.	.	.	2.47E-06	0.999058891	0.000938637	.	0.14403	0.30507	0.782621089	87.25524888	2880.26845	10.16474	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	51	56	chr1	92457937	chr1:92457937	CT	C	51	PASS	AN=2;DP=56	GT	0/1
chr1	94544157	94544157	T	C	exonic	ABCA4	.	nonsynonymous SNV	ABCA4:NM_000350:exon10:c.A1345G:p.N449D	1.27E-28	0.894718807	0.105281193	DISEASE: Fundus flavimaculatus (FFM) [MIM:248200]: Autosomal recessive retinal disorder very similar to Stargardt disease. In contrast to Stargardt disease, FFM is characterized by later onset and slowly progressive course. {ECO:0000269|PubMed:11379881, ECO:0000269|PubMed:11385708, ECO:0000269|PubMed:9781034}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Macular degeneration, age-related, 2 (ARMD2) [MIM:153800]: A form of age-related macular degeneration, a multifactorial eye disease and the most common cause of irreversible vision loss in the developed world. In most patients, the disease is manifest as ophthalmoscopically visible yellowish accumulations of protein and lipid that lie beneath the retinal pigment epithelium and within an elastin-containing structure known as Bruch membrane. {ECO:0000269|PubMed:19028736, ECO:0000269|PubMed:9295268}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Cone-rod dystrophy 3 (CORD3) [MIM:604116]: An inherited retinal dystrophy characterized by retinal pigment deposits visible on fundus examination, predominantly in the macular region, and initial loss of cone photoreceptors followed by rod degeneration. This leads to decreased visual acuity and sensitivity in the central visual field, followed by loss of peripheral vision. Severe loss of vision occurs earlier than in retinitis pigmentosa. {ECO:0000269|PubMed:10958761, ECO:0000269|PubMed:11385708, ECO:0000269|PubMed:11527935}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Retinitis pigmentosa 19 (RP19) [MIM:601718]: A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well. RP19 is characterized by choroidal atrophy. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.09923	0.38763	0.736662821	86.30573248	3827.03692	12.16874	1.0	0.010	T	0.02	0.195	B	0.011	0.201	B	0.344	0.139	N	0.651	0.329	D	0.96	0.240	L	-1.92	0.848	D	-0.61	0.181	N	0.175	0.213	-1.056	0.127	T	0.125	0.430	T	0.057	0.668	D	0.650	0.156	8.499	0.634	0.070	0.867	0.457	D	c	-0.711	-0.536	0.780	0.238	0.554	0.283	0	0.265	0.148	0.472	0.217	0.961	0.567	0.996	0.391	1.000	0.888	5.991	0.186	.	.	.	0.5	.	80	chr1	94544157	chr1:94544157	T	C	.	PASS	AN=0;DP=80	GT	0/1
chr1	101487364	101487364	G	A	intronic	DPH5	.	.	.	0.001899435	0.904856554	0.093244011	.	0.5481	0.10207	0.3032669	72.009908	87.8002	2.00115	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	49	chr1	101487364	chr1:101487364	G	A	.	PASS	AN=0;DP=49	GT	0/1
chr1	103355050	103355050	G	A	exonic	COL11A1	.	synonymous SNV	COL11A1:NM_080630:exon57:c.C4077T:p.L1359L,COL11A1:NM_001190709:exon58:c.C4308T:p.L1436L,COL11A1:NM_001854:exon59:c.C4425T:p.L1475L,COL11A1:NM_080629:exon59:c.C4461T:p.L1487L	0.999980608	1.94E-05	6.79E-22	DISEASE: Stickler syndrome 2 (STL2) [MIM:604841]: An autosomal dominant form of Stickler syndrome, an inherited disorder that associates ocular signs with more or less complete forms of Pierre Robin sequence, bone disorders and sensorineural deafness. Ocular disorders may include juvenile cataract, myopia, strabismus, vitreoretinal or chorioretinal degeneration, retinal detachment, and chronic uveitis. Pierre Robin sequence includes an opening in the roof of the mouth (a cleft palate), a large tongue (macroglossia), and a small lower jaw (micrognathia). Bones are affected by slight platyspondylisis and large, often defective epiphyses. Juvenile joint laxity is followed by early signs of arthrosis. The degree of hearing loss varies among affected individuals and may become more severe over time. Syndrome expressivity is variable. {ECO:0000269|PubMed:20513134, ECO:0000269|PubMed:8872475}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Marshall syndrome (MRSHS) [MIM:154780]: An autosomal dominant disorder characterized by ocular abnormalities, deafness, craniofacial anomalies, and anhidrotic ectodermal dysplasia. Clinical features include short stature; flat or retruded midface with short, depressed nose, flat nasal bridge and anteverted nares; cleft palate with or without the Pierre Robin sequence; appearance of large eyes with ocular hypertelorism; cataracts, either congenital or juvenile; esotropia; high myopia; sensorineural hearing loss; spondyloepiphyseal abnormalities; calcification of the falx cerebri; ectodermal abnormalities, including defects in sweating and dental structures. {ECO:0000269|PubMed:10486316}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Fibrochondrogenesis 1 (FBCG1) [MIM:228520]: A severe short-limbed skeletal dysplasia characterized by broad long-bone metaphyses, pear-shaped vertebral bodies, and characteristic morphology of the growth plate, in which the chondrocytes have a fibroblastic appearance and there are regions of fibrous cartilage extracellular matrix. Clinical features include a flat midface with a small nose and anteverted nares, significant shortening of all limb segments but relatively normal hands and feet, and a small bell-shaped thorax with a protuberant abdomen. {ECO:0000269|PubMed:21035103}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.35429	0.34658	-0.360177779	28.64472753	7076.86232	18.07025	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	36	chr1	103355050	chr1:103355050	G	A	.	PASS	AN=0;DP=36	GT	0/1
chr1	108878690	108878690	C	T	intergenic	NBPF4;NBPF6	dist=91987;dist=114214	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	29	chr1	108878690	chr1:108878690	C	T	.	PASS	AN=0;DP=29	GT	0/1
chr1	112303170	112303170	G	A	exonic	DDX20	.	nonsynonymous SNV	DDX20:NM_007204:exon4:c.G640A:p.D214N	4.19E-07	0.819148759	0.180850822	.	0.1837	0.27351	1.734373503	96.61476763	3458.89491	11.30256	0.0	0.912	D	1.0	0.899	D	1.0	0.971	D	0.000	0.843	D	1	0.810	D	4.42	0.987	H	3.19	0.074	T	-4.76	0.803	D	0.291	0.353	-0.395	0.722	T	0.144	0.467	T	0.118	0.799	D	6.625	0.909	32	0.999	0.993	0.994	0.960	D	c	1.153	1.040	1.000	0.747	0.722	0.854	0	5.49	0.809	9.459	0.968	0.902	0.416	1.000	0.715	1.000	0.888	18.956	0.926	ATP-dependent RNA helicase DEAD-box, conserved site|DEAD/DEAH box helicase domain|Helicase superfamily 1/2, ATP-binding domain|P-loop containing nucleoside triphosphate hydrolase	.	.	0.5	.	22	chr1	112303170	chr1:112303170	G	A	.	PASS	AN=0;DP=22	GT	0/1
chr1	116202162	116202162	A	G	intronic	VANGL1	.	.	.	0.533615186	0.465704188	0.000680626	DISEASE: Sacral defect with anterior meningocele (SDAM) [MIM:600145]: Form of caudal dysgenesis. It is present at birth and becomes symptomatic later in life, usually because of obstructive labor in females, chronic constipation, or meningitis. Inheritance is autosomal dominant. {ECO:0000269|PubMed:17409324}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.1456	0.12678	-0.242430445	36.22906346	1019.35056	6.14174	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	66	37	chr1	116202162	chr1:116202162	A	G	66	PASS	AN=2;DP=37	GT	0/1
chr1	117078514	117078514	A	C	intronic	CD58	.	.	.	0.299199171	0.681299599	0.019501229	.	0.16155	0.20638	0.61555716	83.13871196	82.3264	1.92612	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	56	52	chr1	117078514	chr1:117078514	A	C	56	PASS	AN=2;DP=52	GT	0/1
chr1	155146419	155146419	G	-	UTR5	TRIM46	NM_001282378:c.-1998del-;NM_025058:c.-24del-;NM_001256600:c.-675del-;NM_001282379:c.-24del-;NM_001256599:c.-1449del-	.	.	0.998652125	0.00134787	4.43E-09	.	0.59864	0.14106	-0.843147538	11.2762444	131.25378	2.49537	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	42	60	chr1	155146418	chr1:155146418	AG	A	42	PASS	AN=2;DP=60	GT	0/1
chr1	159032487	159032487	T	-	exonic	AIM2	.	frameshift deletion	AIM2:NM_001348247:exon5:c.712delA:p.T238delinsHREVKRTNSSQLV,AIM2:NM_004833:exon6:c.1027delA:p.T343delinsHREVKRTNSSQLV	9.01E-08	0.089843818	0.910156092	.	0.0693	0.09293	0.038710339	56.92380278	212.89479	3.1502	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	42	13	chr1	159032486	chr1:159032486	GT	G	42	PASS	AN=2;DP=13	GT	0/1
chr1	168550446	168550446	T	C	exonic	XCL1	.	synonymous SNV	XCL1:NM_002995:exon3:c.T333C:p.T111T	0.088160228	0.763202188	0.148637583	.	0.0931	0.20536	0.725794416	85.98136353	269.25512	3.52005	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	71	57	chr1	168550446	chr1:168550446	T	C	71	PASS	AN=2;DP=57	GT	0/1
chr1	169101312	169101312	C	T	UTR3	ATP1B1	NM_001677:c.*519C>T	.	.	0.995564605	0.004434995	4.00E-07	.	0.38527	0.24812	-0.449946534	24.00330267	4.44425	0.16128	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	64	125	chr1	169101312	chr1:169101312	C	T	64	PASS	AN=2;DP=125	GT	0/1
chr1	176681114	176681114	C	T	exonic	PAPPA2	.	synonymous SNV	PAPPA2:NM_020318:exon12:c.C3795T:p.L1265L	0.001250054	0.998749823	1.23E-07	.	0.37518	0.11692	-1.49019634	3.615239443	422.84473	4.29432	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	35	chr1	176681114	chr1:176681114	C	T	.	PASS	AN=0;DP=35	GT	0/1
chr1	177113303	177113303	C	T	intronic	ASTN1	.	.	.	0.999415997	0.000584003	9.68E-13	.	0.12514	0.11666	-1.095046929	6.97688134	570.07336	4.84399	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	50	16	chr1	177113303	chr1:177113303	C	T	50	PASS	AN=2;DP=16	GT	0/1
chr1	180404392	180404392	T	-	intronic	ACBD6	.	.	.	0.064959259	0.920160983	0.014879758	.	0.46704	0.10684	-0.427900189	25.14744043	16.07879	0.56883	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	22.98	51	chr1	180404391	chr1:180404391	AT	A	22.98	PASS	AN=0;DP=51	GT	0/1
chr1	182569235	182569235	A	G	UTR3	RGS16	NM_002928:c.*192T>C	.	.	0.009002649	0.806646881	0.18435047	.	0.18324	0.13041	0.371224249	75.12384996	41.89157	1.22032	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	27	chr1	182569235	chr1:182569235	A	G	.	PASS	AN=0;DP=27	GT	0/1
chr1	198717397	198717397	G	A	intronic	PTPRC	.	.	.	0.999941156	5.88E-05	3.61E-15	DISEASE: Severe combined immunodeficiency autosomal recessive T- cell-negative/B-cell-positive/NK-cell-positive (T(-)B()NK() SCID) [MIM:608971]: A form of severe combined immunodeficiency (SCID), a genetically and clinically heterogeneous group of rare congenital disorders characterized by impairment of both humoral and cell-mediated immunity, leukopenia, and low or absent antibody levels. Patients present in infancy recurrent, persistent infections by opportunistic organisms. The common characteristic of all types of SCID is absence of T-cell-mediated cellular immunity due to a defect in T-cell development. {ECO:0000269|PubMed:11145714}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Multiple sclerosis (MS) [MIM:126200]: A multifactorial, inflammatory, demyelinating disease of the central nervous system. Sclerotic lesions are characterized by perivascular infiltration of monocytes and lymphocytes and appear as indurated areas in pathologic specimens (sclerosis in plaques). The pathological mechanism is regarded as an autoimmune attack of the myelin sheath, mediated by both cellular and humoral immunity. Clinical manifestations include visual loss, extra-ocular movement disorders, paresthesias, loss of sensation, weakness, dysarthria, spasticity, ataxia and bladder dysfunction. Genetic and environmental factors influence susceptibility to the disease. {ECO:0000269|PubMed:11101853}. Note=Disease susceptibility may be associated with variations affecting the gene represented in this entry.; 	0.17677	0.67006	0.231457213	68.57159707	71.3304	1.75714	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	22	chr1	198717397	chr1:198717397	G	A	.	PASS	AN=0;DP=22	GT	0/1
chr1	200939424	200939498	AGGCCACACATCCCCAGACAGGCAGCAGGGCTGGACAGCTGAGGGTGAAGAGATTCCTAGGCTGAATCCAGGGTG	-	UTR3	KIF21B	NM_001252102:c.*3225_*3151delCACCCTGGATTCAGCCTAGGAATCTCTTCACCCTCAGCTGTCCAGCCCTGCTGCCTGTCTGGGGATGTGTGGCCT;NM_001252103:c.*3225_*3151delCACCCTGGATTCAGCCTAGGAATCTCTTCACCCTCAGCTGTCCAGCCCTGCTGCCTGTCTGGGGATGTGTGGCCT;NM_017596:c.*3799_*3725delCACCCTGGATTCAGCCTAGGAATCTCTTCACCCTCAGCTGTCCAGCCCTGCTGCCTGTCTGGGGATGTGTGGCCT;NM_001252100:c.*3799_*3725delCACCCTGGATTCAGCCTAGGAATCTCTTCACCCTCAGCTGTCCAGCCCTGCTGCCTGTCTGGGGATGTGTGGCCT	.	.	0.99941409	0.00058591	3.31E-16	.	0.7728	0.1193	-2.914589271	0.577966502	413.35583	4.25806	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	13.1	23	chr1	200939423	chr1:200939423	CAGGCCACACATCCCCAGACAGGCAGCAGGGCTGGACAGCTGAGGGTGAAGAGATTCCTAGGCTGAATCCAGGGTG	C	13.1	PASS	AN=0;DP=23	GT	0/1
chr1	217784432	217784432	C	-	intronic	GPATCH2	.	.	.	9.66E-05	0.986025695	0.013877705	.	0.35805	.	0.108486928	61.90728946	309.35921	3.7445	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	55	39	chr1	217784431	chr1:217784431	AC	A	55	PASS	AN=2;DP=39	GT	0/1
chr1	227786186	227786186	T	A	intronic	ZNF678	.	.	.	4.67E-07	0.222084042	0.777915492	.	0.19605	.	.	.	258.61102	3.45659	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	33	chr1	227786186	chr1:227786186	T	A	.	PASS	AN=0;DP=33	GT	0/1
chr1	237850692	237850692	C	T	intronic	RYR2	.	.	.	0.999999934	6.56E-08	1.25E-37	DISEASE: Arrhythmogenic right ventricular dysplasia, familial, 2 (ARVD2) [MIM:600996]: A congenital heart disease characterized by infiltration of adipose and fibrous tissue into the right ventricle and loss of myocardial cells, resulting in ventricular and supraventricular arrhythmias. {ECO:0000269|PubMed:11159936}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Ventricular tachycardia, catecholaminergic polymorphic, 1, with or without atrial dysfunction and/or dilated cardiomyopathy (CPVT1) [MIM:604772]: An arrhythmogenic disorder characterized by stress-induced, bidirectional ventricular tachycardia that may degenerate into cardiac arrest and cause sudden death. Patients present with recurrent syncope, seizures, or sudden death after physical activity or emotional stress. {ECO:0000269|PubMed:11157710, ECO:0000269|PubMed:12093772, ECO:0000269|PubMed:12106942, ECO:0000269|PubMed:15046072, ECO:0000269|PubMed:15046073, ECO:0000269|PubMed:15466642, ECO:0000269|PubMed:15544015}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.27314	0.27889	-5.869562633	0.053078556	1401.64962	6.99815	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	27	chr1	237850692	chr1:237850692	C	T	.	PASS	AN=0;DP=27	GT	0/1
chr1	237924231	237924231	T	-	intronic	RYR2	.	.	.	0.999999934	6.56E-08	1.25E-37	DISEASE: Arrhythmogenic right ventricular dysplasia, familial, 2 (ARVD2) [MIM:600996]: A congenital heart disease characterized by infiltration of adipose and fibrous tissue into the right ventricle and loss of myocardial cells, resulting in ventricular and supraventricular arrhythmias. {ECO:0000269|PubMed:11159936}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Ventricular tachycardia, catecholaminergic polymorphic, 1, with or without atrial dysfunction and/or dilated cardiomyopathy (CPVT1) [MIM:604772]: An arrhythmogenic disorder characterized by stress-induced, bidirectional ventricular tachycardia that may degenerate into cardiac arrest and cause sudden death. Patients present with recurrent syncope, seizures, or sudden death after physical activity or emotional stress. {ECO:0000269|PubMed:11157710, ECO:0000269|PubMed:12093772, ECO:0000269|PubMed:12106942, ECO:0000269|PubMed:15046072, ECO:0000269|PubMed:15046073, ECO:0000269|PubMed:15466642, ECO:0000269|PubMed:15544015}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.27314	0.27889	-5.869562633	0.053078556	1401.64962	6.99815	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	41	10	chr1	237924230	chr1:237924230	GT	G	41	PASS	AN=2;DP=10	GT	0/1
chr1	243736308	243736308	G	A	exonic	AKT3	.	nonsynonymous SNV	AKT3:NM_005465:exon8:c.C739T:p.R247C,AKT3:NM_181690:exon8:c.C739T:p.R247C,AKT3:NM_001206729:exon9:c.C739T:p.R247C	0.999585399	0.0004146	1.24E-09	DISEASE: Note=AKT3 is a key modulator of several tumors like melanoma, glioma and ovarian cancer. Active AKT3 increases progressively during melanoma tumor progression with highest levels present in advanced-stage metastatic melanomas. Promotes melanoma tumorigenesis by decreasing apoptosis. Plays a key role in the genesis of ovarian cancers through modulation of G2/M phase transition. With AKT2, plays a pivotal role in the biology of glioblastoma.; DISEASE: Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 2 (MPPH2) [MIM:615937]: A syndrome characterized by megalencephaly, hydrocephalus, and polymicrogyria; polydactyly may also be seen. There is considerable phenotypic similarity between this disorder and the megalencephaly-capillary malformation syndrome. {ECO:0000269|PubMed:22500628, ECO:0000269|PubMed:22729223, ECO:0000269|PubMed:22729224}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.51738	0.24974	-0.251530012	35.42108988	6.85051	0.25446	0.0	0.912	D	1.0	0.899	D	0.999	0.916	D	0.000	0.843	D	1	0.810	D	1.385	0.346	L	-0.2	0.661	T	-7.48	0.950	D	0.905	0.906	-0.389	0.724	T	0.345	0.710	T	0.037	0.574	D	7.311	0.948	34	0.999	0.999	0.930	0.568	D	c	0.799	0.828	1.000	0.747	0.706	0.609	0	5.87	0.942	7.996	0.879	1.048	0.713	1.000	0.715	1.000	0.888	14.980	0.708	Protein kinase domain|Protein kinase-like domain|Serine/threonine/dual specificity protein kinase, catalytic  domain	.	.	0.5	.	32	chr1	243736308	chr1:243736308	G	A	.	PASS	AN=0;DP=32	GT	0/1
chr1	248224489	248224489	A	G	exonic	OR2L3	.	nonsynonymous SNV	OR2L3:NM_001004687:exon1:c.A506G:p.Q169R	6.39E-05	0.283107845	0.716828238	.	0.04593	0.09315	1.128108522	92.19155461	2290.45899	8.85807	0.692	0.043	T	0.0	0.026	B	0.002	0.063	B	0.540	0.053	N	1	0.090	P	-1.23	0.008	N	1.26	0.363	T	1.25	0.010	N	0.036	0.016	-0.982	0.347	T	0.000	0.000	T	.	.	.	-4.554	0.000	0.001	0.237	0.010	0.000	0.004	N	c	-2.905	-2.917	0.062	0.153	0.487	0.133	0	-4.11	0.036	-2.003	0.015	-4.200	0.000	0.000	0.063	0.000	0.016	7.548	0.268	GPCR, rhodopsin-like, 7TM	.	.	0.5	56	12	chr1	248224489	chr1:248224489	A	G	56	PASS	AN=2;DP=12	GT	0/1
chr2	30482653	30482653	C	G	UTR3	LBH	NM_030915:c.*2166C>G	.	.	0.300590032	0.622552463	0.076857505	.	0.1442	.	-0.007201372	53.19061099	187.45852	2.97403	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	40	18	chr2	30482653	chr2:30482653	C	G	40	PASS	AN=2;DP=18	GT	0/1
chr2	32733267	32733267	C	A	exonic	BIRC6	.	synonymous SNV	BIRC6:NM_016252:exon51:c.C9921A:p.T3307T	1	4.09E-15	2.21E-43	.	0.23071	0.09582	-4.329772159	0.106157113	518.6518	4.65379	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	59	chr2	32733267	chr2:32733267	C	A	.	PASS	AN=0;DP=59	GT	0/1
chr2	37276876	37276876	C	T	exonic	HEATR5B	.	synonymous SNV	HEATR5B:NM_019024:exon18:c.G2616A:p.A872A	8.10E-10	0.999999998	7.48E-10	.	0.25312	.	-2.513844451	0.914130691	1161.22267	6.48464	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	48	chr2	37276876	chr2:37276876	C	T	.	PASS	AN=0;DP=48	GT	0/1
chr2	37276980	37276980	C	G	exonic	HEATR5B	.	nonsynonymous SNV	HEATR5B:NM_019024:exon18:c.G2512C:p.A838P	8.10E-10	0.999999998	7.48E-10	.	0.25312	.	-2.513844451	0.914130691	1161.22267	6.48464	0.011	0.555	D	0.998	0.715	D	0.976	0.719	D	0.000	0.843	D	1	0.810	D	2.52	0.738	M	3.1	0.083	T	-3.2	0.647	D	0.879	0.916	-1.169	0.005	T	0.066	0.274	T	0.031	0.530	D	4.839	0.650	24.8	0.998	0.866	0.990	0.891	D	c	0.719	0.706	1.000	0.747	0.719	0.830	0	5.19	0.713	7.333	0.783	0.802	0.324	1.000	0.715	0.994	0.587	18.694	0.915	Armadillo-like helical|Armadillo-type fold	.	.	0.5	.	34	chr2	37276980	chr2:37276980	C	G	.	PASS	AN=0;DP=34	GT	0/1
chr2	39964136	39964137	TG	-	exonic	THUMPD2	.	frameshift deletion	THUMPD2:NM_001321479:exon9:c.548_549del:p.T183Rfs*1,THUMPD2:NM_001321469:exon10:c.971_972del:p.T324Rfs*1,THUMPD2:NM_001321470:exon10:c.923_924del:p.T308Rfs*1,THUMPD2:NM_025264:exon10:c.1250_1251del:p.T417Rfs*1,THUMPD2:NM_001321477:exon11:c.548_549del:p.T183Rfs*1,THUMPD2:NM_001321478:exon11:c.548_549del:p.T183Rfs*1,THUMPD2:NM_001321480:exon11:c.548_549del:p.T183Rfs*1,THUMPD2:NM_001321481:exon11:c.548_549del:p.T183Rfs*1	1.94E-08	0.241386498	0.758613483	.	0.10863	0.098	-0.578583623	18.71903751	235.39647	3.31568	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	43	56	chr2	39964135	chr2:39964135	CTG	C	43	PASS	AN=2;DP=56	GT	0/1
chr2	55193935	55194035	GGATGAGAAGAAAGATGGGAAAATGGCCTGCTGTTGTTGTCATGGGCTGGCCATAGGCTTTGCAGCCTGGAGCTGAGCTTGGGTTTGGAGAAAAGCCCTAG	-	intronic	EML6	.	.	.	0.443032449	0.455367432	0.10160012	.	.	.	-0.613589782	17.49823071	281.49654	3.59206	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	50	40	chr2	55193934	chr2:55193934	TGGATGAGAAGAAAGATGGGAAAATGGCCTGCTGTTGTTGTCATGGGCTGGCCATAGGCTTTGCAGCCTGGAGCTGAGCTTGGGTTTGGAGAAAAGCCCTAG	T	50	PASS	AN=2;DP=40	GT	0/1
chr2	58359058	58359131	AACAAAGTACAAATTTTCAAGTATTTCATCATGTACTGCACCAGGTCTGAAGGGATACATTAAAGGGAGCTAAC	-	exonic	VRK2	.	nonframeshift deletion	VRK2:NM_001288839:exon8:c.438_443del:p.K146_T147del,VRK2:NM_001130480:exon9:c.792_797del:p.K264_T265del,VRK2:NM_001130481:exon9:c.792_797del:p.K264_T265del,VRK2:NM_001130482:exon9:c.723_728del:p.K241_T242del,VRK2:NM_001130483:exon9:c.792_797del:p.K264_T265del,VRK2:NM_006296:exon9:c.792_797del:p.K264_T265del,VRK2:NM_001288836:exon10:c.438_443del:p.K146_T147del,VRK2:NM_001288838:exon11:c.792_797del:p.K264_T265del,VRK2:NM_001288837:exon12:c.792_797del:p.K264_T265del	1.22E-08	0.549410088	0.450589899	.	0.13255	0.0962	0.066214104	58.95848077	3255.28139	10.86391	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	58	18	chr2	58359057	chr2:58359057	AAACAAAGTACAAATTTTCAAGTATTTCATCATGTACTGCACCAGGTCTGAAGGGATACATTAAAGGGAGCTAAC	A	58	PASS	AN=2;DP=18	GT	0/1
chr2	60687371	60687371	G	A	UTR3	BCL11A	NM_022893:c.*168C>T	.	.	0.828999685	0.170844975	0.00015534	DISEASE: Note=Chromosomal aberrations involving BCL11A may be a cause of lymphoid malignancies. Translocation t(2;14)(p13;q32.3) causes BCL11A deregulation and amplification. {ECO:0000269|PubMed:11719382}.; 	0.66876	0.16967	-1.155457828	6.168907761	22.77118	0.7611	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	36	chr2	60687371	chr2:60687371	G	A	.	PASS	AN=0;DP=36	GT	0/1
chr2	69472576	69472576	G	A	exonic	ANTXR1	.	nonsynonymous SNV	ANTXR1:NM_032208:exon18:c.G1654A:p.A552T	0.985283203	0.014716734	6.25E-08	DISEASE: Hemangioma, capillary infantile (HCI) [MIM:602089]: A condition characterized by dull red, firm, dome-shaped hemangiomas, sharply demarcated from surrounding skin, usually presenting at birth or occurring within the first two or three months of life. They result from highly proliferative, localized growth of capillary endothelium and generally undergo regression and involution without scarring. {ECO:0000269|PubMed:18931684}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: GAPO syndrome (GAPO) [MIM:230740]: A disease characterized by growth retardation, alopecia, failure of tooth eruption, and progressive optic atrophy in some patients. {ECO:0000269|PubMed:23602711}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.51987	0.13588	-0.909290275	10.03184713	205.61691	3.09642	0.009	0.574	D	0.001	0.067	B	0.003	0.080	B	0.048	0.232	N	0.890	0.359	D	.	.	.	1.25	0.365	T	-1.05	0.275	N	0.261	0.318	-1.016	0.252	T	0.089	0.343	T	0.030	0.526	D	3.906	0.526	23.5	0.850	0.151	0.926	0.558	D	c	-0.086	0.034	1.000	0.747	0.615	0.372	0	4.43	0.528	5.323	0.654	0.902	0.416	1.000	0.715	0.984	0.507	14.883	0.701	.	.	.	0.5	.	142	chr2	69472576	chr2:69472576	G	A	.	PASS	AN=0;DP=142	GT	0/1
chr2	74303470	74303470	C	T	intronic	TET3	.	.	.	0.999942651	5.73E-05	1.00E-11	.	0.85759	0.1031	-1.512251235	3.479594244	432.06015	4.33811	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	50	chr2	74303470	chr2:74303470	C	T	.	PASS	AN=0;DP=50	GT	0/1
chr2	74763924	74763924	C	-	exonic	LOXL3	.	frameshift deletion	LOXL3:NM_032603:exon5:c.824delG:p.G275Afs*4	5.65E-08	0.991443691	0.008556252	.	0.36983	0.16108	0.003714825	54.06935598	1582.47535	7.35746	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	44	41	chr2	74763923	chr2:74763923	GC	G	44	PASS	AN=2;DP=41	GT	0/1
chr2	103343382	103343382	G	A	exonic	MFSD9	.	synonymous SNV	MFSD9:NM_001322080:exon4:c.C166T:p.L56L,MFSD9:NM_001322081:exon4:c.C166T:p.L56L,MFSD9:NM_032718:exon4:c.C349T:p.L117L	7.72E-06	0.501855498	0.498136782	.	0.10254	.	0.380318343	75.63104506	710.21598	5.29472	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	34	chr2	103343382	chr2:103343382	G	A	.	PASS	AN=0;DP=34	GT	0/1
chr2	103343394	103343394	G	A	exonic	MFSD9	.	synonymous SNV	MFSD9:NM_001322080:exon4:c.C154T:p.L52L,MFSD9:NM_001322081:exon4:c.C154T:p.L52L,MFSD9:NM_032718:exon4:c.C337T:p.L113L	7.72E-06	0.501855498	0.498136782	.	0.10254	.	0.380318343	75.63104506	710.21598	5.29472	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	34	chr2	103343394	chr2:103343394	G	A	.	PASS	AN=0;DP=34	GT	0/1
chr2	109239403	109239403	G	C	intronic	LIMS1	.	.	.	0.347565207	0.649601345	0.002833447	.	0.85268	0.14897	.	.	138.63474	2.56496	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	44	67	chr2	109239403	chr2:109239403	G	C	44	PASS	AN=2;DP=67	GT	0/1
chr2	120831655	120831655	T	-	intronic	EPB41L5	.	.	.	0.022933841	0.977065093	1.07E-06	.	0.19351	0.09111	0.04598748	57.47817882	253.06645	3.42227	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	44	17	chr2	120831654	chr2:120831654	CT	C	44	PASS	AN=2;DP=17	GT	0/1
chr2	131827434	131827434	T	-	intronic	FAM168B	.	.	.	0.043771494	0.849524038	0.106704469	.	.	.	-0.185391282	39.67916962	20.93895	0.70903	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	79	43	chr2	131827433	chr2:131827433	CT	C	79	PASS	AN=2;DP=43	GT	0/1
chr2	165630224	165630224	C	T	intronic	COBLL1	.	.	.	0.012197364	0.987736419	6.62E-05	.	0.60988	0.08604	0.409650696	76.53927813	2197.61027	8.6319	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	25	chr2	165630224	chr2:165630224	C	T	.	PASS	AN=0;DP=25	GT	0/1
chr2	171793186	171793186	G	T	intronic	GORASP2	.	.	.	0.89106444	0.108888812	4.67E-05	.	0.30609	0.14799	-0.26993514	34.59542345	529.4287	4.69614	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	39	30	chr2	171793186	chr2:171793186	G	T	39	PASS	AN=2;DP=30	GT	0/1
chr2	203676526	203676526	A	-	intronic	ICA1L	.	.	.	0.442027586	0.557692446	0.000279968	.	0.12377	.	0.373041938	75.29488087	125.08262	2.43349	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	56	18	chr2	203676525	chr2:203676525	CA	C	56	PASS	AN=2;DP=18	GT	0/1
chr2	217541463	217541463	G	A	UTR3	IGFBP5	NM_000599:c.*11C>T	.	.	0.85997835	0.137886185	0.002135465	.	0.65909	0.31908	.	.	128.68174	2.47216	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	50	chr2	217541463	chr2:217541463	G	A	.	PASS	AN=0;DP=50	GT	0/1
chr2	232673465	232673465	C	T	UTR3	COPS7B	NM_001282949:c.*1110C>T;NM_001282951:c.*1110C>T;NM_022730:c.*1110C>T;NM_001282952:c.*1110C>T;NM_001282950:c.*1136C>T;NM_001308381:c.*1136C>T	.	.	0.207502332	0.783128198	0.00936947	.	0.49504	0.08191	-0.117432389	44.89266336	59.3707	1.56192	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	87	chr2	232673465	chr2:232673465	C	T	.	PASS	AN=0;DP=87	GT	0/1
chr2	234094429	234094429	G	A	intronic	INPP5D	.	.	.	0.167430841	0.832564139	5.02E-06	.	.	0.1054	.	.	1963.99989	8.16671	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	34	chr2	234094429	chr2:234094429	G	A	.	PASS	AN=0;DP=34	GT	0/1
chr2	238275344	238275344	G	-	exonic	COL6A3	.	frameshift deletion	COL6A3:NM_057166:exon8:c.3665delC:p.T1222Mfs*10,COL6A3:NM_057167:exon10:c.4868delC:p.T1623Mfs*10,COL6A3:NM_004369:exon11:c.5486delC:p.T1829Mfs*10	7.79E-11	1	1.79E-10	DISEASE: Bethlem myopathy 1 (BTHLM1) [MIM:158810]: A benign proximal myopathy characterized by early childhood onset and joint contractures most frequently affecting the elbows and ankles. {ECO:0000269|PubMed:10399756, ECO:0000269|PubMed:15689448, ECO:0000269|PubMed:17886299, ECO:0000269|PubMed:9536084}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Ullrich congenital muscular dystrophy 1 (UCMD1) [MIM:254090]: A congenital myopathy characterized by muscle weakness and multiple joint contractures, generally noted at birth or early infancy. The clinical course is more severe than in Bethlem myopathy. {ECO:0000269|PubMed:15689448}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Dystonia 27 (DYT27) [MIM:616411]: A form of dystonia, a disorder defined by the presence of sustained involuntary muscle contraction, often leading to abnormal postures. DYT27 is an autosomal recessive form characterized by segmental isolated dystonia involving the face, neck, bulbar muscles, and upper limbs. {ECO:0000269|PubMed:26004199}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.93588	0.40359	-2.550505158	0.861052135	5032.39412	14.4934	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	25.79	35	chr2	238275343	chr2:238275343	AG	A	25.79	PASS	AN=0;DP=35	GT	0/1
chr2	238672174	238672174	G	A	exonic	LRRFIP1	.	synonymous SNV	LRRFIP1:NM_001137553:exon8:c.G1650A:p.K550K,LRRFIP1:NM_004735:exon10:c.G1746A:p.K582K,LRRFIP1:NM_001137552:exon11:c.G1818A:p.K606K	0.36551249	0.633984856	0.000502654	.	0.11014	0.08981	0.609894095	82.95588582	1129.28257	6.41308	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	58	21	chr2	238672174	chr2:238672174	G	A	58	PASS	AN=2;DP=21	GT	0/1
chr2	242263784	242263784	A	C	intronic	SEPT2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	73	chr2	242263784	chr2:242263784	A	C	.	PASS	AN=0;DP=73	GT	0/1
chr3	4738994	4738994	T	A	intronic	ITPR1	.	.	.	1	5.90E-12	3.24E-32	DISEASE: Spinocerebellar ataxia 15 (SCA15) [MIM:606658]: Spinocerebellar ataxia is a clinically and genetically heterogeneous group of cerebellar disorders. Patients show progressive incoordination of gait and often poor coordination of hands, speech and eye movements, due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCA15 is an autosomal dominant cerebellar ataxia (ADCA). It is very slow progressing form with a wide range of onset, ranging from childhood to adult. Most patients remain ambulatory. {ECO:0000269|PubMed:17590087, ECO:0000269|PubMed:18579805}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Spinocerebellar ataxia 29 (SCA29) [MIM:117360]: An autosomal dominant, congenital spinocerebellar ataxia characterized by early motor delay, hypotonia and mild cognitive delay. Affected individuals develop a very slowly progressive or non-progressive gait and limb ataxia associated with cerebellar atrophy on brain imaging. Additional variable features include nystagmus, dysarthria, and tremor. {ECO:0000269|PubMed:22986007}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.48957	0.4536	-3.352519381	0.401037981	228.28209	3.26405	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	50	123	chr3	4738994	chr3:4738994	T	A	50	PASS	AN=2;DP=123	GT	0/1
chr3	10367959	10367959	A	G	UTR3	ATP2B2	NM_001683:c.*2539T>C;NM_001330611:c.*2898T>C;NM_001001331:c.*2539T>C	.	.	0.999921506	7.85E-05	8.79E-13	.	0.69922	0.18045	-1.943881244	1.893135173	96.26442	2.12107	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	80	30	chr3	10367959	chr3:10367959	A	G	80	PASS	AN=2;DP=30	GT	0/1
chr3	38040542	38040542	G	A	splicing	VILL	NM_015873:exon9:c.1081+1G>A	.	.	3.01E-12	0.679546705	0.320453295	.	0.36993	0.1181	-1.502810938	3.573956122	1844.77155	7.92187	.	.	.	.	.	.	.	.	.	.	.	.	0.992	0.239	N	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.775	0.168	9.311	0.763	0.110	0.553	0.296	D	c	0.227	-0.096	1.000	0.747	0.163	0.030	0	1.98	0.252	2.983	0.488	-0.541	0.048	0.993	0.376	0.000	0.016	9.694	0.391	.	.	.	0.5	.	108	chr3	38040542	chr3:38040542	G	A	.	PASS	AN=0;DP=108	GT	0/1
chr3	38040547	38040547	C	T	intronic	VILL	.	.	.	3.01E-12	0.679546705	0.320453295	.	0.36993	0.1181	-1.502810938	3.573956122	1844.77155	7.92187	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	106	chr3	38040547	chr3:38040547	C	T	.	PASS	AN=0;DP=106	GT	0/1
chr3	47460085	47460085	C	T	intronic	SCAP	.	.	.	0.02255475	0.977439846	5.40E-06	.	0.05282	0.16079	-2.188305787	1.391837698	3410.40993	11.19013	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	79	chr3	47460085	chr3:47460085	C	T	.	PASS	AN=0;DP=79	GT	0/1
chr3	53529170	53529170	T	-	UTR5	CACNA1D	NM_001128839:c.-24del-;NM_000720:c.-24del-;NM_001128840:c.-24del-	.	.	1	1.06E-11	1.34E-31	DISEASE: Sinoatrial node dysfunction and deafness (SANDD) [MIM:614896]: A disease characterized by congenital severe to profound deafness without vestibular dysfunction, associated with episodic syncope due to intermittent pronounced bradycardia. {ECO:0000269|PubMed:21131953}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Primary aldosteronism, seizures, and neurologic abnormalities (PASNA) [MIM:615474]: A disorder characterized by hypertension, hypokalemia, and high aldosterone levels with low plasma renin activity and an elevated aldosterone/renin ratio. Other features include generalized seizures, cerebral palsy, spasticity, intellectual disability, and developmental delay. {ECO:0000269|PubMed:23913001}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.53996	0.14577	-3.512328228	0.324368955	728.73949	5.35831	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	70	127	chr3	53529169	chr3:53529169	GT	G	70	PASS	AN=2;DP=127	GT	0/1
chr3	122078589	122078589	G	C	UTR3	CCDC58	NM_001017928:c.*127C>G;NM_001308326:c.*127C>G	.	.	0.080276122	0.872108394	0.047615484	.	0.59208	0.11262	-0.09720619	46.20193442	9.0286	0.33094	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	59	98	chr3	122078589	chr3:122078589	G	C	59	PASS	AN=2;DP=98	GT	0/1
chr3	122078800	122078800	G	A	intronic	CCDC58	.	.	.	0.080276122	0.872108394	0.047615484	.	0.59208	0.11262	-0.09720619	46.20193442	9.0286	0.33094	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	37	chr3	122078800	chr3:122078800	G	A	.	PASS	AN=0;DP=37	GT	0/1
chr3	132221198	132221199	AC	-	exonic	DNAJC13	.	frameshift deletion	DNAJC13:NM_015268:exon40:c.4602_4603del:p.Q1535Dfs*17,DNAJC13:NM_001329126:exon41:c.4617_4618del:p.Q1540Dfs*17	1	3.18E-10	4.43E-30	DISEASE: Parkinson disease 21 (PARK21) [MIM:616361]: An autosomal dominant form of adult-onset Parkinson disease, a complex neurodegenerative disorder characterized by bradykinesia, resting tremor, muscular rigidity and postural instability, as well as by a clinically significant response to treatment with levodopa. The pathology involves the loss of dopaminergic neurons in the substantia nigra and the presence of Lewy bodies (intraneuronal accumulations of aggregated proteins), in surviving neurons in various areas of the brain. {ECO:0000269|PubMed:24218364}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.41777	0.13911	0.17442557	65.77022883	851.5822	5.70174	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	19.14	36	chr3	132221197	chr3:132221197	TAC	T	19.14	PASS	AN=0;DP=36	GT	0/1
chr3	137890399	137890399	T	-	intronic	DBR1	.	.	.	8.71E-05	0.930719935	0.069193013	.	0.26524	0.11154	-0.466531444	23.51380042	128.83429	2.47412	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	14.43	23	chr3	137890398	chr3:137890398	GT	G	14.43	PASS	AN=0;DP=23	GT	0/1
chr3	141905409	141905409	C	T	intronic	GK5	.	.	.	0.519887601	0.480081245	3.12E-05	.	0.11834	0.10568	-0.582225231	18.44184949	25.18144	0.82292	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	40	chr3	141905409	chr3:141905409	C	T	.	PASS	AN=0;DP=40	GT	0/1
chr3	169381231	169381231	C	T	UTR5	MECOM	NM_001205194:c.-531966G>A;NM_004991:c.-71G>A	.	.	0.999085313	0.000914686	3.49E-10	DISEASE: Note=A chromosomal aberration involving EVI1 is a cause of chronic myelogenous leukemia (CML). Translocation t(3;21)(q26;q22) with RUNX1/AML1. {ECO:0000269|PubMed:8313895}.; 	0.47994	0.30246	-0.993849454	8.56334041	1129.59722	6.41503	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	147	chr3	169381231	chr3:169381231	C	T	.	PASS	AN=0;DP=147	GT	0/1
chr3	170727779	170727781	ATT	-	exonic	SLC2A2	.	nonframeshift deletion	SLC2A2:NM_001278658:exon3:c.105_107del:p.I36del,SLC2A2:NM_000340:exon4:c.462_464del:p.I155del	7.53E-05	0.98036244	0.019562243	DISEASE: Fanconi-Bickel syndrome (FBS) [MIM:227810]: Rare, well- defined clinical entity, inherited in an autosomal recessive mode and characterized by hepatorenal glycogen accumulation, proximal renal tubular dysfunction, and impaired utilization of glucose and galactose. {ECO:0000269|PubMed:10987651, ECO:0000269|PubMed:11044475}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.54341	0.73053	-0.224023033	37.4321774	1965.19505	8.16817	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	13.23	73	chr3	170727778	chr3:170727778	AATT	A	13.23	PASS	AN=0;DP=73	GT	0/1
chr3	184289032	184289032	T	G	intronic	EPHB3	.	.	.	0.956539592	0.043460371	3.73E-08	.	0.42115	0.22788	-2.677226852	0.731304553	89.15737	2.02905	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	43	58	chr3	184289032	chr3:184289032	T	G	43	PASS	AN=2;DP=58	GT	0/1
chr3	186917751	186917751	C	G	exonic	RTP1	.	nonsynonymous SNV	RTP1:NM_153708:exon2:c.C685G:p.Q229E	0.563829726	0.423951854	0.01221842	.	0.79035	0.11684	0.064394823	58.84642604	2341.27335	8.96348	1.0	0.010	T	0.0	0.026	B	0.0	0.013	B	0.003	0.351	N	1	0.090	P	0.55	0.145	N	1.62	0.282	T	-0.48	0.154	N	0.056	0.039	-0.976	0.358	T	0.000	0.000	T	.	.	.	0.084	0.102	3.442	0.622	0.067	0.018	0.056	N	c	-0.780	-0.618	0.910	0.263	0.615	0.372	0	5.74	0.900	1.719	0.374	0.133	0.217	0.528	0.269	0.580	0.285	12.993	0.579	.	ENSG00000198491.3|ENSG00000175077.5	Artery_Aorta|Nerve_Tibial	0.5	53	12	chr3	186917751	chr3:186917751	C	G	53	PASS	AN=2;DP=12	GT	0/1
chr4	1107119	1107119	C	T	intronic	RNF212	.	.	.	0.125225584	0.869720008	0.005054408	.	0.13995	.	.	.	166.87321	2.82299	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	122	chr4	1107119	chr4:1107119	C	T	.	PASS	AN=0;DP=122	GT	0/1
chr4	25315781	25315781	G	A	exonic	ZCCHC4	.	nonsynonymous SNV	ZCCHC4:NM_001318148:exon2:c.G241A:p.E81K,ZCCHC4:NM_024936:exon2:c.G241A:p.E81K	3.22E-05	0.986356163	0.013611642	.	0.1632	0.09095	1.798708763	96.91554612	690.84581	5.24094	0.051	0.393	T	0.999	0.764	D	0.982	0.739	D	0.000	0.843	D	1	0.810	D	2.47	0.719	M	1.84	0.247	T	-2.45	0.535	N	0.642	0.663	-0.978	0.355	T	0.155	0.486	T	0.014	0.337	T	7.141	0.943	34	0.999	0.988	0.939	0.592	D	c	0.855	0.862	1.000	0.747	0.660	0.490	0	5.77	0.910	9.313	0.953	0.953	0.551	1.000	0.715	1.000	0.888	18.772	0.918	Zinc finger, GRF-type	.	.	0.5	.	37	chr4	25315781	chr4:25315781	G	A	.	PASS	AN=0;DP=37	GT	0/1
chr4	37947218	37947218	G	A	intronic	TBC1D1	.	.	.	3.94E-08	0.9998784	0.00012156	.	0.16285	0.20642	0.009173042	54.15782024	2012.94334	8.2609	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	55	chr4	37947218	chr4:37947218	G	A	.	PASS	AN=0;DP=55	GT	0/1
chr4	55130041	55130041	C	T	exonic	PDGFRA	.	nonsynonymous SNV	PDGFRA:NM_001347827:exon4:c.C575T:p.T192I,PDGFRA:NM_001347829:exon4:c.C575T:p.T192I,PDGFRA:NM_001347830:exon4:c.C614T:p.T205I,PDGFRA:NM_006206:exon4:c.C575T:p.T192I,PDGFRA:NM_001347828:exon5:c.C650T:p.T217I	0.99987673	0.00012327	5.34E-13	DISEASE: Note=A chromosomal aberration involving PDGFRA is found in some cases of hypereosinophilic syndrome. Interstitial chromosomal deletion del(4)(q12q12) causes the fusion of FIP1L1 and PDGFRA (FIP1L1-PDGFRA). Mutations that cause overexpression and/or constitutive activation of PDGFRA may be a cause of hypereosinophilic syndrome. {ECO:0000269|PubMed:12808148}.; DISEASE: Gastrointestinal stromal tumor (GIST) [MIM:606764]: Common mesenchymal neoplasms arising in the gastrointestinal tract, most often in the stomach. They are histologically, immunohistochemically, and genetically different from typical leiomyomas, leiomyosarcomas, and schwannomas. Most GISTs are composed of a fairly uniform population of spindle-shaped cells. Some tumors are dominated by epithelioid cells or contain a mixture of spindle and epithelioid morphologies. Primary GISTs in the gastrointestinal tract commonly metastasize in the omentum and mesenteries, often as multiple nodules. However, primary tumors may also occur outside of the gastrointestinal tract, in other intra-abdominal locations, especially in the omentum and mesentery. {ECO:0000269|PubMed:12522257, ECO:0000269|PubMed:15928335}. Note=The gene represented in this entry may be involved in disease pathogenesis. Mutations causing PDGFRA constitutive activation have been found in gastrointestinal stromal tumors lacking KIT mutations (PubMed:12522257). {ECO:0000269|PubMed:12522257}.; 	0.96377	0.1167	-0.635637306	16.76102854	599.71226	4.95653	0.204	0.200	T	0.001	0.192	B	0.002	0.236	B	0.005	0.328	U	1.000	0.195	N	1.9	0.507	L	3.47	0.052	T	-1.62	0.518	N	0.311	0.372	-0.998	0.306	T	0.018	0.077	T	0.011	0.276	T	1.684	0.263	14.32	0.803	0.127	0.046	0.101	N	c	-0.568	-0.511	0.997	0.350	0.598	0.340	0	2.97	0.333	0.369	0.200	0.069	0.176	0.000	0.063	0.204	0.218	9.131	0.358	Immunoglobulin-like domain|Immunoglobulin-like fold	.	.	0.5	50	35	chr4	55130041	chr4:55130041	C	T	50	PASS	AN=2;DP=35	GT	0/1
chr4	84519902	84519902	C	T	intronic	GPAT3	.	.	.	.	.	.	.	0.13125	0.11511	-0.089927255	46.99221515	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	99	chr4	84519902	chr4:84519902	C	T	.	PASS	AN=0;DP=99	GT	0/1
chr4	86396732	86396732	G	A	intronic	ARHGAP24	.	.	.	0.004696081	0.995038485	0.000265435	.	0.39284	0.12435	-0.617221851	17.44515216	242.67907	3.36262	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	38	chr4	86396732	chr4:86396732	G	A	.	PASS	AN=0;DP=38	GT	0/1
chr4	100009921	100009921	G	A	UTR5	ADH5	NM_000671:c.-70C>T	.	.	9.11E-07	0.313157521	0.686841567	.	0.26363	0.34407	0.193034296	66.82000472	62.29801	1.61087	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	58	109	chr4	100009921	chr4:100009921	G	A	58	PASS	AN=2;DP=109	GT	0/1
chr4	113681900	113681900	C	T	intergenic	LARP7;ANK2	dist=103152;dist=57339	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	22	chr4	113681900	chr4:113681900	C	T	.	PASS	AN=0;DP=22	GT	0/1
chr4	134071880	134071880	G	A	exonic	PCDH10	.	synonymous SNV	PCDH10:NM_020815:exon1:c.G585A:p.A195A,PCDH10:NM_032961:exon1:c.G585A:p.A195A	0.894430213	0.105568021	1.77E-06	.	0.58985	0.10504	-1.240018202	5.461193678	95.22371	2.1059	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	46	chr4	134071880	chr4:134071880	G	A	.	PASS	AN=0;DP=46	GT	0/1
chr4	140291505	140291505	G	A	exonic	NAA15	.	nonsynonymous SNV	NAA15:NM_057175:exon15:c.G1894A:p.D632N	0.99857684	0.00142316	2.07E-10	.	0.9902	0.19761	-0.890882376	10.30313753	36.48516	1.09367	0.146	0.250	T	0.011	0.147	B	0.053	0.243	B	0.035	0.247	N	1	0.810	D	2.38	0.688	M	0.98	0.421	T	-1.56	0.377	N	0.16	0.192	-1.025	0.221	T	0.129	0.439	T	0.014	0.343	T	5.568	0.757	26.4	0.999	0.940	0.993	0.941	D	c	0.232	0.418	1.000	0.747	0.732	0.924	0	5.77	0.910	9.406	0.966	1.048	0.713	1.000	0.715	0.999	0.750	19.599	0.955	.	.	.	0.5	.	26	chr4	140291505	chr4:140291505	G	A	.	PASS	AN=0;DP=26	GT	0/1
chr4	169048922	169048922	C	T	intronic	ANXA10	.	.	.	1.28E-08	0.561130781	0.438869206	.	.	0.09365	0.817616644	87.95116773	140.03091	2.58142	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	62	chr4	169048922	chr4:169048922	C	T	.	PASS	AN=0;DP=62	GT	0/1
chr4	187518071	187518071	C	A	exonic	FAT1	.	nonsynonymous SNV	FAT1:NM_005245:exon25:c.G12623T:p.R4208L	1.78E-10	1	5.46E-11	.	0.43649	0.17117	-0.392997457	27.05826846	12587.77428	24.10511	0.01	0.564	D	0.61	0.377	P	0.082	0.276	B	0.006	0.322	N	0.995	0.233	N	1.995	0.543	M	-0.69	0.727	T	-1.57	0.379	N	0.235	0.288	-0.804	0.549	T	0.214	0.575	T	0.039	0.588	D	3.440	0.471	23.0	0.949	0.251	0.630	0.317	D	c	-0.508	-0.559	0.929	0.269	0.707	0.730	0	2.07	0.259	1.413	0.341	-0.328	0.075	0.232	0.244	0.003	0.074	8.717	0.334	.	.	.	0.5	.	40	chr4	187518071	chr4:187518071	C	A	.	PASS	AN=0;DP=40	GT	0/1
chr5	482225	482225	G	A	exonic	SLC9A3	.	synonymous SNV	SLC9A3:NM_001284351:exon8:c.C1377T:p.S459S,SLC9A3:NM_004174:exon8:c.C1404T:p.S468S	0.988153998	0.011845965	3.67E-08	.	0.13048	0.0991	-1.785892633	2.25878745	215.86732	3.17181	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	29	chr5	482225	chr5:482225	G	A	.	PASS	AN=0;DP=29	GT	0/1
chr5	17498289	17498289	A	G	intergenic	LINC02218;LINC02223	dist=14234;dist=309094	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	74	230	chr5	17498289	chr5:17498289	A	G	74	PASS	AN=2;DP=230	GT	0/1
chr5	31435976	31435976	A	-	intronic	DROSHA	.	.	.	0.996399648	0.003600352	2.77E-14	.	0.60911	0.25509	-0.461076406	23.66124086	2101.94263	8.44322	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	63	11	chr5	31435975	chr5:31435975	CA	C	63	PASS	AN=2;DP=11	GT	0/1
chr5	37036545	37036546	AT	-	exonic	NIPBL	.	frameshift deletion	NIPBL:NM_015384:exon33:c.5927_5928del:p.D1976Efs*3,NIPBL:NM_133433:exon33:c.5927_5928del:p.D1976Efs*2	1	9.20E-18	1.38E-43	DISEASE: Cornelia de Lange syndrome 1 (CDLS1) [MIM:122470]: A form of Cornelia de Lange syndrome, a clinically heterogeneous developmental disorder associated with malformations affecting multiple systems. Characterized by facial dysmorphisms, abnormal hands and feet, growth delay, cognitive retardation, hirsutism, gastroesophageal dysfunction and cardiac, ophthalmologic and genitourinary anomalies. {ECO:0000269|PubMed:15146185, ECO:0000269|PubMed:15146186, ECO:0000269|PubMed:15318302, ECO:0000269|PubMed:20124326, ECO:0000269|PubMed:20358602, ECO:0000269|PubMed:21934712, ECO:0000269|PubMed:23254390, ECO:0000269|PubMed:25447906}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.94334	0.10487	-2.44943873	1.014390186	759.33568	5.46172	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	60	118	chr5	37036544	chr5:37036544	GAT	G	60	PASS	AN=2;DP=118	GT	0/1
chr5	50055533	50055533	C	G	exonic	PARP8	.	nonsynonymous SNV	PARP8:NM_001178056:exon4:c.C241G:p.P81A,PARP8:NM_001331028:exon4:c.C178G:p.P60A,PARP8:NM_024615:exon4:c.C241G:p.P81A,PARP8:NM_001178055:exon5:c.C241G:p.P81A	0.119242934	0.880756988	7.77E-08	.	0.35408	.	-0.911109353	9.961075725	112.79172	2.31004	0.011	0.564	D	0.996	0.670	D	0.981	0.736	D	0.000	0.843	D	1.000	0.810	D	0.345	0.112	N	.	.	.	-1.05	0.916	N	0.595	0.723	-0.722	0.594	T	0.250	0.619	T	0.008	0.220	T	3.513	0.480	23.1	0.995	0.664	0.857	0.446	D	c	0.489	0.526	1.000	0.747	0.706	0.609	0	5.31	0.750	2.945	0.485	0.935	0.490	1.000	0.715	1.000	0.888	16.84	0.858	.	.	.	0.5	79	68	chr5	50055533	chr5:50055533	C	G	79	PASS	AN=2;DP=68	GT	0/1
chr5	68396765	68396765	G	-	intronic	SLC30A5	.	.	.	0.230512232	0.769423834	6.39E-05	.	0.61924	0.13187	-0.088107893	47.06298655	141.89318	2.60037	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	61	16	chr5	68396764	chr5:68396764	TG	T	61	PASS	AN=2;DP=16	GT	0/1
chr5	72204842	72204842	C	A	UTR3	TNPO1	NM_002270:c.*342C>A;NM_153188:c.*342C>A	.	.	0.999998701	1.30E-06	9.85E-16	.	0.97077	0.18297	-0.780646273	12.77423921	36.30496	1.0871	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	27	chr5	72204842	chr5:72204842	C	A	.	PASS	AN=0;DP=27	GT	0/1
chr5	96513395	96513399	AAAGC	-	intronic	RIOK2	.	.	.	0.001140112	0.988993674	0.009866214	.	0.64042	0.09168	1.065596954	91.61358811	3638.14552	11.71409	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	58	21	chr5	96513394	chr5:96513394	TAAAGC	T	58	PASS	AN=2;DP=21	GT	0/1
chr5	112175279	112175279	C	T	exonic	APC	.	nonsynonymous SNV	APC:NM_001127511:exon14:c.C3934T:p.P1312S,APC:NM_000038:exon16:c.C3988T:p.P1330S,APC:NM_001127510:exon17:c.C3988T:p.P1330S	0.999999928	7.23E-08	1.20E-23	DISEASE: Familial adenomatous polyposis (FAP) [MIM:175100]: A cancer predisposition syndrome characterized by adenomatous polyps of the colon and rectum, but also of upper gastrointestinal tract (ampullary, duodenal and gastric adenomas). This is a viciously premalignant disease with one or more polyps progressing through dysplasia to malignancy in untreated gene carriers with a median age at diagnosis of 40 years. {ECO:0000269|PubMed:10470088, ECO:0000269|PubMed:1338691, ECO:0000269|PubMed:1338764, ECO:0000269|PubMed:1338904, ECO:0000269|PubMed:1651563, ECO:0000269|PubMed:7833149, ECO:0000269|PubMed:7833931, ECO:0000269|PubMed:8990002}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Hereditary desmoid disease (HDD) [MIM:135290]: Autosomal dominant trait with 100% penetrance and possible variable expression among affected relatives. HDD patients show multifocal fibromatosis of the paraspinal muscles, breast, occiput, arms, lower ribs, abdominal wall, and mesentery. Desmoid tumors appears also as a complication of familial adenomatous polyposis. {ECO:0000269|PubMed:10782927, ECO:0000269|PubMed:8940264}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Medulloblastoma (MDB) [MIM:155255]: Malignant, invasive embryonal tumor of the cerebellum with a preferential manifestation in children. {ECO:0000269|PubMed:10666372}. Note=The gene represented in this entry may be involved in disease pathogenesis.; DISEASE: Mismatch repair cancer syndrome (MMRCS) [MIM:276300]: An autosomal recessive, rare, childhood cancer predisposition syndrome encompassing a broad tumor spectrum. This includes hematological malignancies, central nervous system tumors, Lynch syndrome-associated malignancies such as colorectal tumors as well as multiple intestinal polyps, embryonic tumors and rhabdomyosarcoma. Multiple cafe-au-lait macules, a feature reminiscent of neurofibromatosis type 1, are often found as first manifestation of the underlying cancer. Areas of skin hypopigmentation have also been reported in MMRCS patients. {ECO:0000269|PubMed:7661930}. Note=The gene represented in this entry may be involved in disease pathogenesis.; DISEASE: Gastric cancer (GASC) [MIM:613659]: A malignant disease which starts in the stomach, can spread to the esophagus or the small intestine, and can extend through the stomach wall to nearby lymph nodes and organs. It also can metastasize to other parts of the body. The term gastric cancer or gastric carcinoma refers to adenocarcinoma of the stomach that accounts for most of all gastric malignant tumors. Two main histologic types are recognized, diffuse type and intestinal type carcinomas. Diffuse tumors are poorly differentiated infiltrating lesions, resulting in thickening of the stomach. In contrast, intestinal tumors are usually exophytic, often ulcerating, and associated with intestinal metaplasia of the stomach, most often observed in sporadic disease. Note=The gene represented in this entry may be involved in disease pathogenesis.; DISEASE: Hepatocellular carcinoma (HCC) [MIM:114550]: A primary malignant neoplasm of epithelial liver cells. The major risk factors for HCC are chronic hepatitis B virus (HBV) infection, chronic hepatitis C virus (HCV) infection, prolonged dietary aflatoxin exposure, alcoholic cirrhosis, and cirrhosis due to other causes. Note=The gene represented in this entry may be involved in disease pathogenesis.; 	0.53216	0.57092	-2.523543479	0.902335456	395.17068	4.17713	0.532	0.070	T	0.0	0.026	B	0.0	0.013	B	0.836	0.091	N	1	0.090	N	0	0.065	N	-2.47	0.890	D	-2.3	0.511	N	0.05	0.080	-0.787	0.559	T	0.356	0.719	T	0.062	0.688	D	-1.816	0.011	0.002	0.814	0.132	0.566	0.299	D	c	-1.319	-1.272	0.011	0.121	0.707	0.730	0	-4.0	0.038	1.156	0.311	-1.032	0.021	0.517	0.269	0.006	0.095	9.433	0.376	.	.	.	0.5	.	34	chr5	112175279	chr5:112175279	C	T	.	PASS	AN=0;DP=34	GT	0/1
chr5	115628156	115628157	TA	-	exonic	COMMD10	.	frameshift deletion	COMMD10:NM_001308080:exon7:c.537_538del:p.I180Tfs*56,COMMD10:NM_016144:exon7:c.579_580del:p.I194Tfs*56	7.84E-06	0.301803272	0.698188891	.	0.2446	0.1102	0.193034296	66.82000472	893.61877	5.82649	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	44	18	chr5	115628155	chr5:115628155	CTA	C	44	PASS	AN=2;DP=18	GT	0/1
chr5	138718948	138718948	G	A	UTR5	SLC23A1	NM_152685:c.-6C>T;NM_005847:c.-6C>T	.	.	0.024322306	0.972818626	0.002859068	.	0.15514	0.14852	0.266447942	70.5826846	399.62426	4.19635	0.502	0.077	T	.	.	.	.	.	.	.	.	.	1.000	0.201	N	.	.	.	.	.	.	0.64	0.024	N	0.1	0.103	-1.017	0.247	T	0.034	0.145	T	.	.	.	1.738	0.270	14.63	0.970	0.315	0.426	0.267	N	c	-0.372	-0.415	1.000	0.747	0.660	0.495	0	1.08	0.194	1.060	0.299	0.154	0.240	0.737	0.288	0.995	0.604	1.435	0.022	.	.	.	0.5	.	64	chr5	138718948	chr5:138718948	G	A	.	PASS	AN=0;DP=64	GT	0/1
chr5	138718965	138718965	G	A	UTR5	SLC23A1	NM_152685:c.-23C>T;NM_005847:c.-23C>T	.	.	0.024322306	0.972818626	0.002859068	.	0.15514	0.14852	0.266447942	70.5826846	399.62426	4.19635	0.006	0.614	D	.	.	.	.	.	.	.	.	.	1	0.810	D	.	.	.	.	.	.	-0.66	0.191	N	0.064	0.049	-0.745	0.582	T	0.229	0.594	T	.	.	.	1.582	0.252	13.75	0.995	0.692	0.790	0.388	D	c	0.029	0.038	1.000	0.747	0.421	0.056	0	4.15	0.478	2.812	0.474	0.154	0.240	0.823	0.298	0.923	0.397	8.439	0.318	.	.	.	0.5	.	69	chr5	138718965	chr5:138718965	G	A	.	PASS	AN=0;DP=69	GT	0/1
chr5	147474010	147474010	C	T	exonic	SPINK5	.	nonsynonymous SNV	SPINK5:NM_001127698:exon9:c.C760T:p.H254Y,SPINK5:NM_001127699:exon9:c.C760T:p.H254Y,SPINK5:NM_006846:exon9:c.C760T:p.H254Y	2.12E-17	0.920781311	0.079218689	DISEASE: Netherton syndrome (NETH) [MIM:256500]: An autosomal recessive congenital ichthyosis associated with hair shaft abnormalities and anomalies of the immune system. Typical features are ichthyosis linearis circumflexa, ichthyosiform erythroderma, trichorrhexis invaginata (bamboo hair), atopic dermatitis, and hayfever. High postnatal mortality is due to failure to thrive, infections and hypernatremic dehydration. {ECO:0000269|PubMed:10835624}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.2529	0.29285	2.831581484	99.08586931	18873.47781	29.29597	0.136	0.457	T	0.541	0.493	P	0.434	0.676	B	0.000	0.537	D	0.761	0.295	N	0.845	0.213	L	5.14	0.012	T	0.8	0.033	N	0.797	0.787	-0.977	0.357	T	0.008	0.028	T	0.015	0.353	T	5.885	0.807	27.4	0.991	0.520	0.696	0.340	D	c	0.041	0.153	0.999	0.390	0.615	0.372	0	5.04	0.672	2.764	0.470	0.852	0.362	1.000	0.715	1.000	0.888	14.256	0.655	Kazal domain	.	.	0.5	.	38	chr5	147474010	chr5:147474010	C	T	.	PASS	AN=0;DP=38	GT	0/1
chr5	148683326	148683335	GAAATTAATA	-	intronic	AFAP1L1	.	.	.	4.07E-08	0.986445947	0.013554012	.	0.09622	0.10351	-0.124924535	44.10238264	344.87064	3.93917	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	11.09	19	chr5	148683325	chr5:148683325	GGAAATTAATA	G	11.09	PASS	AN=0;DP=19	GT	0/1
chr5	171710717	171710719	CCG	-	UTR5	UBTD2	NM_152277:c.-48_-50delCGG	.	.	0.748758502	0.241081607	0.010159892	.	0.39637	0.11262	0.125076652	62.7388535	49.28609	1.37266	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	43	9	chr5	171710716	chr5:171710716	CCCG	C	43	PASS	AN=2;DP=9	GT	0/1
chr5	179041835	179041835	C	T	UTR3	HNRNPH1	NM_005520:c.*126G>A;NM_001257293:c.*126G>A	.	.	0.999148294	0.000851699	7.16E-09	.	0.83563	.	-0.273576253	33.97027601	18.26126	0.63463	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	33	chr5	179041835	chr5:179041835	C	T	.	PASS	AN=0;DP=33	GT	0/1
chr5	179762959	179762959	T	-	intronic	GFPT2	.	.	.	6.63E-07	0.993862342	0.006136996	.	0.72946	0.28603	-0.819281839	11.93677754	1696.47592	7.59462	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	13.37	29	chr5	179762958	chr5:179762958	AT	A	13.37	PASS	AN=0;DP=29	GT	0/1
chr6	10532046	10532046	G	T	intronic	GCNT2	.	.	.	0.019397722	0.900537076	0.080065202	DISEASE: Cataract 13, with adult i phenotype (CTRCT13) [MIM:116700]: An opacification of the crystalline lens of the eye that frequently results in visual impairment or blindness. Opacities vary in morphology, are often confined to a portion of the lens, and may be static or progressive. In general, the more posteriorly located and dense an opacity, the greater the impact on visual function. CTRCT13 is associated with the rare adult i phenotype, in which adult red blood cells are rich in i antigen and contain low levels of I antigen. {ECO:0000269|PubMed:11739194}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.21275	0.15862	-1.300731691	4.948100967	83.70152	1.94658	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	25	chr6	10532046	chr6:10532046	G	T	.	PASS	AN=0;DP=25	GT	0/1
chr6	25426693	25426693	C	G	intronic	CARMIL1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	61	60	chr6	25426693	chr6:25426693	C	G	61	PASS	AN=2;DP=60	GT	0/1
chr6	26368343	26368343	T	G	intronic	BTN3A2	.	.	.	0.000124519	0.840379954	0.159495527	.	0.06491	0.07172	0.795569043	87.49115357	1740.69093	7.70186	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	53	10	chr6	26368343	chr6:26368343	T	G	53	PASS	AN=2;DP=10	GT	0/1
chr6	26422353	26422353	C	T	ncRNA_exonic	BTN2A3P	.	.	.	.	.	.	.	0.08337	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	79	chr6	26422353	chr6:26422353	C	T	.	PASS	AN=0;DP=79	GT	0/1
chr6	35262831	35262831	A	-	intronic	ZNF76	.	.	.	5.07E-16	0.006453546	0.993546454	.	0.26454	0.10496	0.404185162	76.48619958	1199.49311	6.56948	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	53	54	chr6	35262830	chr6:35262830	CA	C	53	PASS	AN=2;DP=54	GT	0/1
chr6	44274142	44274144	AGA	-	intronic	AARS2	.	.	.	1.65E-07	0.999922899	7.69E-05	DISEASE: Combined oxidative phosphorylation deficiency 8 (COXPD8) [MIM:614096]: A mitochondrial disease characterized by a lethal infantile hypertrophic cardiomyopathy, generalized muscle dysfunction and some neurologic involvement. The liver is not affected. {ECO:0000269|PubMed:21549344}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Leukoencephalopathy, progressive, with ovarian failure (LKENP) [MIM:615889]: An autosomal recessive neurodegenerative disorder characterized by childhood- to adulthood-onset of signs of neurologic deterioration consisting of ataxia, spasticity, and cognitive decline with features of frontal lobe dysfunction. Brain MRI shows leukoencephalopathy with striking involvement of deep white matter, and cerebellar atrophy. All female patients develop premature ovarian failure. {ECO:0000269|PubMed:24808023}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.143	0.11236	1.14268501	92.37438075	592.72341	4.93503	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	85	21	chr6	44274141	chr6:44274141	GAGA	G	85	PASS	AN=2;DP=21	GT	0/1
chr6	45390255	45390255	C	G	intronic	RUNX2	.	.	.	0.995958899	0.004040782	3.19E-07	DISEASE: Cleidocranial dysplasia (CLCD) [MIM:119600]: Autosomal dominant skeletal disorder with high penetrance and variable expressivity. It is due to defective endochondral and intramembranous bone formation. Typical features include hypoplasia/aplasia of clavicles, patent fontanelles, wormian bones (additional cranial plates caused by abnormal ossification of the calvaria), supernumerary teeth, short stature, and other skeletal changes. In some cases defects in RUNX2 are exclusively associated with dental anomalies. {ECO:0000269|PubMed:10521292, ECO:0000269|PubMed:10545612, ECO:0000269|PubMed:10689183, ECO:0000269|PubMed:10980549, ECO:0000269|PubMed:11857736, ECO:0000269|PubMed:12081718, ECO:0000269|PubMed:12196916, ECO:0000269|PubMed:12424590, ECO:0000269|PubMed:16270353, ECO:0000269|PubMed:19744171, ECO:0000269|PubMed:20082269, ECO:0000269|PubMed:20648631, ECO:0000269|PubMed:9182765, ECO:0000269|PubMed:9207800}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Metaphyseal dysplasia with maxillary hypoplasia with or without brachydactyly (MDMHB) [MIM:156510]: An autosomal dominant bone dysplasia characterized by metaphyseal flaring of long bones, enlargement of the medial halves of the clavicles, maxillary hypoplasia, variable brachydactyly, and dystrophic teeth. {ECO:0000269|PubMed:23290074}. Note=The disease is caused by mutations affecting the gene represented in this entry. Analysis for copy-number variations revealed that a 105 kb duplication within RUNX2 segregated with the MDMHB phenotype in a region with maximum linkage. Real-time PCR for copy-number variation in genomic DNA in eight samples, as well as sequence analysis of fibroblast cDNA from one subject with MDMHB confirmed that affected family members were heterozygous for the presence of an intragenic duplication encompassing exons 3 to 5 of RUNX2. These three exons code for the Q/A domain and the functionally essential DNA-binding Runt domain of RUNX2. The RUNX2 duplication found in individuals with MDMHB leads to a gain of function (PubMed:23290074). {ECO:0000269|PubMed:23290074}.; 	0.53349	0.8758	-0.446304853	24.33356924	87.92892	2.00467	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	81	445	chr6	45390255	chr6:45390255	C	G	81	PASS	AN=2;DP=445	GT	0/1
chr6	56626502	56626502	-	A	intronic	DST	.	.	.	1	9.56E-15	4.08E-50	DISEASE: Neuropathy, hereditary sensory and autonomic, 6 (HSAN6) [MIM:614653]: A form of hereditary sensory and autonomic neuropathy, a genetically and clinically heterogeneous group of disorders characterized by degeneration of dorsal root and autonomic ganglion cells, and by sensory and/or autonomic abnormalities. HSAN6 is a severe autosomal recessive disorder characterized by neonatal hypotonia, respiratory and feeding difficulties, lack of psychomotor development, and autonomic abnormalities including labile cardiovascular function, lack of corneal reflexes leading to corneal scarring, areflexia, and absent axonal flare response after intradermal histamine injection. {ECO:0000269|PubMed:22522446}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Epidermolysis bullosa simplex, autosomal recessive 2 (EBSB2) [MIM:615425]: A form of epidermolysis bullosa, a dermatologic disorder characterized by localized blistering on the dorsal, lateral and plantar surfaces of the feet. EBSB2 is characterized by trauma-induced blistering mainly occurring on the feet and ankles. Ultrastructural analysis of skin biopsy shows abnormal hemidesmosomes with poorly formed inner plaques. {ECO:0000269|PubMed:20164846, ECO:0000269|PubMed:22113475}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.87634	0.40727	-0.532709792	20.70653456	9099.85464	20.71216	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	11.84	31	chr6	56626502	chr6:56626502	T	TA	11.84	PASS	AN=0;DP=31	GT	0/1
chr6	91296568	91296570	GAG	-	exonic	MAP3K7	.	nonframeshift deletion	MAP3K7:NM_003188:exon1:c.33_35del:p.S14del,MAP3K7:NM_145331:exon1:c.33_35del:p.S14del,MAP3K7:NM_145332:exon1:c.33_35del:p.S14del,MAP3K7:NM_145333:exon1:c.33_35del:p.S14del	0.998336232	0.001663766	1.50E-09	.	0.79955	0.33817	-0.427900189	25.14744043	14.73281	0.53078	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	54	29	chr6	91296567	chr6:91296567	CGAG	C	54	PASS	AN=2;DP=29	GT	0/1
chr6	111701463	111701463	T	-	intronic	REV3L	.	.	.	1	6.81E-14	7.45E-35	.	0.85968	0.1947	-2.097226344	1.551073366	1709.50934	7.62408	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	44	15	chr6	111701462	chr6:111701462	CT	C	44	PASS	AN=2;DP=15	GT	0/1
chr6	126075618	126075618	C	T	exonic	HEY2	.	nonsynonymous SNV	HEY2:NM_012259:exon4:c.C254T:p.A85V	0.444357733	0.549107414	0.006534853	.	0.37195	0.17951	-0.404032746	26.53338051	218.50627	3.19585	0.002	0.721	D	0.563	0.365	P	0.632	0.500	P	0.000	0.843	D	1	0.810	D	0.895	0.225	L	-4.62	0.979	D	-3.36	0.665	D	0.816	0.805	0.939	0.962	D	0.880	0.960	D	0.328	0.917	D	5.430	0.736	26.1	0.999	0.973	0.984	0.822	D	c	0.457	0.589	1.0	0.983	0.706	0.609	0	5.96	0.967	7.568	0.814	0.935	0.490	1.000	0.715	0.999	0.750	20.414	0.990	Myc-type, basic helix-loop-helix (bHLH) domain	.	.	0.5	.	29	chr6	126075618	chr6:126075618	C	T	.	PASS	AN=0;DP=29	GT	0/1
chr6	130387489	130387489	C	T	intronic	L3MBTL3	.	.	.	0.999498723	0.000501277	8.05E-11	.	0.63431	0.09837	-0.777005578	12.9747582	66.98885	1.69207	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	42	chr6	130387489	chr6:130387489	C	T	.	PASS	AN=0;DP=42	GT	0/1
chr6	134212885	134212885	G	A	exonic	TCF21	.	nonsynonymous SNV	TCF21:NM_003206:exon2:c.G485A:p.S162N,TCF21:NM_198392:exon2:c.G485A:p.S162N	0.805369944	0.189537108	0.005092948	.	0.50048	0.24689	0.25917371	70.05779665	477.84739	4.51344	0.789	0.032	T	0.0	0.026	B	0.0	0.013	B	0.001	0.437	N	0.966	0.259	N	-0.405	0.030	N	-3.94	0.961	D	-0.09	0.084	N	0.017	0.004	-0.679	0.615	T	0.312	0.683	T	0.040	0.592	D	0.972	0.187	10.50	0.938	0.232	0.713	0.347	D	c	-0.635	-0.401	1.000	0.500	0.598	0.340	0	2.85	0.322	0.542	0.228	0.154	0.240	0.998	0.411	1.000	0.888	9.156	0.360	.	.	.	0.5	.	226	chr6	134212885	chr6:134212885	G	A	.	PASS	AN=0;DP=226	GT	0/1
chr6	143746939	143746939	C	A	UTR3	ADAT2	NM_182503:c.*2661G>T;NM_001286259:c.*2661G>T	.	.	2.09E-08	0.073719475	0.926280504	.	0.33152	0.15545	0.193034296	66.82000472	44.95237	1.2876	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	218	chr6	143746939	chr6:143746939	C	A	.	PASS	AN=0;DP=218	GT	0/1
chr6	159191717	159191720	GTGG	-	intronic	EZR	.	.	.	0.98811019	0.011889627	1.83E-07	.	0.64339	0.72105	-1.197736472	5.785562633	62.54234	1.61602	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	42	15	chr6	159191716	chr6:159191716	AGTGG	A	42	PASS	AN=2;DP=15	GT	0/1
chr6	163991839	163991839	C	T	UTR3	QKI	NM_001301085:c.*97C>T;NM_206855:c.*7062C>T;NM_206854:c.*6097C>T;NM_206853:c.*4836C>T;NM_006775:c.*97C>T	.	.	0.963163356	0.036821914	1.47E-05	.	0.28593	0.19768	-0.229483771	36.86010852	6.7048	0.2474	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	39	chr6	163991839	chr6:163991839	C	T	.	PASS	AN=0;DP=39	GT	0/1
chr7	2686639	2686639	C	T	exonic	TTYH3	.	synonymous SNV	TTYH3:NM_025250:exon2:c.C276T:p.I92I	0.979598759	0.02039783	3.41E-06	.	0.20673	0.13236	-0.354480518	29.42911064	106.07775	2.23473	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	87	chr7	2686639	chr7:2686639	C	T	.	PASS	AN=0;DP=87	GT	0/1
chr7	6647756	6647756	C	A	exonic	C7orf26	.	synonymous SNV	C7orf26:NM_024067:exon6:c.C1314A:p.I438I,C7orf26:NM_001303039:exon7:c.C1023A:p.I341I	0.82656656	0.172642585	0.000790855	.	0.15371	0.10416	-0.336073593	30.55555556	176.14971	2.8877	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	68	chr7	6647756	chr7:6647756	C	A	.	PASS	AN=0;DP=68	GT	0/1
chr7	21583121	21583121	C	T	exonic	DNAH11	.	synonymous SNV	DNAH11:NM_001277115:exon1:c.C258T:p.N86N	.	.	.	DISEASE: Kartagener syndrome (KTGS) [MIM:244400]: An autosomal recessive disorder characterized by the association of primary ciliary dyskinesia with situs inversus. Clinical features include recurrent respiratory infections, bronchiectasis, infertility, and lateral transposition of the viscera of the thorax and abdomen. The situs inversus is most often total, although it can be partial in some cases (isolated dextrocardia or isolated transposition of abdominal viscera). {ECO:0000269|PubMed:12142464, ECO:0000269|PubMed:18022865, ECO:0000269|PubMed:25186273}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Ciliary dyskinesia, primary, 7 (CILD7) [MIM:611884]: A disorder characterized by abnormalities of motile cilia. Respiratory infections leading to chronic inflammation and bronchiectasis are recurrent, due to defects in the respiratory cilia; reduced fertility is often observed in male patients due to abnormalities of sperm tails. Half of the patients exhibit randomization of left-right body asymmetry and situs inversus, due to dysfunction of monocilia at the embryonic node. Primary ciliary dyskinesia associated with situs inversus is referred to as Kartagener syndrome. {ECO:0000269|PubMed:12142464, ECO:0000269|PubMed:18022865}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.12513	0.12171	.	.	20704.35568	30.36052	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	57	chr7	21583121	chr7:21583121	C	T	.	PASS	AN=0;DP=57	GT	0/1
chr7	26883762	26883762	A	-	intronic	SKAP2	.	.	.	0.909797278	0.090174061	2.87E-05	.	0.82035	0.26241	0.17280645	65.75843359	1007.31849	6.11261	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	18.44	23	chr7	26883761	chr7:26883761	TA	T	18.44	PASS	AN=0;DP=23	GT	0/1
chr7	44664014	44664014	A	G	exonic	OGDH	.	synonymous SNV	OGDH:NM_001003941:exon2:c.A72G:p.S24S,OGDH:NM_001165036:exon2:c.A72G:p.S24S,OGDH:NM_002541:exon2:c.A72G:p.S24S	0.993695121	0.006304878	3.21E-10	.	0.54935	0.63558	-0.484940685	22.75300778	342.2782	3.9227	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	79	94	chr7	44664014	chr7:44664014	A	G	79	PASS	AN=2;DP=94	GT	0/1
chr7	56129429	56129429	G	T	intronic	CCT6A	.	.	.	0.998661755	0.001338223	2.15E-08	.	0.24693	0.43796	-0.291981272	33.20358575	345.9113	3.94523	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	91	chr7	56129429	chr7:56129429	G	T	.	PASS	AN=0;DP=91	GT	0/1
chr7	69064959	69064959	C	-	intronic	AUTS2	.	.	.	0.996187482	0.003812518	9.39E-11	.	0.83083	0.1075	-1.967739992	1.816466148	320.02805	3.80007	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	43	18	chr7	69064958	chr7:69064958	AC	A	43	PASS	AN=2;DP=18	GT	0/1
chr7	92855652	92855652	G	A	intronic	HEPACAM2	.	.	.	8.71E-09	0.157127629	0.842872362	.	.	0.09316	0.639420866	83.8995046	181.19055	2.92629	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	25	chr7	92855652	chr7:92855652	G	A	.	PASS	AN=0;DP=25	GT	0/1
chr7	128249582	128249582	T	-	intergenic	METTL2B;LINC01000	dist=106604;dist=31713	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	43	19	chr7	128249581	chr7:128249581	GT	G	43	PASS	AN=2;DP=19	GT	0/1
chr7	131113757	131113757	T	-	intronic	MKLN1	.	.	.	0.999577505	0.000422495	5.31E-11	.	0.35761	0.14611	-0.427900189	25.14744043	19.26303	0.66403	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	44	21	chr7	131113756	chr7:131113756	CT	C	44	PASS	AN=2;DP=21	GT	0/1
chr7	138348905	138348905	G	C	intronic	SVOPL	.	.	.	0.001133272	0.953834922	0.045031805	.	0.11987	0.10578	-0.062423436	48.86765747	5022.7372	14.47469	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	86	299	chr7	138348905	chr7:138348905	G	C	86	PASS	AN=2;DP=299	GT	0/1
chr7	152055676	152055729	TTCCACAATCGTTTCTGTTTCTGTTGTCTCCAGCCCATCCATGCTGTCCTCATC	-	exonic	KMT2C	.	nonframeshift deletion	KMT2C:NM_170606:exon2:c.193_246del:p.D65_E82del	1	2.53E-15	2.34E-47	.	0.46876	0.10649	-2.516369113	0.908233074	8094.45636	19.4302	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	12.66	18	chr7	152055675	chr7:152055675	TTTCCACAATCGTTTCTGTTTCTGTTGTCTCCAGCCCATCCATGCTGTCCTCATC	T	12.66	PASS	AN=0;DP=18	GT	0/1
chr8	12459318	12459320	GGT	-	ncRNA_exonic	LOC729732	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	42	31	chr8	12459317	chr8:12459317	AGGT	A	42	PASS	AN=2;DP=31	GT	0/1
chr8	21955746	21955746	T	C	exonic	FAM160B2	.	synonymous SNV	FAM160B2:NM_022749:exon6:c.T693C:p.A231A	2.05E-05	0.974736924	0.025242552	.	0.14877	.	-0.591542347	18.24722812	2808.87174	10.00178	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	19	chr8	21955746	chr8:21955746	T	C	.	PASS	AN=0;DP=19	GT	0/1
chr8	28203175	28203175	C	A	UTR3	ZNF395	NM_018660:c.*3061G>T	.	.	0.819057406	0.180905829	3.68E-05	.	0.32677	.	-0.821100135	11.88369899	68.62215	1.71442	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	50	chr8	28203175	chr8:28203175	C	A	.	PASS	AN=0;DP=50	GT	0/1
chr8	37978439	37978439	C	-	intronic	ASH2L	.	.	.	0.995792116	0.00420787	1.44E-08	.	0.14146	0.11705	-0.26993514	34.59542345	107.32611	2.24775	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	45	21	chr8	37978438	chr8:37978438	TC	T	45	PASS	AN=2;DP=21	GT	0/1
chr8	52733079	52733079	A	C	exonic	PCMTD1	.	nonsynonymous SNV	PCMTD1:NM_001286782:exon4:c.T678G:p.S226R,PCMTD1:NM_001286783:exon6:c.T378G:p.S126R,PCMTD1:NM_052937:exon6:c.T906G:p.S302R	2.56E-06	0.503470629	0.496526814	.	.	0.10723	0.169169615	65.33380514	3481.72932	11.35685	0.069	0.496	T	0.999	0.764	D	0.994	0.807	D	0.000	0.629	N	1.000	0.588	D	1.955	0.530	M	0.98	0.421	T	-0.9	0.468	N	0.411	0.776	-0.920	0.455	T	0.174	0.518	T	.	.	.	1.490	0.241	13.26	0.998	0.850	0.846	0.434	D	c	0.047	0.054	0.982	0.303	0.707	0.730	0	0.773	0.176	1.452	0.345	0.237	0.263	1.000	0.715	0.999	0.750	6.433	0.209	S-adenosyl-L-methionine-dependent methyltransferase	.	.	0.5	65	19	chr8	52733079	chr8:52733079	A	C	65	PASS	AN=2;DP=19	GT	0/1
chr8	56025044	56025044	C	T	intronic	XKR4	.	.	.	0.97759169	0.022404012	4.30E-06	.	0.17775	0.1101	-0.824740496	11.67728238	24.17631	0.79377	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	31	chr8	56025044	chr8:56025044	C	T	.	PASS	AN=0;DP=31	GT	0/1
chr8	79673860	79673860	C	A	intronic	IL7	.	.	.	0.879873742	0.118691896	0.001434362	.	0.10724	0.49624	0.21326276	67.71644256	134.94454	2.52665	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	70	chr8	79673860	chr8:79673860	C	A	.	PASS	AN=0;DP=70	GT	0/1
chr8	95893369	95893369	T	G	UTR3	CCNE2	NM_057749:c.*491A>C	.	.	0.338179976	0.661197446	0.000622578	.	0.99576	0.16847	-0.005381972	53.50908233	124.43094	2.42611	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	42	40	chr8	95893369	chr8:95893369	T	G	42	PASS	AN=2;DP=40	GT	0/1
chr8	131140276	131140276	C	T	exonic	ASAP1	.	synonymous SNV	ASAP1:NM_018482:exon16:c.G1278A:p.E426E,ASAP1:NM_001247996:exon17:c.G1257A:p.E419E	0.999983091	1.69E-05	8.56E-16	.	0.41578	0.17656	-1.240018202	5.461193678	937.06285	5.93485	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	39	chr8	131140276	chr8:131140276	C	T	.	PASS	AN=0;DP=39	GT	0/1
chr8	131140355	131140355	G	A	intronic	ASAP1	.	.	.	0.999983091	1.69E-05	8.56E-16	.	0.41578	0.17656	-1.240018202	5.461193678	937.06285	5.93485	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	33	chr8	131140355	chr8:131140355	G	A	.	PASS	AN=0;DP=33	GT	0/1
chr8	139658939	139658940	AC	-	intronic	COL22A1	.	.	.	8.26E-32	0.34578943	0.65421057	.	0.08309	.	0.161491526	64.92686954	2203.69391	8.64163	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	10.87	22	chr8	139658938	chr8:139658938	TAC	T	10.87	PASS	AN=0;DP=22	GT	0/1
chr8	145106711	145106711	G	A	exonic	OPLAH	.	synonymous SNV	OPLAH:NM_017570:exon27:c.C3639T:p.A1213A	2.99E-11	0.887670231	0.112329769	DISEASE: 5-oxoprolinase deficiency (OPLAHD) [MIM:260005]: A disorder characterized by calcium oxalate/carbonate urolithiasis, and excessive urinary 5-oxo-L-proline. Affected individuals have recurrent episodes of vomiting, diarrhea, and abdominal pain. {ECO:0000269|PubMed:21651516}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.11816	0.18621	.	.	2315.28938	8.91132	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	77	chr8	145106711	chr8:145106711	G	A	.	PASS	AN=0;DP=77	GT	0/1
chr8	145537799	145537799	G	T	exonic	HSF1	.	nonsynonymous SNV	HSF1:NM_005526:exon13:c.G1396T:p.V466L	0.586374295	0.413181557	0.000444148	.	0.11458	0.16496	-0.865195027	10.79853739	350.11867	3.96676	0.009	0.574	D	0.576	0.368	P	0.301	0.393	B	0.000	0.843	D	1.000	0.548	D	2.81	0.821	M	.	.	.	-1.68	0.401	N	0.325	0.560	-0.519	0.680	T	0.284	0.656	T	0.060	0.680	D	5.077	0.684	25.3	0.994	0.640	0.977	0.761	D	c	0.501	0.580	1.0	0.983	0.672	0.522	0	5.62	0.857	4.555	0.602	0.944	0.532	1.000	0.715	0.999	0.750	17.162	0.866	Vertebrate heat shock transcription factor, C-terminal domain	.	.	0.5	.	186	chr8	145537799	chr8:145537799	G	T	.	PASS	AN=0;DP=186	GT	0/1
chr9	4125713	4125713	A	-	intronic	GLIS3	.	.	.	0.000100597	0.997176535	0.002722868	.	0.59622	.	-0.007415459	52.86034442	744.78269	5.41665	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	67	51	chr9	4125712	chr9:4125712	GA	G	67	PASS	AN=2;DP=51	GT	0/1
chr9	33034351	33034351	C	T	intronic	DNAJA1	.	.	.	0.260111369	0.738699815	0.001188817	.	0.49896	0.36254	-0.560178693	19.30879925	6.16298	0.23238	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	28	chr9	33034351	chr9:33034351	C	T	.	PASS	AN=0;DP=28	GT	0/1
chr9	37034032	37034032	G	T	UTR5	PAX5	NM_001280555:c.-4C>A;NM_001280554:c.-4C>A;NM_001280550:c.-4C>A;NM_001280548:c.-4C>A;NM_001280547:c.-4C>A;NM_001280553:c.-4C>A;NM_001280552:c.-4C>A;NM_001280551:c.-18953C>A;NM_016734:c.-4C>A;NM_001280549:c.-4C>A;NM_001280556:c.-18953C>A	.	.	0.984243989	0.015747099	8.91E-06	DISEASE: Note=A chromosomal aberration involving PAX5 is a cause of acute lymphoblastic leukemia. Translocation t(9;18)(p13;q11.2) with ZNF521. Translocation t(9;3)(p13;p14.1) with FOXP1. Translocation t(9;12)(p13;p13) with ETV6. {ECO:0000269|PubMed:17344859}.; DISEASE: Leukemia, acute lymphoblastic, 3 (ALL3) [MIM:613065]: A subtype of acute leukemia, a cancer of the white blood cells. Acute lymphoblastic anemia is a malignant disease of bone marrow and the most common malignancy diagnosed in children. The malignant cells are lymphoid precursor cells (lymphoblasts) that are arrested in an early stage of development. The lymphoblasts replace the normal marrow elements, resulting in a marked decrease in the production of normal blood cells. Consequently, anemia, thrombocytopenia, and neutropenia occur to varying degrees. The lymphoblasts also proliferate in organs other than the marrow, particularly the liver, spleen, and lymphonodes. {ECO:0000269|PubMed:24013638}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; 	0.43685	0.08086	-0.003562597	53.72729417	148.49912	2.65773	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	86	chr9	37034032	chr9:37034032	G	T	.	PASS	AN=0;DP=86	GT	0/1
chr9	66457322	66457322	G	C	ncRNA_exonic	LINC01410	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	62	chr9	66457322	chr9:66457322	G	C	.	PASS	AN=0;DP=62	GT	0/1
chr9	74331480	74331480	G	A	intronic	TMEM2	.	.	.	1.28E-09	0.999862594	0.000137405	.	0.07506	0.13257	-0.472233057	22.84147205	5982.23661	16.11897	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	33	chr9	74331480	chr9:74331480	G	A	.	PASS	AN=0;DP=33	GT	0/1
chr9	82335174	82335174	G	A	exonic	TLE4	.	nonsynonymous SNV	TLE4:NM_001351564:exon13:c.G1522A:p.A508T,TLE4:NM_001282753:exon14:c.G1597A:p.A533T,TLE4:NM_001351562:exon14:c.G1576A:p.A526T,TLE4:NM_001351563:exon14:c.G1570A:p.A524T,TLE4:NM_001282749:exon15:c.G1729A:p.A577T,TLE4:NM_001351547:exon15:c.G1753A:p.A585T,TLE4:NM_001351550:exon15:c.G1744A:p.A582T,TLE4:NM_001351552:exon15:c.G1741A:p.A581T,TLE4:NM_001351556:exon15:c.G1735A:p.A579T,TLE4:NM_001351558:exon15:c.G1732A:p.A578T,TLE4:NM_001351560:exon15:c.G1726A:p.A576T,TLE4:NM_001351542:exon16:c.G1807A:p.A603T,TLE4:NM_001351543:exon16:c.G1801A:p.A601T,TLE4:NM_001351546:exon16:c.G1798A:p.A600T,TLE4:NM_007005:exon16:c.G1804A:p.A602T,TLE4:NM_001282748:exon17:c.G1900A:p.A634T,TLE4:NM_001282760:exon17:c.G1441A:p.A481T,TLE4:NM_001351541:exon17:c.G1843A:p.A615T	0.99992164	7.84E-05	4.33E-12	.	0.94973	0.14686	-0.556537043	19.72753008	90.91723	2.05178	0.004	0.721	D	0.99	0.899	D	0.8	0.679	P	0.000	0.843	D	1	0.810	D	2.08	0.576	M	0.23	0.597	T	-3.05	0.629	D	0.786	0.779	-0.388	0.724	T	0.369	0.729	T	0.035	0.561	D	6.891	0.931	33	0.999	0.992	0.992	0.922	D	c	0.815	0.821	1.000	0.747	0.707	0.730	0	5.71	0.890	10.003	0.997	0.998	0.613	1.000	0.715	0.966	0.452	19.856	0.967	WD40 repeat, conserved site|WD40-repeat-containing domain|WD40/YVTN repeat-like-containing domain;WD40-repeat-containing domain|WD40/YVTN repeat-like-containing domain	.	.	0.5	.	47	chr9	82335174	chr9:82335174	G	A	.	PASS	AN=0;DP=47	GT	0/1
chr9	91992903	91992903	G	A	UTR3	SEMA4D	NM_006378:c.*716C>T	.	.	0.995825192	0.004174794	1.41E-08	.	0.2355	0.224	0.123045693	62.23755603	3261.67374	10.88836	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	58	33	chr9	91992903	chr9:91992903	G	A	58	PASS	AN=2;DP=33	GT	0/1
chr9	95051604	95051605	TT	-	exonic	IARS	.	frameshift deletion	IARS:NM_002161:exon2:c.97_98del:p.K33Afs*4,IARS:NM_013417:exon2:c.97_98del:p.K33Afs*4	4.35E-09	0.999995165	4.83E-06	.	0.71817	0.19154	-1.074802575	7.336635999	1316.65812	6.82478	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	14.77	44	chr9	95051603	chr9:95051603	CTT	C	14.77	PASS	AN=0;DP=44	GT	0/1
chr9	95277135	95277135	C	-	exonic	ECM2	.	frameshift deletion	ECM2:NM_001197295:exon4:c.766delG:p.E256Rfs*15,ECM2:NM_001197296:exon4:c.766delG:p.E256Rfs*15,ECM2:NM_001393:exon4:c.832delG:p.E278Rfs*15	1.56E-06	0.85172241	0.148276027	.	0.08752	.	0.424410872	77.25878745	175.72328	2.88468	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	60	126	chr9	95277134	chr9:95277134	TC	T	60	PASS	AN=2;DP=126	GT	0/1
chr9	99962758	99962758	G	A	ncRNA_exonic	ANKRD18CP	.	.	.	.	.	.	.	0.02598	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	41	chr9	99962758	chr9:99962758	G	A	.	PASS	AN=0;DP=41	GT	0/1
chr9	101051946	101051946	C	T	UTR3	GABBR2	NM_005458:c.*920G>A	.	.	0.999790263	0.000209737	9.64E-12	.	0.72097	0.15588	-1.285933373	5.083746167	1340.48679	6.87315	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	22	chr9	101051946	chr9:101051946	C	T	.	PASS	AN=0;DP=22	GT	0/1
chr9	101797339	101797339	A	G	exonic	COL15A1	.	nonsynonymous SNV	COL15A1:NM_001855:exon18:c.A2123G:p.K708R	3.68E-06	0.999996136	1.80E-07	.	0.21122	.	1.844643849	97.10426987	3519.49319	11.44267	0.052	0.390	T	0.01	0.144	B	0.016	0.166	B	0.102	0.198	N	1.000	0.186	N	0.685	0.165	N	-3.24	0.935	D	-0.62	0.183	N	0.114	0.124	-0.527	0.677	T	0.466	0.794	T	0.030	0.524	D	0.739	0.164	9.081	0.847	0.149	0.289	0.235	N	c	-0.745	-0.573	1.000	0.517	0.487	0.133	0	4.53	0.548	1.061	0.299	1.199	0.960	0.158	0.235	0.949	0.424	9.853	0.400	.	.	.	0.5	42	78	chr9	101797339	chr9:101797339	A	G	42	PASS	AN=2;DP=78	GT	0/1
chr9	125866154	125866154	C	T	UTR3	RABGAP1	NM_012197:c.*662C>T	.	.	0.9999998	2.00E-07	1.04E-17	.	0.29209	0.11542	-1.50825116	3.503184713	121.41418	2.40018	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	50	25	chr9	125866154	chr9:125866154	C	T	50	PASS	AN=2;DP=25	GT	0/1
chr9	131284958	131284958	G	A	exonic	GLE1	.	synonymous SNV	GLE1:NM_001003722:exon4:c.G444A:p.R148R,GLE1:NM_001499:exon4:c.G444A:p.R148R	1.54E-05	0.998327206	0.001657412	DISEASE: Lethal congenital contracture syndrome 1 (LCCS1) [MIM:253310]: A form of lethal congenital contracture syndrome, an autosomal recessive disorder characterized by degeneration of anterior horn neurons, extreme skeletal muscle atrophy, and congenital non-progressive joint contractures (arthrogryposis). The contractures can involve the upper or lower limbs and/or the vertebral column, leading to various degrees of flexion or extension limitations evident at birth. LCCS1 patients manifest early fetal hydrops and akinesia, micrognathia, pulmonary hypoplasia, pterygia, and multiple joint contractures. It leads to prenatal death. {ECO:0000269|PubMed:18204449}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Lethal arthrogryposis with anterior horn cell disease (LAAHD) [MIM:611890]: A disorder characterized by fetal akinesia, arthrogryposis and motor neuron loss. The fetus often survives delivery, but dies early as a result of respiratory failure. Neuropathological findings resemble those of lethal congenital contracture syndrome type 1, but are less severe. {ECO:0000269|PubMed:18204449}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.33736	0.10182	-0.088107893	47.06298655	1002.42975	6.09812	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	55	chr9	131284958	chr9:131284958	G	A	.	PASS	AN=0;DP=55	GT	0/1
chr9	132935014	132935014	C	T	intronic	NCS1	.	.	.	0.947220876	0.052601383	0.000177741	.	0.18713	0.18619	-0.141298762	42.87567823	2.47706	0.0911	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	53	chr9	132935014	chr9:132935014	C	T	.	PASS	AN=0;DP=53	GT	0/1
chr9	133270429	133270429	C	T	exonic	HMCN2	.	unknown	UNKNOWN	.	.	.	.	0.12716	.	.	.	2669.68768	9.71594	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	68	chr9	133270429	chr9:133270429	C	T	.	PASS	AN=0;DP=68	GT	0/1
chr9	133271583	133271583	C	G	exonic	HMCN2	.	unknown	UNKNOWN	.	.	.	.	0.12716	.	.	.	2669.68768	9.71594	.	.	.	0.08	0.230	B	0.025	0.193	B	.	.	.	.	.	.	-0.235	0.039	N	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.122	0.105	3.842	0.446	0.034	0.034	0.084	N	n	0.705	1.261	0.021	0.133	0.253	0.035	0	1.58	0.224	-0.550	0.061	-0.035	0.126	0.000	0.063	0.001	0.043	6.762	0.226	Immunoglobulin I-set|Immunoglobulin subtype|Immunoglobulin-like domain|Immunoglobulin-like fold	.	.	0.5	89	411	chr9	133271583	chr9:133271583	C	G	89	PASS	AN=2;DP=411	GT	0/1
chr9	133271590	133271590	G	A	exonic	HMCN2	.	unknown	UNKNOWN	.	.	.	.	0.12716	.	.	.	2669.68768	9.71594	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	206	chr9	133271590	chr9:133271590	G	A	.	PASS	AN=0;DP=206	GT	0/1
chr9	135612574	135612574	T	C	intronic	AK8	.	.	.	1.51E-07	0.384769812	0.615230037	.	0.13923	0.15909	0.068033485	59.0351498	497.62894	4.58369	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	17	chr9	135612574	chr9:135612574	T	C	.	PASS	AN=0;DP=17	GT	0/1
chr9	135981408	135981408	C	A	intronic	RALGDS	.	.	.	0.296706348	0.703257909	3.57E-05	.	0.48158	0.16125	-1.344833561	4.641424864	2512.28764	9.3358	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	49	chr9	135981408	chr9:135981408	C	A	.	PASS	AN=0;DP=49	GT	0/1
chr9	137314506	137314523	GGACACTCCCCACTCCCG	-	intronic	RXRA	.	.	.	0.943607123	0.056350112	4.28E-05	.	0.72501	0.7625	-0.690637458	15.12149092	54.60468	1.47935	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	50	125	chr9	137314505	chr9:137314505	CGGACACTCCCCACTCCCG	C	50	PASS	AN=2;DP=125	GT	0/1
chr9	138648987	138648987	C	T	intronic	KCNT1	.	.	.	0.005348738	0.994649439	1.82E-06	DISEASE: Epileptic encephalopathy, early infantile, 14 (EIEE14) [MIM:614959]: A rare epileptic encephalopathy of infancy that combines pharmacoresistant seizures with developmental delay. This severe neurologic disorder is characterized by onset in the first 6 months of life of refractory focal seizures and arrest of psychomotor development. Ictal EEG shows discharges that arise randomly from various areas of both hemispheres and migrate from one brain region to another. {ECO:0000269|PubMed:23086397}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Epilepsy, nocturnal frontal lobe, 5 (ENFL5) [MIM:615005]: An autosomal dominant focal epilepsy syndrome characterized by childhood onset of clusters of motor seizures during sleep. Some patients may develop behavioral or psychiatric manifestations and/or intellectual disability. The phenotype is more severe than observed in other genetic forms of nocturnal frontal lobe epilepsy. {ECO:0000269|PubMed:23086396}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.10242	0.10521	-2.070835943	1.615947157	121.99362	2.40558	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	100	chr9	138648987	chr9:138648987	C	T	.	PASS	AN=0;DP=100	GT	0/1
chr9	140147003	140147003	G	-	ncRNA_intronic	STPG3-AS1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	65	66	chr9	140147002	chr9:140147002	CG	C	65	PASS	AN=2;DP=66	GT	0/1
chr10	5922203	5922203	G	T	intronic	ANKRD16	.	.	.	2.58E-06	0.505168379	0.494829043	.	0.09505	.	0.707379532	85.62750649	1385.5909	6.96821	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	46	chr10	5922203	chr10:5922203	G	T	.	PASS	AN=0;DP=46	GT	0/1
chr10	42922698	42922698	C	T	ncRNA_intronic	CCNYL2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	43	chr10	42922698	chr10:42922698	C	T	.	PASS	AN=0;DP=43	GT	0/1
chr10	61897078	61897078	T	-	intronic	ANK3	.	.	.	1	7.92E-14	8.89E-37	DISEASE: Note=Genetic variations in ANK3 may be associated with autism spectrum disorders susceptibility. {ECO:0000269|PubMed:22865819}.; DISEASE: Mental retardation, autosomal recessive 37 (MRT37) [MIM:615493]: A disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. MRT37 patients manifest delayed global development with speech delay, hypotonia, spasticity, and a sleep disorder. Severe behavioral abnormalities include aggression, hyperactivity, and grinding of the teeth. Note=The disease is caused by mutations affecting the gene represented in this entry. A homozygous deletion in ANK3 predicted to result in frameshift and premature truncation, has been shown to be the cause of moderate intellectual disability, an ADHD-like phenotype and behavioral problems in a consanguineous family (PubMed:23390136). {ECO:0000269|PubMed:23390136}.; 	0.85781	0.22949	-3.496995436	0.33616419	2889.35508	10.18323	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	20.1	65	chr10	61897077	chr10:61897077	AT	A	20.1	PASS	AN=0;DP=65	GT	0/1
chr10	71664597	71664597	C	T	intronic	COL13A1	.	.	.	0.003928968	0.996068184	2.85E-06	.	0.28276	0.14899	-0.440847477	24.59896202	250.76638	3.41203	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	33	chr10	71664597	chr10:71664597	C	T	.	PASS	AN=0;DP=33	GT	0/1
chr10	72620135	72620135	T	-	intronic	SGPL1	.	.	.	0.122514048	0.877267858	0.000218094	.	0.16544	0.43246	-0.290161348	33.33923095	406.33204	4.22621	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	44	19	chr10	72620134	chr10:72620134	CT	C	44	PASS	AN=2;DP=19	GT	0/1
chr10	75415529	75415529	C	G	intronic	SYNPO2L	.	.	.	0.026739766	0.96128115	0.011979084	.	0.20396	0.09102	-0.486758915	22.69992923	4908.06476	14.28002	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	72	189	chr10	75415529	chr10:75415529	C	G	72	PASS	AN=2;DP=189	GT	0/1
chr10	75560464	75560464	C	-	exonic	ZSWIM8	.	frameshift deletion	ZSWIM8:NM_001242487:exon24:c.5078delC:p.Y1696Tfs*16,ZSWIM8:NM_001242488:exon24:c.5054delC:p.Y1688Tfs*119,ZSWIM8:NM_015037:exon24:c.5093delC:p.Y1701Tfs*16	0.999999921	7.91E-08	2.18E-19	.	0.68729	0.10641	-1.945684699	1.887237556	65.2417	1.66201	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	44	80	chr10	75560463	chr10:75560463	TC	T	44	PASS	AN=2;DP=80	GT	0/1
chr10	75675042	75675115	CTGTTGTGAAGCTGATTTCCCACCGGGAGTGTCAGCAGCCCCACTACTACGGCTCTGAAGTCACCACCAAAATG	-	exonic	PLAU	.	frameshift deletion	PLAU:NM_001145031:exon9:c.953_1026del:p.V320Cfs*2,PLAU:NM_001319191:exon9:c.746_819del:p.V251Cfs*2,PLAU:NM_002658:exon10:c.1004_1077del:p.V337Cfs*2	0.00055027	0.972496454	0.026953276	DISEASE: Quebec platelet disorder (QPD) [MIM:601709]: An autosomal dominant bleeding disorder due to a gain-of-function defect in fibrinolysis. Although affected individuals do not exhibit systemic fibrinolysis, they show delayed onset bleeding after challenge, such as surgery. The hallmark of the disorder is markedly increased PLAU levels within platelets, which causes intraplatelet plasmin generation and secondary degradation of alpha-granule proteins. {ECO:0000269|PubMed:20007542}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.08249	0.90261	0.308721233	72.59966973	135.07501	2.52903	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	70	99	chr10	75675041	chr10:75675041	ACTGTTGTGAAGCTGATTTCCCACCGGGAGTGTCAGCAGCCCCACTACTACGGCTCTGAAGTCACCACCAAAATG	A	70	PASS	AN=2;DP=99	GT	0/1
chr10	77157785	77157785	T	-	UTR3	ZNF503	NM_032772:c.*722delA	.	.	0.887882313	0.110917243	0.001200444	.	0.92206	0.11115	.	.	889.95494	5.81207	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	43	40	chr10	77157784	chr10:77157784	CT	C	43	PASS	AN=2;DP=40	GT	0/1
chr10	78729786	78729786	T	-	exonic	KCNMA1	.	frameshift deletion	KCNMA1:NM_001161353:exon19:c.2132delA:p.K711Sfs*16,KCNMA1:NM_001271518:exon19:c.1982delA:p.K661Sfs*16,KCNMA1:NM_001322832:exon19:c.2132delA:p.K711Sfs*16,KCNMA1:NM_002247:exon19:c.2132delA:p.K711Sfs*16,KCNMA1:NM_001014797:exon20:c.2144delA:p.K715Sfs*16,KCNMA1:NM_001161352:exon20:c.2306delA:p.K769Sfs*16,KCNMA1:NM_001271519:exon20:c.2141delA:p.K714Sfs*16,KCNMA1:NM_001322829:exon20:c.2141delA:p.K714Sfs*16,KCNMA1:NM_001322835:exon20:c.2144delA:p.K715Sfs*16,KCNMA1:NM_001322836:exon20:c.2141delA:p.K714Sfs*16,KCNMA1:NM_001322837:exon20:c.2144delA:p.K715Sfs*16,KCNMA1:NM_001322830:exon21:c.2153delA:p.K718Sfs*16,KCNMA1:NM_001322838:exon21:c.1679delA:p.K560Sfs*16	0.999216603	0.000783397	1.98E-12	DISEASE: Generalized epilepsy and paroxysmal dyskinesia (GEPD) [MIM:609446]: Epilepsy is one of the most common and debilitating neurological disorders. Paroxysmal dyskinesias are neurological disorders characterized by sudden, unpredictable, disabling attacks of involuntary movement often requiring life-long treatment. The coexistence of epilepsy and paroxysmal dyskinesia in the same individual or family is an increasingly recognized phenomenon. Patients manifest absence seizures, generalized tonic- clonic seizures, paroxysmal nonkinesigenic dyskinesia, involuntary dystonic or choreiform movements. Onset is usually in childhood and patients may have seizures only, dyskinesia only, or both. {ECO:0000269|PubMed:15937479}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.76173	0.14035	-1.682848699	2.653927813	154.36657	2.71502	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	44	17	chr10	78729785	chr10:78729785	CT	C	44	PASS	AN=2;DP=17	GT	0/1
chr10	79551014	79551014	C	T	UTR3	DLG5	NM_004747:c.*1184G>A	.	.	0.999998542	1.46E-06	2.19E-18	.	0.27889	0.16537	-2.369063868	1.126444916	774.17189	5.50725	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	62	chr10	79551014	chr10:79551014	C	T	.	PASS	AN=0;DP=62	GT	0/1
chr10	114153810	114153810	C	-	intronic	ACSL5	.	.	.	0.016763711	0.983194812	4.15E-05	.	0.14592	0.15681	0.268267497	70.64166077	551.73015	4.77877	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	54	11	chr10	114153809	chr10:114153809	GC	G	54	PASS	AN=2;DP=11	GT	0/1
chr11	376149	376149	C	T	exonic	B4GALNT4	.	nonsynonymous SNV	B4GALNT4:NM_178537:exon12:c.C1171T:p.R391C	0.816930491	0.183069195	3.15E-07	.	0.13468	0.09235	.	.	1517.92316	7.2418	0.001	0.784	D	1.0	0.899	D	0.994	0.807	D	0.000	0.445	D	1.000	0.548	D	2.77	0.812	M	-0.63	0.720	T	-5.49	0.857	D	0.788	0.779	-0.177	0.783	T	0.422	0.767	T	0.687	0.974	D	7.024	0.938	33	0.999	0.950	0.789	0.387	D	c	0.370	0.279	0.057	0.151	0.696	0.567	0	3.01	0.337	0.665	0.246	0.742	0.308	0.999	0.424	0.994	0.587	10.272	0.425	.	.	.	0.5	.	490	chr11	376149	chr11:376149	C	T	.	PASS	AN=0;DP=490	GT	0/1
chr11	376239	376239	G	A	intronic	B4GALNT4	.	.	.	0.816930491	0.183069195	3.15E-07	.	0.13468	0.09235	.	.	1517.92316	7.2418	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	152	chr11	376239	chr11:376239	G	A	.	PASS	AN=0;DP=152	GT	0/1
chr11	792865	792865	C	G	intronic	SLC25A22	.	.	.	0.568405565	0.42907803	0.002516405	.	0.4027	0.12155	0.128714042	63.19886766	219.59154	3.20559	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	97	286	chr11	792865	chr11:792865	C	G	97	PASS	AN=2;DP=286	GT	0/1
chr11	1276551	1276554	GCAC	-	intronic	MUC5B	.	.	.	0.999999706	2.94E-07	6.12E-25	DISEASE: Pulmonary fibrosis, idiopathic (IPF) [MIM:178500]: A lung disease characterized by shortness of breath, radiographically evident diffuse pulmonary infiltrates, and varying degrees of inflammation and fibrosis on biopsy. In some cases, the disorder can be rapidly progressive and characterized by sequential acute lung injury with subsequent scarring and end-stage lung disease. {ECO:0000269|PubMed:21506741, ECO:0000269|PubMed:21506748}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry. A common polymorphism in the promoter of MUC5B is associated with familial interstitial pneumonia and idiopathic pulmonary fibrosis, suggesting that dysregulated MUC5B expression in the lung may be involved in the pathogenesis of pulmonary fibrosis (PubMed:21506741). {ECO:0000269|PubMed:21506741}.; 	0.07831	.	16.52445195	99.97640953	6531.39188	16.99148	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	43	40	chr11	1276550	chr11:1276550	TGCAC	T	43	PASS	AN=2;DP=40	GT	0/1
chr11	3844147	3844147	C	T	exonic	PGAP2	.	nonsynonymous SNV	PGAP2:NM_001256235:exon4:c.C143T:p.A48V,PGAP2:NM_001346402:exon4:c.C209T:p.A70V	0.15222416	0.830890196	0.016885643	.	.	.	-0.291981272	33.20358575	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1.000	0.090	N	.	.	.	.	.	.	.	.	.	0.106	0.112	.	.	.	.	.	.	.	.	.	0.180	0.111	4.463	0.709	0.092	0.013	0.044	N	n	-0.128	-0.183	0.548	0.213	0.162	0.029	0	-2.29	0.064	-0.354	0.077	0.630	0.290	0.000	0.063	0.032	0.149	7.014	0.239	.	.	.	0.5	.	49	chr11	3844147	chr11:3844147	C	T	.	PASS	AN=0;DP=49	GT	0/1
chr11	6461846	6461846	A	-	intronic	HPX	.	.	.	0.004121447	0.988189736	0.007688816	.	0.27843	0.54325	0.112125503	62.09601321	344.00549	3.93368	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	67	45	chr11	6461845	chr11:6461845	TA	T	67	PASS	AN=2;DP=45	GT	0/1
chr11	46001356	46001358	GTG	-	exonic	PHF21A	.	nonframeshift deletion	PHF21A:NM_001101802:exon6:c.313_315del:p.H105del,PHF21A:NM_016621:exon6:c.313_315del:p.H105del	0.999675486	0.000324514	1.38E-10	.	0.45911	0.13081	-0.622676946	17.30950696	1807.75543	7.84684	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	40	36	chr11	46001355	chr11:46001355	CGTG	C	40	PASS	AN=2;DP=36	GT	0/1
chr11	61050464	61050464	C	T	intronic	VWCE	.	.	.	5.90E-13	0.798483808	0.201516192	.	0.19722	0.10094	-0.902027742	10.1556971	191.21648	2.99921	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	39	chr11	61050464	chr11:61050464	C	T	.	PASS	AN=0;DP=39	GT	0/1
chr11	64374091	64374091	G	T	UTR3	NRXN2	NM_138734:c.*577C>A;NM_138732:c.*577C>A;NM_015080:c.*577C>A	.	.	0.999895574	0.000104426	7.22E-14	.	0.24191	0.10189	-2.164449385	1.427223402	1296.88776	6.77694	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	110	chr11	64374091	chr11:64374091	G	T	.	PASS	AN=0;DP=110	GT	0/1
chr11	64602486	64602486	C	T	intronic	CDC42BPG	.	.	.	1.41E-17	0.874375116	0.125624884	.	0.12008	0.10369	-1.464556369	3.75678226	2467.86866	9.25649	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	64	155	chr11	64602486	chr11:64602486	C	T	64	PASS	AN=2;DP=155	GT	0/1
chr11	68522887	68522887	T	-	UTR3	CPT1A	NM_001876:c.*2225delA	.	.	0.939139733	0.060860249	1.76E-08	DISEASE: Carnitine palmitoyltransferase 1A deficiency (CPT1AD) [MIM:255120]: Rare autosomal recessive metabolic disorder of long- chain fatty acid oxidation characterized by severe episodes of hypoketotic hypoglycemia usually occurring after fasting or illness. Onset is in infancy or early childhood. {ECO:0000269|PubMed:11350182, ECO:0000269|PubMed:11441142, ECO:0000269|PubMed:12189492, ECO:0000269|PubMed:14517221, ECO:0000269|PubMed:15110323, ECO:0000269|PubMed:15669684, ECO:0000269|PubMed:9691089}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.11869	0.57549	-0.483123186	22.78249587	317.78824	3.78518	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	56	25	chr11	68522886	chr11:68522886	CT	C	56	PASS	AN=2;DP=25	GT	0/1
chr11	104869744	104869744	C	-	exonic	CASP5	.	frameshift deletion	CASP5:NM_001136110:exon5:c.538delG:p.E180Nfs*74,CASP5:NM_001136109:exon6:c.790delG:p.E264Nfs*74,CASP5:NM_001136112:exon7:c.1003delG:p.E335Nfs*74,CASP5:NM_004347:exon7:c.964delG:p.E322Nfs*74	8.11E-09	0.273167235	0.726832757	.	0.1193	0.11456	1.199707453	92.98183534	431.34997	4.33449	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	65	14	chr11	104869743	chr11:104869743	TC	T	65	PASS	AN=2;DP=14	GT	0/1
chr11	111800579	111800579	T	G	exonic	DIXDC1	.	nonsynonymous SNV	DIXDC1:NM_001278542:exon2:c.T2G:p.M1R	4.27E-06	0.997885057	0.002110675	.	0.28623	0.1069	.	.	168.08416	2.83065	0.0	0.912	D	.	.	.	.	.	.	.	.	.	1.000	0.202	N	.	.	.	-1.09	0.772	T	0.31	0.040	N	0.403	0.462	0.109	0.843	D	0.527	0.824	D	0.146	0.829	D	5.466	0.742	26.2	0.981	0.380	0.900	0.506	D	c	0.335	0.403	0.998	0.360	0.554	0.283	0	5.2	0.716	3.860	0.555	1.011	0.635	1.000	0.715	1.000	0.888	11.380	0.488	.	.	.	0.5	.	28	chr11	111800579	chr11:111800579	T	G	.	PASS	AN=0;DP=28	GT	0/1
chr11	118769058	118769058	G	A	UTR3	BCL9L	NM_182557:c.*66C>T	.	.	0.998124599	0.001875399	2.01E-09	.	0.49572	0.2	-1.473536006	3.727294173	883.69076	5.78927	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	145	chr11	118769058	chr11:118769058	G	A	.	PASS	AN=0;DP=145	GT	0/1
chr11	124609887	124609887	G	C	UTR5	NRGN	NM_001126181:c.-94G>C;NM_006176:c.-94G>C	.	.	0.536942023	0.405084011	0.057973966	.	0.39546	0.19444	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	78	30	chr11	124609887	chr11:124609887	G	C	78	PASS	AN=2;DP=30	GT	1/0
chr12	2764329	2764410	CCCTGAATGATACCACAGAGATCAACCGGAACAACAACTTTCAGACCTTCCCCCAGGCCGTGCTGCTCCTCTTCAGGTGGGT	-	exonic	CACNA1C	.	frameshift deletion	CACNA1C:NM_001129837:exon33:c.4124_4199del:p.A1375Gfs*55,CACNA1C:NM_001129838:exon33:c.4124_4199del:p.A1375Gfs*55,CACNA1C:NM_001129839:exon33:c.4118_4193del:p.A1373Gfs*55,CACNA1C:NM_001129846:exon33:c.4124_4199del:p.A1375Gfs*55,CACNA1C:NM_001167625:exon33:c.4124_4199del:p.A1375Gfs*55,CACNA1C:NM_000719:exon34:c.4157_4232del:p.A1386Gfs*55,CACNA1C:NM_001129829:exon34:c.4223_4298del:p.A1408Gfs*55,CACNA1C:NM_001129830:exon34:c.4157_4232del:p.A1386Gfs*55,CACNA1C:NM_001129833:exon34:c.4157_4232del:p.A1386Gfs*55,CACNA1C:NM_001129834:exon34:c.4157_4232del:p.A1386Gfs*55,CACNA1C:NM_001129835:exon34:c.4157_4232del:p.A1386Gfs*55,CACNA1C:NM_001129836:exon34:c.4208_4283del:p.A1403Gfs*55,CACNA1C:NM_001129840:exon34:c.4157_4232del:p.A1386Gfs*55,CACNA1C:NM_001129841:exon34:c.4157_4232del:p.A1386Gfs*55,CACNA1C:NM_001129842:exon34:c.4157_4232del:p.A1386Gfs*55,CACNA1C:NM_001129843:exon34:c.4157_4232del:p.A1386Gfs*55,CACNA1C:NM_001129844:exon34:c.4148_4223del:p.A1383Gfs*55,CACNA1C:NM_001167623:exon34:c.4157_4232del:p.A1386Gfs*55,CACNA1C:NM_001167624:exon34:c.4157_4232del:p.A1386Gfs*55,CACNA1C:NM_001129831:exon35:c.4241_4316del:p.A1414Gfs*55,CACNA1C:NM_001129832:exon35:c.4217_4292del:p.A1406Gfs*55,CACNA1C:NM_001129827:exon36:c.4301_4376del:p.A1434Gfs*55,CACNA1C:NM_199460:exon36:c.4301_4376del:p.A1434Gfs*55	0.999998433	1.57E-06	4.37E-21	DISEASE: Timothy syndrome (TS) [MIM:601005]: Disorder characterized by multiorgan dysfunction including lethal arrhythmias, webbing of fingers and toes, congenital heart disease, immune deficiency, intermittent hypoglycemia, cognitive abnormalities and autism. {ECO:0000269|PubMed:15454078, ECO:0000269|PubMed:15863612, ECO:0000269|PubMed:25260352}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Brugada syndrome 3 (BRGDA3) [MIM:611875]: A heart disease characterized by the association of Brugada syndrome with shortened QT intervals. Brugada syndrome is a tachyarrhythmia characterized by right bundle branch block and ST segment elevation on an electrocardiogram (ECG). It can cause the ventricles to beat so fast that the blood is prevented from circulating efficiently in the body. When this situation occurs, the individual will faint and may die in a few minutes if the heart is not reset. {ECO:0000269|PubMed:17224476}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.66288	0.13071	-2.087541484	1.574663836	257.23512	3.4497	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	71	53	chr12	2764328	chr12:2764328	GCCCTGAATGATACCACAGAGATCAACCGGAACAACAACTTTCAGACCTTCCCCCAGGCCGTGCTGCTCCTCTTCAGGTGGGT	G	71	PASS	AN=2;DP=53	GT	0/1
chr12	7864223	7864223	C	T	exonic	DPPA3	.	synonymous SNV	DPPA3:NM_199286:exon1:c.C57T:p.T19T	0.165194336	0.772640391	0.062165272	.	0.02429	0.07229	0.591694063	82.45458835	39.72884	1.1709	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	47	chr12	7864223	chr12:7864223	C	T	.	PASS	AN=0;DP=47	GT	0/1
chr12	27109508	27109508	C	A	exonic	FGFR1OP2	.	synonymous SNV	FGFR1OP2:NM_001171887:exon3:c.C168A:p.V56V,FGFR1OP2:NM_001171888:exon3:c.C168A:p.V56V,FGFR1OP2:NM_015633:exon3:c.C168A:p.V56V	0.429728003	0.568760515	0.001511482	.	0.16605	0.12716	-0.361761279	28.6329323	26.47953	0.85687	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	52	chr12	27109508	chr12:27109508	C	A	.	PASS	AN=0;DP=52	GT	0/1
chr12	40924177	40924177	G	A	intronic	MUC19	.	.	.	.	.	.	.	0.11557	.	.	.	41933.48624	39.90294	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	24	chr12	40924177	chr12:40924177	G	A	.	PASS	AN=0;DP=24	GT	0/1
chr12	48298283	48298283	C	G	intronic	VDR	.	.	.	0.392125212	0.605864041	0.002010747	DISEASE: Rickets vitamin D-dependent 2A (VDDR2A) [MIM:277440]: A disorder of vitamin D metabolism resulting in severe rickets, hypocalcemia and secondary hyperparathyroidism. Most patients have total alopecia in addition to rickets. {ECO:0000269|PubMed:1652893, ECO:0000269|PubMed:2177843, ECO:0000269|PubMed:2849209, ECO:0000269|PubMed:7828346, ECO:0000269|PubMed:8106618, ECO:0000269|PubMed:8381803, ECO:0000269|PubMed:8392085, ECO:0000269|PubMed:8675579, ECO:0000269|PubMed:8961271, ECO:0000269|PubMed:9005998}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.28629	0.77234	-0.622676946	17.30950696	55.75589	1.49969	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	69	36	chr12	48298283	chr12:48298283	C	G	69	PASS	AN=2;DP=36	GT	0/1
chr12	49398697	49398697	G	A	ncRNA_intronic	DDN-AS1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	35	chr12	49398697	chr12:49398697	G	A	.	PASS	AN=0;DP=35	GT	0/1
chr12	53045772	53045772	C	G	exonic	KRT2	.	nonsynonymous SNV	KRT2:NM_000423:exon1:c.G155C:p.G52A	0.067349919	0.929718637	0.002931445	DISEASE: Ichthyosis bullosa of Siemens (IBS) [MIM:146800]: A rare autosomal dominant skin disorder displaying a type of epidermolytic hyperkeratosis characterized by generalized erythema and extensive blistering from birth. Large, dark gray hyperkeratoses are observed in later weeks. The skin of IBS patients is unusually fragile and has a tendency to shed the outer layers of the epidermis, producing localized denuded areas (molting effect). IBS usually improves with age so that in most middle-aged patients the hyperkeratosis and keratotic lichenification is limited to the flexural folds of the major joints. {ECO:0000269|PubMed:10084318, ECO:0000269|PubMed:10233323, ECO:0000269|PubMed:10564334, ECO:0000269|PubMed:10620137, ECO:0000269|PubMed:10688369, ECO:0000269|PubMed:11167982, ECO:0000269|PubMed:11531804, ECO:0000269|PubMed:15949009, ECO:0000269|PubMed:7521371, ECO:0000269|PubMed:7524919, ECO:0000269|PubMed:8077693, ECO:0000269|PubMed:9036938, ECO:0000269|PubMed:9204966, ECO:0000269|PubMed:9804344, ECO:0000269|PubMed:9833038}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.15783	0.10965	0.292133603	71.59707478	2551.90953	9.43604	0.129	0.268	T	0.956	0.527	P	0.409	0.430	B	.	.	.	0.625	0.327	D	1.405	0.356	L	-3.82	0.958	D	-1.19	0.303	N	0.306	0.366	0.587	0.917	D	0.777	0.924	D	0.061	0.684	D	1.351	0.226	12.53	0.969	0.308	0.781	0.382	D	c	-0.129	-0.229	0.084	0.159	0.497	0.185	0	3.9	0.441	-0.057	0.116	0.035	0.151	0.000	0.063	0.004	0.083	7.921	0.288	Keratin type II head	.	.	0.5	74	172	chr12	53045772	chr12:53045772	C	G	74	PASS	AN=2;DP=172	GT	0/1
chr12	56622965	56622965	G	A	exonic	NABP2	.	nonsynonymous SNV	NABP2:NM_024068:exon7:c.G604A:p.G202S	0.956804648	0.043087592	0.00010776	.	0.29478	.	-0.141298762	42.87567823	1.67296	0.05407	0.01	0.564	D	1.0	0.899	D	0.987	0.759	D	0.000	0.629	D	1.000	0.480	D	0.975	0.246	L	-0.5	0.705	T	-2.38	0.524	N	0.57	0.618	-0.164	0.786	T	0.479	0.801	T	0.102	0.776	D	7.402	0.950	34	0.996	0.748	0.980	0.788	D	c	0.719	0.717	1.000	0.747	0.732	0.924	0	5.39	0.775	5.924	0.696	1.048	0.713	1.000	0.715	1.000	0.888	16.442	0.837	.	.	.	0.5	.	87	chr12	56622965	chr12:56622965	G	A	.	PASS	AN=0;DP=87	GT	0/1
chr12	56826840	56826840	G	A	exonic	TIMELESS	.	synonymous SNV	TIMELESS:NM_001330295:exon6:c.C501T:p.L167L,TIMELESS:NM_003920:exon6:c.C501T:p.L167L	1.04E-25	0.155176324	0.844823676	.	0.32396	0.2043	0.372852703	75.12974758	9968.9554	21.74053	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	59	chr12	56826840	chr12:56826840	G	A	.	PASS	AN=0;DP=59	GT	0/1
chr12	76752551	76752552	TG	-	exonic	OSBPL8	.	frameshift deletion	OSBPL8:NM_001319655:exon19:c.2293_2294del:p.Q765Efs*12,OSBPL8:NM_001003712:exon21:c.2242_2243del:p.Q748Efs*12,OSBPL8:NM_001319653:exon22:c.2359_2360del:p.Q787Efs*12,OSBPL8:NM_020841:exon22:c.2368_2369del:p.Q790Efs*12,OSBPL8:NM_001319652:exon24:c.2242_2243del:p.Q748Efs*12	0.988348146	0.011651854	2.92E-10	.	0.77324	0.11113	-0.512444034	21.55579146	62.14451	1.60766	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	62	16	chr12	76752550	chr12:76752550	CTG	C	62	PASS	AN=2;DP=16	GT	0/1
chr12	99640033	99640033	G	A	intronic	ANKS1B	.	.	.	0.992771668	0.007228332	9.07E-11	.	0.21201	0.20962	-1.216154	5.667610285	347.70248	3.95239	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	21	chr12	99640033	chr12:99640033	G	A	.	PASS	AN=0;DP=21	GT	0/1
chr12	109510087	109510087	T	-	intronic	USP30	.	.	.	0.309014179	0.69082627	0.000159551	.	0.17615	0.11045	-0.135838822	43.77211607	446.0984	4.39699	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	62	36	chr12	109510086	chr12:109510086	GT	G	62	PASS	AN=2;DP=36	GT	0/1
chr12	122018029	122018029	G	A	UTR5	KDM2B	NM_001005366:c.-72C>T	.	.	0.999785914	0.000214086	8.39E-14	.	0.3817	0.10945	-2.166248113	1.421325784	100.32428	2.17057	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	58	70	chr12	122018029	chr12:122018029	G	A	58	PASS	AN=2;DP=70	GT	0/1
chr12	124498691	124498691	G	-	UTR3	ZNF664	NM_152437:c.*1214delG;NM_001204298:c.*1214delG	.	.	0.001626794	0.457661202	0.540712004	.	0.24976	0.12378	0.347360312	73.97381458	461.1138	4.45297	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	17.93	72	chr12	124498690	chr12:124498690	AG	A	17.93	PASS	AN=0;DP=72	GT	0/1
chr12	125396196	125396196	G	C	UTR3	UBC	NM_021009:c.*64C>G	.	.	0.704156667	0.292254881	0.003588452	.	.	.	-0.80269335	12.23755603	8.43713	0.30824	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	52	chr12	125396196	chr12:125396196	G	C	.	PASS	AN=0;DP=52	GT	0/1
chr13	39603418	39603418	G	A	exonic	PROSER1	.	nonsynonymous SNV	PROSER1:NM_025138:exon4:c.C275T:p.S92L	0.736135592	0.263842666	2.17E-05	.	0.10421	0.09566	-0.170835809	40.65227648	338.0786	3.90357	0.466	0.122	T	0.103	0.764	B	0.03	0.774	B	.	.	.	0.998	0.442	D	-0.145	0.044	N	1.52	0.307	T	-2.34	0.587	N	0.252	0.308	-1.037	0.183	T	0.072	0.294	T	0.009	0.236	T	2.260	0.333	17.91	0.278	0.014	0.880	0.475	D	c	0.244	0.394	1.000	0.747	0.732	0.924	0	5.46	0.799	7.033	0.761	0.998	0.613	1.000	0.715	0.996	0.625	10.267	0.424	Domain of unknown function DUF4476	.	.	0.5	.	74	chr13	39603418	chr13:39603418	G	A	.	PASS	AN=0;DP=74	GT	0/1
chr13	44964489	44964489	G	A	intronic	SERP2	.	.	.	0.229121363	0.646467406	0.12441123	.	0.26504	.	0.101211609	60.95777306	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	22	chr13	44964489	chr13:44964489	G	A	.	PASS	AN=0;DP=22	GT	0/1
chr13	45710920	45710920	T	C	exonic	GTF2F2	.	nonsynonymous SNV	GTF2F2:NM_004128:exon2:c.T119C:p.V40A	0.025230232	0.96173341	0.013036358	.	0.15957	0.11833	-0.163345027	41.24793583	12.47447	0.45368	0.066	0.361	T	0.997	0.689	D	0.989	0.769	D	0.000	0.843	D	1	0.810	D	2.455	0.715	M	.	.	.	-2.92	0.611	D	0.475	0.524	-0.208	0.775	T	0.415	0.762	T	0.027	0.503	D	4.361	0.584	24.1	0.999	0.940	0.917	0.539	D	c	0.690	0.656	1.000	0.747	0.732	0.924	0	5.44	0.793	6.056	0.705	1.011	0.635	1.000	0.715	1.000	0.888	13.445	0.604	Transcription Factor IIF, Rap30/Rap74, interaction	.	.	0.5	44	49	chr13	45710920	chr13:45710920	T	C	44	PASS	AN=2;DP=49	GT	0/1
chr13	112763092	112763092	C	T	downstream	LINC00403	dist=763	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	35	chr13	112763092	chr13:112763092	C	T	.	PASS	AN=0;DP=35	GT	0/1
chr14	21762919	21762919	C	A	exonic	RPGRIP1	.	nonsynonymous SNV	RPGRIP1:NM_020366:exon2:c.C169A:p.H57N	2.57E-21	0.046731913	0.953268087	DISEASE: Leber congenital amaurosis 6 (LCA6) [MIM:613826]: A severe dystrophy of the retina, typically becoming evident in the first years of life. Visual function is usually poor and often accompanied by nystagmus, sluggish or near-absent pupillary responses, photophobia, high hyperopia and keratoconus. {ECO:0000269|PubMed:11528500, ECO:0000269|PubMed:18682808}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Cone-rod dystrophy 13 (CORD13) [MIM:608194]: An inherited retinal dystrophy characterized by retinal pigment deposits visible on fundus examination, predominantly in the macular region, and initial loss of cone photoreceptors followed by rod degeneration. This leads to decreased visual acuity and sensitivity in the central visual field, followed by loss of peripheral vision. Severe loss of vision occurs earlier than in retinitis pigmentosa. {ECO:0000269|PubMed:10958648, ECO:0000269|PubMed:12920076}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Note=Heterozygous non-synonymous variants of RPGRIP1 may cause or increase the susceptibility to various forms of glaucoma, a genetically heterogeneous disorder. It is the second cause of blindness worldwide owing to the progressive degeneration of retinal ganglion neurons (PubMed:21224891). {ECO:0000269|PubMed:21224891}.; 	0.0819	0.1823	1.298854499	93.91365888	2951.663	10.29586	1.0	0.010	T	0.172	0.271	B	0.015	0.162	B	0.003	0.363	N	1	0.090	N	1.08	0.273	L	-0.28	0.676	T	-0.3	0.142	N	0.178	0.466	-1.006	0.282	T	0.122	0.423	T	0.012	0.300	T	-0.568	0.052	0.150	0.677	0.082	0.043	0.097	N	c	-0.819	-0.763	0.002	0.087	0.487	0.133	0	2.64	0.304	0.073	0.144	0.832	0.339	0.024	0.198	0.419	0.257	9.075	0.355	.	.	.	0.5	.	49	chr14	21762919	chr14:21762919	C	A	.	PASS	AN=0;DP=49	GT	0/1
chr14	21762920	21762920	A	T	exonic	RPGRIP1	.	nonsynonymous SNV	RPGRIP1:NM_020366:exon2:c.A170T:p.H57L	2.57E-21	0.046731913	0.953268087	DISEASE: Leber congenital amaurosis 6 (LCA6) [MIM:613826]: A severe dystrophy of the retina, typically becoming evident in the first years of life. Visual function is usually poor and often accompanied by nystagmus, sluggish or near-absent pupillary responses, photophobia, high hyperopia and keratoconus. {ECO:0000269|PubMed:11528500, ECO:0000269|PubMed:18682808}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Cone-rod dystrophy 13 (CORD13) [MIM:608194]: An inherited retinal dystrophy characterized by retinal pigment deposits visible on fundus examination, predominantly in the macular region, and initial loss of cone photoreceptors followed by rod degeneration. This leads to decreased visual acuity and sensitivity in the central visual field, followed by loss of peripheral vision. Severe loss of vision occurs earlier than in retinitis pigmentosa. {ECO:0000269|PubMed:10958648, ECO:0000269|PubMed:12920076}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Note=Heterozygous non-synonymous variants of RPGRIP1 may cause or increase the susceptibility to various forms of glaucoma, a genetically heterogeneous disorder. It is the second cause of blindness worldwide owing to the progressive degeneration of retinal ganglion neurons (PubMed:21224891). {ECO:0000269|PubMed:21224891}.; 	0.0819	0.1823	1.298854499	93.91365888	2951.663	10.29586	0.007	0.599	D	0.915	0.486	P	0.302	0.394	B	0.003	0.363	N	1	0.090	N	2.36	0.681	M	-1.21	0.787	T	-4.57	0.787	D	0.522	0.663	-0.748	0.581	T	0.243	0.611	T	0.035	0.562	D	1.437	0.235	12.98	0.939	0.233	0.047	0.103	N	c	-0.324	-0.447	0.001	0.075	0.487	0.133	0	0.783	0.176	2.220	0.423	0.064	0.169	0.036	0.206	0.414	0.256	0.820	0.010	.	.	.	0.5	.	49	chr14	21762920	chr14:21762920	A	T	.	PASS	AN=0;DP=49	GT	0/1
chr14	23795278	23795278	G	A	UTR3	BCL2L2-PABPN1;PABPN1	NM_001199864:c.*783G>A;NM_004643:c.*783G>A	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	50	chr14	23795278	chr14:23795278	G	A	.	PASS	AN=0;DP=50	GT	0/1
chr14	53223298	53223298	C	T	exonic	STYX	.	nonsynonymous SNV	STYX:NM_145251:exon5:c.C272T:p.P91L,STYX:NM_001130701:exon6:c.C272T:p.P91L	0.972068618	0.027923972	7.41E-06	.	0.34326	0.10535	-0.163345027	41.24793583	41.45856	1.21063	0.029	0.457	D	0.883	0.466	P	0.751	0.542	P	0.000	0.843	N	1	0.810	D	2.265	0.646	M	-1.97	0.852	D	-4.26	0.761	D	0.83	0.825	0.113	0.844	D	0.671	0.886	D	0.062	0.687	D	5.296	0.716	25.7	0.998	0.897	0.989	0.889	D	c	0.579	0.611	1.000	0.747	0.706	0.609	0	5.47	0.803	6.924	0.755	0.848	0.348	1.000	0.715	1.000	0.888	19.704	0.960	Dual specificity phosphatase, catalytic domain|Dual specificity protein phosphatase domain|Protein-tyrosine phosphatase-like	.	.	0.5	.	49	chr14	53223298	chr14:53223298	C	T	.	PASS	AN=0;DP=49	GT	0/1
chr14	59798084	59798084	G	C	exonic	DAAM1	.	nonsynonymous SNV	DAAM1:NM_014992:exon13:c.G1718C:p.G573A,DAAM1:NM_001270520:exon14:c.G1718C:p.G573A	0.999990849	9.15E-06	9.48E-16	.	0.80371	0.12758	-1.550537744	3.249587167	138.50311	2.56335	1.0	0.010	T	0.004	0.112	B	0.008	0.127	B	0.000	0.843	D	1.000	0.588	D	2.11	0.588	M	2.03	0.210	T	-1.43	0.352	N	0.349	0.410	-1.085	0.064	T	0.077	0.308	T	0.022	0.447	T	1.182	0.208	11.65	0.862	0.159	0.990	0.896	D	c	0.243	0.418	1.000	0.747	0.651	0.465	0	6.16	0.993	7.458	0.797	1.048	0.713	1.000	0.715	0.965	0.450	20.470	0.992	.	.	.	0.5	71	54	chr14	59798084	chr14:59798084	G	C	71	PASS	AN=2;DP=54	GT	0/1
chr14	69254591	69254591	C	T	UTR3	ZFP36L1	NM_001244701:c.*1659G>A;NM_004926:c.*1659G>A;NM_001244698:c.*942G>A	.	.	0.506697565	0.474555905	0.01874653	.	0.93468	.	-0.053113545	49.38664779	17.82662	0.62283	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	70	chr14	69254591	chr14:69254591	C	T	.	PASS	AN=0;DP=70	GT	0/1
chr14	72204995	72204995	G	T	exonic	SIPA1L1	.	nonsynonymous SNV	SIPA1L1:NM_001284245:exon20:c.G5161T:p.D1721Y,SIPA1L1:NM_001284246:exon20:c.G5158T:p.D1720Y,SIPA1L1:NM_001284247:exon20:c.G5221T:p.D1741Y,SIPA1L1:NM_015556:exon21:c.G5224T:p.D1742Y	0.999999774	2.26E-07	1.15E-19	.	0.53561	0.11441	-2.73449852	0.701816466	229.73804	3.27537	1.0	0.059	T	0.904	0.479	P	0.439	0.490	B	0.000	0.513	D	0.998	0.444	D	-0.35	0.031	N	1.55	0.299	T	-0.63	0.249	N	0.645	0.711	-1.080	0.073	T	0.054	0.230	T	0.008	0.218	T	3.841	0.518	23.4	0.284	0.015	0.963	0.685	D	c	0.088	0.283	1.000	0.747	0.732	0.924	0	5.92	0.955	3.817	0.551	1.048	0.713	1.000	0.715	1.000	0.888	14.470	0.669	Signal-induced proliferation-associated 1-like protein, C-terminal	.	.	0.5	.	27	chr14	72204995	chr14:72204995	G	T	.	PASS	AN=0;DP=27	GT	0/1
chr14	73959622	73959622	C	T	exonic	RIOX1	.	unknown	UNKNOWN	.	.	.	.	.	.	.	.	.	.	.	.	.	0.803	0.432	P	0.471	0.450	P	.	.	.	1	0.810	D	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	1.406	0.232	12.82	0.904	0.191	0.882	0.477	D	n	1.877	0.469	1.000	0.747	0.288	0.042	1	5.95	0.964	3.791	0.549	0.935	0.490	1.000	0.715	0.998	0.697	18.574	0.911	.	.	.	0.5	.	29	chr14	73959622	chr14:73959622	C	T	.	PASS	AN=0;DP=29	GT	0/1
chr14	76198733	76198734	GG	-	exonic	TTLL5	.	frameshift deletion	TTLL5:NM_015072:exon13:c.1095_1096del:p.E366Sfs*9	1.98E-09	0.999999387	6.11E-07	DISEASE: Cone-rod dystrophy 19 (CORD19) [MIM:615860]: A form of cone-rod dystrophy, an inherited retinal dystrophy characterized by retinal pigment deposits visible on fundus examination, predominantly in the macular region, and initial loss of cone photoreceptors followed by rod degeneration. This leads to decreased visual acuity and sensitivity in the central visual field, followed by loss of peripheral vision. Severe loss of vision occurs earlier than in retinitis pigmentosa. {ECO:0000269|PubMed:24791901}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.60603	.	-0.916836882	9.831328143	5848.36871	15.85461	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	10.05	24	chr14	76198732	chr14:76198732	TGG	T	10.05	PASS	AN=0;DP=24	GT	0/1
chr14	77491444	77491444	G	A	UTR3	IRF2BPL	NM_024496:c.*301C>T	.	.	0.968935346	0.031017133	4.75E-05	.	0.69645	0.11157	.	.	62.7394	1.62021	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	41	chr14	77491444	chr14:77491444	G	A	.	PASS	AN=0;DP=41	GT	0/1
chr14	80677829	80677829	T	C	ncRNA_exonic	DIO2-AS1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	60	66	chr14	80677829	chr14:80677829	T	C	60	PASS	AN=2;DP=66	GT	0/1
chr14	94245589	94245589	G	A	exonic	PRIMA1	.	synonymous SNV	PRIMA1:NM_178013:exon3:c.C162T:p.C54C	0.367086766	0.583623514	0.049289721	.	0.17164	0.15948	-0.163345027	41.24793583	5.69887	0.21345	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	61	chr14	94245589	chr14:94245589	G	A	.	PASS	AN=0;DP=61	GT	0/1
chr14	97022210	97022210	C	G	exonic	PAPOLA	.	nonsynonymous SNV	PAPOLA:NM_001293632:exon16:c.C941G:p.T314R,PAPOLA:NM_001293627:exon18:c.C1688G:p.T563R,PAPOLA:NM_001293628:exon18:c.C941G:p.T314R,PAPOLA:NM_032632:exon18:c.C1691G:p.T564R	0.99997169	2.83E-05	3.62E-13	.	0.90955	0.10702	-0.626318434	17.03231894	20.93686	0.70876	0.398	0.310	T	0.365	0.382	B	0.135	0.316	B	0.000	0.523	D	1.000	0.503	D	2.005	0.547	M	.	.	.	-0.2	0.197	N	0.329	0.674	-1.017	0.247	T	0.111	0.400	T	0.005	0.125	T	2.244	0.331	17.80	0.967	0.301	0.975	0.752	D	c	0.070	0.224	1.000	0.747	0.707	0.730	0	4.92	0.640	5.366	0.656	0.935	0.490	1.000	0.715	1.000	0.888	15.066	0.715	.	.	.	0.5	55	46	chr14	97022210	chr14:97022210	C	G	55	PASS	AN=2;DP=46	GT	0/1
chr14	99976600	99976600	C	T	exonic	CCNK	.	synonymous SNV	CCNK:NM_001099402:exon11:c.C1224T:p.A408A	0.997144332	0.002855531	1.37E-07	.	0.88116	0.11977	-0.361761279	28.6329323	38.13805	1.13298	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	161	chr14	99976600	chr14:99976600	C	T	.	PASS	AN=0;DP=161	GT	0/1
chr14	99976649	99976649	C	A	exonic	CCNK	.	nonsynonymous SNV	CCNK:NM_001099402:exon11:c.C1273A:p.P425T	0.997144332	0.002855531	1.37E-07	.	0.88116	0.11977	-0.361761279	28.6329323	38.13805	1.13298	0.0	0.912	D	0.19	0.277	B	0.055	0.246	B	0.000	0.629	D	1.000	0.810	D	0.975	0.246	L	2.01	0.213	T	-2.39	0.526	N	0.373	0.434	-1.066	0.103	T	0.032	0.139	T	0.025	0.484	D	2.436	0.354	19.06	0.971	0.316	0.960	0.670	D	c	-0.541	-0.466	1.000	0.489	0.651	0.465	0	3.07	0.343	5.323	0.654	0.708	0.301	1.000	0.715	0.554	0.280	11.447	0.492	.	.	.	0.5	.	267	chr14	99976649	chr14:99976649	C	A	.	PASS	AN=0;DP=267	GT	0/1
chr14	100595003	100595004	CC	-	exonic	EVL	.	frameshift deletion	EVL:NM_001330221:exon6:c.629_630del:p.Q211Gfs*83,EVL:NM_016337:exon6:c.635_636del:p.Q213Gfs*83	0.99261527	0.007384449	2.82E-07	.	0.74284	0.16663	-0.359940251	28.93371078	237.51255	3.32761	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	62	151	chr14	100595002	chr14:100595002	GCC	G	62	PASS	AN=2;DP=151	GT	0/1
chr14	101012878	101012878	C	T	exonic	BEGAIN	.	nonsynonymous SNV	BEGAIN:NM_001159531:exon2:c.G136A:p.A46T,BEGAIN:NM_020836:exon3:c.G136A:p.A46T	0.890710075	0.109057883	0.000232042	.	0.15443	0.10913	-0.600630256	18.06440198	2832.62632	10.04643	0.084	0.329	T	1.0	0.899	D	0.998	0.875	D	0.000	0.843	U	1	0.810	D	1.67	0.430	L	0.89	0.456	T	-0.59	0.221	N	0.403	0.462	-0.946	0.417	T	0.169	0.510	T	0.427	0.939	D	6.399	0.883	29.6	0.997	0.787	0.751	0.365	D	c	0.340	0.344	1.0	0.983	0.685	0.552	0	4.59	0.561	2.610	0.457	0.869	0.378	0.970	0.340	0.997	0.653	14.965	0.707	.	.	.	0.5	.	91	chr14	101012878	chr14:101012878	C	T	.	PASS	AN=0;DP=91	GT	0/1
chr14	103193645	103193645	G	T	UTR3	RCOR1	NM_015156:c.*802G>T	.	.	0.994042795	0.005957038	1.67E-07	.	0.15896	0.16064	-0.251530012	35.42108988	30.15903	0.962	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	66	chr14	103193645	chr14:103193645	G	T	.	PASS	AN=0;DP=66	GT	0/1
chr15	30011233	30011233	G	A	exonic	TJP1	.	nonsynonymous SNV	TJP1:NM_175610:exon20:c.C2873T:p.T958I,TJP1:NM_001301026:exon21:c.C2885T:p.T962I,TJP1:NM_001330239:exon21:c.C3113T:p.T1038I,TJP1:NM_003257:exon21:c.C3113T:p.T1038I,TJP1:NM_001301025:exon22:c.C3314T:p.T1105I	0.999999982	1.77E-08	4.72E-23	.	0.25442	0.73774	-1.784094322	2.264685067	1761.96515	7.74921	0.083	0.361	T	0.0	0.026	B	0.001	0.063	B	0.000	0.523	D	0.997	0.227	N	-0.345	0.033	N	3.36	0.059	T	-1.4	0.404	N	0.025	0.012	-0.917	0.460	T	0.008	0.028	T	0.005	0.128	T	1.444	0.236	13.02	0.978	0.354	0.861	0.451	D	c	-0.447	-0.234	0.999	0.387	0.707	0.730	0	4.05	0.462	0.794	0.264	0.094	0.197	0.996	0.391	0.872	0.365	2.983	0.056	.	.	.	0.5	.	29	chr15	30011233	chr15:30011233	G	A	.	PASS	AN=0;DP=29	GT	0/1
chr15	41793740	41793740	A	C	exonic	ITPKA	.	nonsynonymous SNV	ITPKA:NM_002220:exon2:c.A569C:p.Q190P	0.821022369	0.17811602	0.000861612	.	0.21376	0.12708	.	.	45.24026	1.29149	0.001	0.784	D	0.998	0.715	D	0.992	0.790	D	0.000	0.843	D	1	0.810	D	2.415	0.700	M	2.16	0.192	T	-5.36	0.865	D	0.938	0.963	-0.878	0.500	T	0.139	0.458	T	0.078	0.729	D	5.972	0.821	27.7	0.992	0.559	0.990	0.899	D	c	0.755	0.710	1.000	0.747	0.455	0.088	0	4.71	0.589	9.315	0.954	1.088	0.866	1.000	0.715	0.994	0.587	14.341	0.660	.	.	.	0.5	75	103	chr15	41793740	chr15:41793740	A	C	75	PASS	AN=2;DP=103	GT	0/1
chr15	62994910	62994990	TGGCACTGGAGGAAATGCGTTTTCTTTCCAATTAAGGTGTGTTGTTTGTTCACAGCCTCGACAGACAGTTTTGACTGCTGC	-	exonic	TLN2	.	frameshift deletion	TLN2:NM_015059:exon16:c.1906_1931del:p.P636Wfs*17	0.999853231	0.000146769	3.85E-21	.	0.30553	0.44698	-3.469503166	0.353857042	2221.48407	8.67915	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	18.23	16	chr15	62994909	chr15:62994909	ATGGCACTGGAGGAAATGCGTTTTCTTTCCAATTAAGGTGTGTTGTTTGTTCACAGCCTCGACAGACAGTTTTGACTGCTGC	A	18.23	PASS	AN=0;DP=16	GT	0/1
chr15	63578882	63578882	G	C	intronic	APH1B	.	.	.	0.000234972	0.755441753	0.244323275	.	0.35427	0.1717	0.527368849	80.73248408	641.866	5.09067	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	73	69	chr15	63578882	chr15:63578882	G	C	73	PASS	AN=2;DP=69	GT	0/1
chr16	1388492	1388492	G	T	intronic	BAIAP3	.	.	.	2.21E-19	0.088488031	0.911511969	.	0.29593	0.09988	-2.150176731	1.468506723	719.07294	5.32413	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	53	chr16	1388492	chr16:1388492	G	T	.	PASS	AN=0;DP=53	GT	0/1
chr16	4659106	4659106	G	A	UTR3	UBALD1	NM_145253:c.*528C>T;NM_001330467:c.*528C>T	.	.	0.700158646	0.283270811	0.016570543	.	0.21518	.	0.25917371	70.05779665	2776.98923	9.95318	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	68	chr16	4659106	chr16:4659106	G	A	.	PASS	AN=0;DP=68	GT	0/1
chr16	29376056	29376056	T	A	ncRNA_exonic	SNX29P2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	31	chr16	29376056	chr16:29376056	T	A	.	PASS	AN=0;DP=31	GT	0/1
chr16	29825016	29825016	C	-	exonic	PRRT2	.	frameshift deletion	PRRT2:NM_001256442:exon2:c.641delC:p.R217Efs*11,PRRT2:NM_001256443:exon2:c.641delC:p.R217Efs*11,PRRT2:NM_145239:exon2:c.641delC:p.R217Efs*11	0.301735693	0.679146035	0.019118272	DISEASE: Episodic kinesigenic dyskinesia 1 (EKD1) [MIM:128200]: An autosomal dominant neurologic condition characterized by recurrent and brief attacks of abnormal involuntary movements, triggered by sudden voluntary movement. These attacks usually have onset during childhood or early adulthood and can involve dystonic postures, chorea, or athetosis. {ECO:0000269|PubMed:22101681, ECO:0000269|PubMed:22120146, ECO:0000269|PubMed:22131361, ECO:0000269|PubMed:22209761}. Note=The disease is caused by mutations affecting the gene represented in this entry. Disease- causing mutations that produce truncation of the C-terminus of the protein alter subcellular location, from plasma membrane to cytosplasm (PubMed:22101681). {ECO:0000269|PubMed:22101681}.; DISEASE: Convulsions, familial infantile, with paroxysmal choreoathetosis (ICCA) [MIM:602066]: A syndrome characterized by clinical features of benign familial infantile seizures and episodic kinesigenic dyskinesia. Benign familial infantile seizures is a disorder characterized by afebrile seizures occurring during the first year of life, without neurologic sequelae. Paroxysmal choreoathetosis is a disorder of involuntary movements characterized by attacks that occur spontaneously or are induced by a variety of stimuli. {ECO:0000269|PubMed:22243967}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Seizures, benign familial infantile 2 (BFIS2) [MIM:605751]: An autosomal dominant disorder in which afebrile seizures occur in clusters during the first year of life, without neurologic sequelae. {ECO:0000269|PubMed:22243967, ECO:0000269|PubMed:22399141, ECO:0000269|PubMed:22623405}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.30697	0.08082	0.549415813	81.38122199	216.41438	3.17873	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	66	44	chr16	29825015	chr16:29825015	GC	G	66	PASS	AN=2;DP=44	GT	0/1
chr16	30680303	30680303	G	A	intronic	FBRS	.	.	.	0.981524682	0.018462136	1.32E-05	.	0.32662	.	.	.	201.82278	3.06617	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	57	chr16	30680303	chr16:30680303	G	A	.	PASS	AN=0;DP=57	GT	0/1
chr16	31734070	31734070	C	T	exonic	ZNF720	.	synonymous SNV	ZNF720:NM_001130913:exon2:c.C127T:p.L43L	0.055960456	0.707057236	0.236982308	.	0.06899	.	0.58987904	82.3720217	19.56487	0.67154	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	47	chr16	31734070	chr16:31734070	C	T	.	PASS	AN=0;DP=47	GT	0/1
chr16	67212710	67212710	C	-	intronic	KIAA0895L	.	.	.	0.018433058	0.961138313	0.02042863	.	.	.	0.150760231	64.51403633	718.9968	5.32337	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	65	162	chr16	67212709	chr16:67212709	GC	G	65	PASS	AN=2;DP=162	GT	0/1
chr16	67763279	67763281	GAG	-	exonic	RANBP10	.	nonframeshift deletion	RANBP10:NM_001320238:exon9:c.903_905del:p.S305del,RANBP10:NM_001320239:exon9:c.1086_1088del:p.S366del,RANBP10:NM_020850:exon10:c.1254_1256del:p.S422del,RANBP10:NM_001320240:exon13:c.567_569del:p.S193del	0.951824229	0.04817459	1.18E-06	.	0.5861	0.11289	-0.843147538	11.2762444	72.21908	1.77081	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	43	38	chr16	67763278	chr16:67763278	CGAG	C	43	PASS	AN=2;DP=38	GT	0/1
chr16	68057932	68057932	G	A	intronic	DUS2	.	.	.	0.000272032	0.999072268	0.0006557	.	0.08346	0.11249	-0.400392389	26.85185185	261.28866	3.47039	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	72	chr16	68057932	chr16:68057932	G	A	.	PASS	AN=0;DP=72	GT	0/1
chr16	72817165	72817165	C	T	UTR3	ZFHX3	NM_006885:c.*3898G>A;NM_001164766:c.*3898G>A	.	.	1	1.41E-10	8.85E-27	.	0.74579	0.15507	-4.263203714	0.117952347	6032.74571	16.21079	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	41	chr16	72817165	chr16:72817165	C	T	.	PASS	AN=0;DP=41	GT	0/1
chr16	72830474	72830474	G	A	exonic	ZFHX3	.	nonsynonymous SNV	ZFHX3:NM_001164766:exon8:c.C3365T:p.T1122I,ZFHX3:NM_006885:exon9:c.C6107T:p.T2036I	1	1.41E-10	8.85E-27	.	0.74579	0.15507	-4.263203714	0.117952347	6032.74571	16.21079	0.008	0.614	D	0.889	0.469	P	0.444	0.441	B	0.001	0.415	D	1.000	0.588	D	0.55	0.145	N	-0.82	0.741	T	-2.68	0.572	D	0.501	0.575	-0.362	0.732	T	0.320	0.689	T	0.059	0.677	D	2.478	0.359	19.33	0.988	0.461	0.982	0.799	D	c	0.180	0.230	1.000	0.473	0.651	0.465	0	4.69	0.584	6.931	0.755	0.056	0.163	1.000	0.715	0.989	0.536	16.740	0.852	.	.	.	0.5	.	74	chr16	72830474	chr16:72830474	G	A	.	PASS	AN=0;DP=74	GT	0/1
chr16	81744000	81744000	A	G	UTR3	CMIP	NM_198390:c.*596A>G;NM_030629:c.*596A>G	.	.	0.999886587	0.000113413	5.26E-11	.	.	.	-1.530301957	3.367539514	21.62477	0.72736	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	81	187	chr16	81744000	chr16:81744000	A	G	81	PASS	AN=2;DP=187	GT	0/1
chr16	81744041	81744041	C	T	UTR3	CMIP	NM_198390:c.*637C>T;NM_030629:c.*637C>T	.	.	0.999886587	0.000113413	5.26E-11	.	.	.	-1.530301957	3.367539514	21.62477	0.72736	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	181	chr16	81744041	chr16:81744041	C	T	.	PASS	AN=0;DP=181	GT	0/1
chr16	89652189	89652189	G	A	exonic	CPNE7	.	nonsynonymous SNV	CPNE7:NM_153636:exon7:c.G776A:p.G259E,CPNE7:NM_014427:exon9:c.G1001A:p.G334E	1.63E-13	0.026868774	0.973131226	.	0.10022	.	-1.343026423	4.647322482	1754.91457	7.73074	0.506	0.076	T	0.0	0.067	B	0.001	0.063	B	0.108	0.196	N	1.000	0.207	N	0.495	0.134	N	2.5	0.145	T	0.02	0.068	N	0.048	0.029	-0.940	0.427	T	0.014	0.057	T	0.004	0.088	T	-1.122	0.028	0.009	0.267	0.013	0.099	0.153	N	c	-1.187	-1.130	0.999	0.371	0.706	0.609	0	-2.01	0.070	1.953	0.397	-0.061	0.121	0.998	0.411	0.048	0.163	9.838	0.400	C2 domain	.	.	0.5	.	107	chr16	89652189	chr16:89652189	G	A	.	PASS	AN=0;DP=107	GT	0/1
chr16	89828321	89828321	T	C	intronic	FANCA	.	.	.	2.08E-34	0.000122619	0.999877381	DISEASE: Fanconi anemia, complementation group A (FANCA) [MIM:227650]: A disorder affecting all bone marrow elements and resulting in anemia, leukopenia and thrombopenia. It is associated with cardiac, renal and limb malformations, dermal pigmentary changes, and a predisposition to the development of malignancies. At the cellular level it is associated with hypersensitivity to DNA-damaging agents, chromosomal instability (increased chromosome breakage) and defective DNA repair. {ECO:0000269|PubMed:10094191, ECO:0000269|PubMed:10210316, ECO:0000269|PubMed:10521298, ECO:0000269|PubMed:10807541, ECO:0000269|PubMed:11091222, ECO:0000269|PubMed:17924555, ECO:0000269|PubMed:9371798, ECO:0000269|PubMed:9399890, ECO:0000269|PubMed:9929978}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.23385	0.24341	-0.101294944	45.66525124	1788.01434	7.80511	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	41	29	chr16	89828321	chr16:89828321	T	C	41	PASS	AN=2;DP=29	GT	0/1
chr17	4623871	4623871	G	T	exonic	ARRB2	.	nonsynonymous SNV	ARRB2:NM_001257331:exon13:c.G1063T:p.V355F,ARRB2:NM_001257330:exon14:c.G1108T:p.V370F	0.769282968	0.230644341	7.27E-05	.	0.58827	0.57942	-0.670411825	15.61689078	141.04803	2.59189	.	.	.	0.013	0.154	B	0.017	0.170	B	0.038	0.243	U	1	0.090	N	.	.	.	2.51	0.143	T	.	.	.	0.12	0.134	-1.081	0.070	T	0.040	0.173	T	0.001	0.007	T	-0.581	0.051	0.139	0.172	0.005	0.030	0.078	N	c	-1.501	-1.618	1.000	0.489	0.732	0.924	0	-3.08	0.050	-2.289	0.012	-2.092	0.004	0.000	0.063	0.000	0.016	1.004	0.014	Arrestin, C-terminal|Immunoglobulin E-set	.	.	0.5	.	46	chr17	4623871	chr17:4623871	G	T	.	PASS	AN=0;DP=46	GT	0/1
chr17	5118228	5118229	TC	-	exonic	SCIMP	.	frameshift deletion	SCIMP:NM_001271842:exon4:c.253_254del:p.E85Rfs*19,SCIMP:NM_001319190:exon4:c.253_254del:p.E85Rfs*64,SCIMP:NM_207103:exon4:c.274_275del:p.E92Rfs*19	0.012575344	0.855696202	0.131728455	.	0.1304	.	-0.163345027	41.24793583	10.11893	0.36946	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	12.39	37	chr17	5118227	chr17:5118227	TTC	T	12.39	PASS	AN=0;DP=37	GT	0/1
chr17	8063677	8063677	G	C	UTR3	VAMP2	NM_001330125:c.*496C>G;NM_014232:c.*496C>G	.	.	0.837117601	0.159707638	0.003174761	.	0.42512	0.11262	-0.053113545	49.38664779	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	65	46	chr17	8063677	chr17:8063677	G	C	65	PASS	AN=2;DP=46	GT	0/1
chr17	12920458	12920458	C	T	intronic	ELAC2	.	.	.	4.06E-11	0.920902555	0.079097445	DISEASE: Combined oxidative phosphorylation deficiency 17 (COXPD17) [MIM:615440]: An autosomal recessive disorder of mitochondrial dysfunction characterized by onset of severe hypertrophic cardiomyopathy in the first year of life. Other features include hypotonia, poor growth, lactic acidosis, and failure to thrive. The disorder may be fatal in early childhood. {ECO:0000269|PubMed:23849775}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.04345	0.09787	-0.905656269	10.12031139	1342.48638	6.87747	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	19	chr17	12920458	chr17:12920458	C	T	.	PASS	AN=0;DP=19	GT	0/1
chr17	19314785	19314786	CA	-	intronic	RNF112	.	.	.	0.00365674	0.987234978	0.009108282	.	0.32157	0.24246	.	.	57.58728	1.53211	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	78	125	chr17	19314784	chr17:19314784	TCA	T	78	PASS	AN=2;DP=125	GT	0/1
chr17	21535980	21535981	CA	-	intergenic	C17orf51;UBBP4	dist=81039;dist=193620	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	43	15	chr17	21535979	chr17:21535979	TCA	T	43	PASS	AN=2;DP=15	GT	0/1
chr17	29171852	29171852	G	A	splicing	ATAD5	NM_024857:exon6:c.2369-1G>A	.	.	0.999999945	5.46E-08	8.84E-20	.	0.36789	.	-0.053328617	48.95022411	8284.30154	19.69105	.	.	.	.	.	.	.	.	.	.	.	.	1	0.810	D	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	5.681	0.775	26.7	0.994	0.637	0.992	0.921	D	c	1.181	1.041	1.000	0.500	0.156	0.027	0	5.74	0.900	7.180	0.770	1.030	0.653	1.000	0.715	1.000	0.888	17.498	0.876	.	.	.	0.5	.	73	chr17	29171852	chr17:29171852	G	A	.	PASS	AN=0;DP=73	GT	0/1
chr17	36352489	36352489	A	C	ncRNA_exonic	LOC440434	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	69	8	chr17	36352489	chr17:36352489	A	C	69	PASS	AN=2;DP=8	GT	1/0
chr17	39257792	39257801	GAGGGGAGGG	-	intronic	KRTAP4-8	.	.	.	0.009770819	0.598577344	0.391651837	.	0.12236	.	.	.	6576.55433	17.09261	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	107	40	chr17	39257791	chr17:39257791	TGAGGGGAGGG	T	107	PASS	AN=2;DP=40	GT	0/1
chr17	41622671	41622671	G	A	exonic	ETV4	.	nonsynonymous SNV	ETV4:NM_001261437:exon2:c.C8T:p.P3L,ETV4:NM_001261438:exon2:c.C8T:p.P3L,ETV4:NM_001079675:exon3:c.C125T:p.P42L,ETV4:NM_001986:exon3:c.C125T:p.P42L	0.00270291	0.994402078	0.002895012	.	0.5648	0.45988	0.286674996	71.49681529	207.59681	3.11139	0.086	0.912	T	0.465	0.899	P	0.033	0.916	B	0.602	0.109	N	0.999	0.479	D	1.845	0.488	L	2.08	0.202	T	-1.31	0.328	N	0.374	0.442	-1.149	0.011	T	0.100	0.372	T	0.013	0.331	T	4.969	0.668	25.1	0.999	0.941	0.941	0.598	D	c	0.322	0.366	1.000	0.747	0.564	0.319	0	4.32	0.507	5.122	0.643	1.047	0.674	1.000	0.715	0.998	0.697	12.962	0.577	PEA3-type ETS-domain transcription factor, N-terminal	.	.	0.5	.	60	chr17	41622671	chr17:41622671	G	A	.	PASS	AN=0;DP=60	GT	0/1
chr17	45727516	45727516	C	T	UTR5	KPNB1	NM_002265:c.-95C>T	.	.	0.999994328	5.67E-06	7.22E-15	.	0.99948	0.5595	-0.624497208	17.16206653	28.74247	0.91953	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	50	chr17	45727516	chr17:45727516	C	T	.	PASS	AN=0;DP=50	GT	0/1
chr17	48594609	48594612	CCTG	-	intronic	MYCBPAP	.	.	.	0.001733006	0.998221165	4.58E-05	.	0.09337	0.08885	2.011818712	97.67633876	2351.86361	8.98627	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	40	13	chr17	48594608	chr17:48594608	TCCTG	T	40	PASS	AN=2;DP=13	GT	0/1
chr17	60814330	60814330	C	T	exonic	MARCH10	.	nonsynonymous SNV	MARCH10:NM_001100875:exon6:c.G899A:p.C300Y,MARCH10:NM_152598:exon6:c.G899A:p.C300Y,MARCH10:NM_001288779:exon7:c.G1013A:p.C338Y,MARCH10:NM_001288780:exon7:c.G896A:p.C299Y	.	.	.	.	.	.	.	.	.	.	0.041	0.419	D	0.143	0.287	B	0.057	0.308	B	0.009	0.306	N	1.000	0.192	N	0	0.065	N	1.49	0.315	T	-0.18	0.098	N	0.156	0.214	-0.989	0.329	T	0.031	0.135	T	0.001	0.012	T	0.290	0.122	5.598	0.592	0.060	0.007	0.030	N	c	-0.933	-0.821	0.242	0.186	0.447	0.083	0	4.16	0.480	1.732	0.375	0.182	0.247	0.957	0.332	0.001	0.043	7.162	0.247	.	.	.	0.5	.	26	chr17	60814330	chr17:60814330	C	T	.	PASS	AN=0;DP=26	GT	0/1
chr17	65068106	65068106	C	T	UTR3	HELZ	NM_014877:c.*6262G>A;NM_001330447:c.*6262G>A	.	.	1	3.48E-11	7.19E-27	.	0.33626	0.09834	-1.210720546	5.708893607	2913.40807	10.24388	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	66	chr17	65068106	chr17:65068106	C	T	.	PASS	AN=0;DP=66	GT	0/1
chr17	66525038	66525038	C	T	exonic	PRKAR1A	.	nonsynonymous SNV	PRKAR1A:NM_001276290:exon8:c.C797T:p.T266M,PRKAR1A:NM_001278433:exon9:c.C797T:p.T266M,PRKAR1A:NM_002734:exon9:c.C797T:p.T266M,PRKAR1A:NM_212471:exon9:c.C797T:p.T266M,PRKAR1A:NM_212472:exon9:c.C797T:p.T266M,PRKAR1A:NM_001276289:exon10:c.C797T:p.T266M	0.999223269	0.000776725	5.72E-09	DISEASE: Carney complex 1 (CNC1) [MIM:160980]: CNC is a multiple neoplasia syndrome characterized by spotty skin pigmentation, cardiac and other myxomas, endocrine tumors, and psammomatous melanotic schwannomas. {ECO:0000269|PubMed:15371594, ECO:0000269|PubMed:18241045, ECO:0000269|PubMed:22785148, ECO:0000269|PubMed:23323113}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Intracardiac myxoma (INTMYX) [MIM:255960]: Inheritance is autosomal recessive. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Primary pigmented nodular adrenocortical disease 1 (PPNAD1) [MIM:610489]: A rare bilateral adrenal defect causing ACTH-independent Cushing syndrome. Macroscopic appearance of the adrenals is characteristic with small pigmented micronodules observed in the cortex. Clinical manifestations of Cushing syndrome include facial and truncal obesity, abdominal striae, muscular weakness, osteoporosis, arterial hypertension, diabetes. PPNAD1 is most often diagnosed in patients with Carney complex, a multiple neoplasia syndrome. However it can also be observed in patients without other manifestations. {ECO:0000269|PubMed:12213893}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Acrodysostosis 1, with or without hormone resistance (ACRDYS1) [MIM:101800]: A form of skeletal dysplasia characterized by short stature, severe brachydactyly, facial dysostosis, and nasal hypoplasia. Affected individuals often have advanced bone age and obesity. Laboratory studies show resistance to multiple hormones, including parathyroid, thyrotropin, calcitonin, growth hormone-releasing hormone, and gonadotropin. However, not all patients show endocrine abnormalities. {ECO:0000269|PubMed:21651393, ECO:0000269|PubMed:22464250, ECO:0000269|PubMed:22464252, ECO:0000269|PubMed:22723333, ECO:0000269|PubMed:23043190, ECO:0000269|PubMed:23425300}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.93386	0.7266	-0.339715008	30.06605331	5.79493	0.21858	0.011	0.555	D	0.999	0.764	D	0.854	0.591	P	0.000	0.843	D	1	0.810	D	3.18	0.890	M	-0.6	0.717	T	-4.4	0.773	D	0.699	0.703	0.320	0.879	D	0.598	0.857	D	0.153	0.835	D	5.630	0.767	26.6	0.998	0.854	0.982	0.806	D	c	0.908	0.869	1.000	0.747	0.732	0.924	0	5.89	0.947	6.180	0.717	0.015	0.141	1.000	0.715	0.706	0.311	20.244	0.984	Cyclic nucleotide-binding domain|Cyclic nucleotide-binding-like|RmlC-like jelly roll fold	.	.	0.5	58	53	chr17	66525038	chr17:66525038	C	T	58	PASS	AN=2;DP=53	GT	0/1
chr17	73258083	73258085	GCG	-	intronic	GGA3;MRPS7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	54	64	chr17	73258082	chr17:73258082	AGCG	A	54	PASS	AN=2;DP=64	GT	0/1
chr17	73570259	73570259	A	T	intronic	LLGL2	.	.	.	8.27E-07	0.999084868	0.000914305	.	.	.	1.04528704	91.31280962	9919.23727	21.67473	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	32	chr17	73570259	chr17:73570259	A	T	.	PASS	AN=0;DP=32	GT	0/1
chr17	73967906	73967906	T	-	intronic	ACOX1	.	.	.	0.094435306	0.905495422	6.93E-05	.	0.16046	0.77183	0.134171522	63.57041755	194.54546	3.02364	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	42	45	chr17	73967905	chr17:73967905	GT	G	42	PASS	AN=2;DP=45	GT	0/1
chr17	74017790	74017790	C	A	exonic	EVPL	.	nonsynonymous SNV	EVPL:NM_001320747:exon8:c.G880T:p.V294L,EVPL:NM_001988:exon8:c.G880T:p.V294L	6.49E-14	0.99720216	0.00279784	.	0.45755	0.25979	0.769689266	86.89549422	2455.91155	9.22294	0.801	0.031	T	0.43	0.338	B	0.1	0.291	B	0.005	0.332	N	0.830	0.288	N	1.43	0.360	L	1.54	0.301	T	-0.74	0.208	N	0.227	0.278	-1.015	0.253	T	0.037	0.162	T	0.011	0.275	T	2.800	0.397	21.4	0.961	0.281	0.672	0.331	D	c	-0.544	-0.460	0.034	0.142	0.515	0.199	0	0.936	0.185	-0.394	0.073	0.889	0.393	0.087	0.223	0.996	0.625	3.251	0.064	.	.	.	0.5	.	65	chr17	74017790	chr17:74017790	C	A	.	PASS	AN=0;DP=65	GT	0/1
chr17	74017795	74017795	C	T	exonic	EVPL	.	nonsynonymous SNV	EVPL:NM_001320747:exon8:c.G875A:p.R292H,EVPL:NM_001988:exon8:c.G875A:p.R292H	6.49E-14	0.99720216	0.00279784	.	0.45755	0.25979	0.769689266	86.89549422	2455.91155	9.22294	0.007	0.599	D	0.993	0.899	D	0.64	0.850	P	0.000	0.559	D	0.999	0.455	D	2.35	0.677	M	1.44	0.327	T	-3.02	0.626	D	0.479	0.528	-0.739	0.585	T	0.184	0.533	T	0.112	0.791	D	6.262	0.865	29.0	0.999	0.997	0.585	0.304	D	c	0.437	0.374	0.994	0.335	0.515	0.199	0	4.33	0.509	2.194	0.421	0.889	0.393	0.554	0.271	0.981	0.494	14.345	0.661	.	.	.	0.5	.	60	chr17	74017795	chr17:74017795	C	T	.	PASS	AN=0;DP=60	GT	0/1
chr17	74388160	74388160	C	-	exonic	UBE2O	.	frameshift deletion	UBE2O:NM_022066:exon16:c.2981delG:p.R994Qfs*35	0.999985318	1.47E-05	7.32E-14	.	0.53648	0.1104	-0.813834387	12.05472989	3680.76091	11.80398	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	69	36	chr17	74388159	chr17:74388159	TC	T	69	PASS	AN=2;DP=36	GT	0/1
chr17	74722910	74722910	C	T	upstream	JMJD6;METTL23	dist=2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	42	chr17	74722910	chr17:74722910	C	T	.	PASS	AN=0;DP=42	GT	0/1
chr17	74723008	74723009	GC	-	UTR5	METTL23	NM_001206985:c.-6169_-6168del-;NM_001080510:c.-2785_-2784del-;NM_001206987:c.-6169_-6168del-;NM_001206986:c.-6169_-6168del-;NM_001206983:c.-2785_-2784del-	.	.	0.113237609	0.778025357	0.108737034	DISEASE: Mental retardation, autosomal recessive 44 (MRT44) [MIM:615942]: A disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. MRT44 manifestations include mild to severe cognitive impairment, delayed psychomotor development, seizures in some patients, and dysmorphic features. {ECO:0000269|PubMed:24501276, ECO:0000269|PubMed:24626631}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	.	0.08223	0.349177632	74.18023119	73.16169	1.78753	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	66	111	chr17	74723007	chr17:74723007	GGC	G	66	PASS	AN=2;DP=111	GT	0/1
chr17	77807049	77807049	G	T	UTR3	CBX4	NM_003655:c.*709C>A	.	.	0.381198482	0.608349045	0.010452473	.	0.87942	0.1035	0.106667882	61.73036093	1044.2776	6.20429	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	72	chr17	77807049	chr17:77807049	G	T	.	PASS	AN=0;DP=72	GT	0/1
chr17	80396772	80396823	GGGGCGAGGCTCCTCCTCCCCCAGAGCAGCGGCGCATCCTTCAGGCGAGCCT	-	intronic	HEXDC	.	.	.	1.59E-06	0.854020781	0.145977631	.	0.1403	.	0.560331224	81.70559094	113.59821	2.32178	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	10.07	24	chr17	80396771	chr17:80396771	CGGGGCGAGGCTCCTCCTCCCCCAGAGCAGCGGCGCATCCTTCAGGCGAGCCT	C	10.07	PASS	AN=0;DP=24	GT	0/1
chr18	11999004	11999004	G	A	intronic	IMPA2	.	.	.	0.237822649	0.755127914	0.007049436	.	0.53908	0.23623	0.327131069	73.27199811	212.72651	3.14791	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	93	chr18	11999004	chr18:11999004	G	A	.	PASS	AN=0;DP=93	GT	0/1
chr18	30908006	30908006	A	G	intronic	CCDC178	.	.	.	4.11E-29	4.49E-06	0.999995511	.	0.71144	.	1.449540683	95.14626091	1397.05643	6.99037	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	83	340	chr18	30908006	chr18:30908006	A	G	83	PASS	AN=2;DP=340	GT	0/1
chr18	48584781	48584781	C	G	exonic	SMAD4	.	nonsynonymous SNV	SMAD4:NM_005359:exon7:c.C859G:p.H287D	0.967432536	0.032565268	2.20E-06	DISEASE: Pancreatic cancer (PNCA) [MIM:260350]: A malignant neoplasm of the pancreas. Tumors can arise from both the exocrine and endocrine portions of the pancreas, but 95% of them develop from the exocrine portion, including the ductal epithelium, acinar cells, connective tissue, and lymphatic tissue. {ECO:0000269|PubMed:8553070}. Note=The gene represented in this entry may be involved in disease pathogenesis.; DISEASE: Juvenile polyposis syndrome (JPS) [MIM:174900]: Autosomal dominant gastrointestinal hamartomatous polyposis syndrome in which patients are at risk for developing gastrointestinal cancers. The lesions are typified by a smooth histological appearance, predominant stroma, cystic spaces and lack of a smooth muscle core. Multiple juvenile polyps usually occur in a number of Mendelian disorders. Sometimes, these polyps occur without associated features as in JPS; here, polyps tend to occur in the large bowel and are associated with an increased risk of colon and other gastrointestinal cancers. {ECO:0000269|PubMed:12417513, ECO:0000269|PubMed:9811934}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome (JP/HHT) [MIM:175050]: JP/HHT syndrome phenotype consists of the coexistence of juvenile polyposis (JIP) and hereditary hemorrhagic telangiectasia (HHT) [MIM:187300] in a single individual. JIP and HHT are autosomal dominant disorders with distinct and non-overlapping clinical features. The former, an inherited gastrointestinal malignancy predisposition, is caused by mutations in SMAD4 or BMPR1A, and the latter is a vascular malformation disorder caused by mutations in ENG or ACVRL1. All four genes encode proteins involved in the transforming-growth- factor-signaling pathway. Although there are reports of patients and families with phenotypes of both disorders combined, the genetic etiology of this association is unknown. {ECO:0000269|PubMed:15031030}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Colorectal cancer (CRC) [MIM:114500]: A complex disease characterized by malignant lesions arising from the inner wall of the large intestine (the colon) and the rectum. Genetic alterations are often associated with progression from premalignant lesion (adenoma) to invasive adenocarcinoma. Risk factors for cancer of the colon and rectum include colon polyps, long-standing ulcerative colitis, and genetic family history. {ECO:0000269|PubMed:16959974}. Note=The disease may be caused by mutations affecting the gene represented in this entry.; DISEASE: Note=SMAD4 variants may be associated with susceptibility to pulmonary hypertension, a disorder characterized by plexiform lesions of proliferating endothelial cells in pulmonary arterioles. The lesions lead to elevated pulmonary arterial pression, right ventricular failure, and death. The disease can occur from infancy throughout life and it has a mean age at onset of 36 years. Penetrance is reduced. Although familial pulmonary hypertension is rare, cases secondary to known etiologies are more common and include those associated with the appetite-suppressant drugs. {ECO:0000269|PubMed:21898662}.; DISEASE: Myhre syndrome (MYHRS) [MIM:139210]: A syndrome characterized by pre- and postnatal growth deficiency, mental retardation, generalized muscle hypertrophy and striking muscular build, decreased joint mobility, cryptorchidism, and unusual facies. Dysmorphic facial features include microcephaly, midface hypoplasia, prognathism, and blepharophimosis. Typical skeletal anomalies are short stature, square body shape, broad ribs, iliac hypoplasia, brachydactyly, flattened vertebrae, and thickened calvaria. Other features, such as congenital heart disease, may also occur. {ECO:0000269|PubMed:22158539, ECO:0000269|PubMed:22243968}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.99992	0.79641	-0.315847836	31.68789809	15.10025	0.54284	0.429	0.096	T	0.613	0.378	P	0.256	0.375	B	0.000	0.843	D	1.000	0.810	D	2.22	0.631	M	-4.11	0.967	D	-1.96	0.454	N	0.778	0.770	0.660	0.927	D	0.834	0.944	D	0.204	0.870	D	2.699	0.385	20.8	0.982	0.386	0.991	0.919	D	c	0.460	0.594	1.000	0.747	0.707	0.730	0	6.17	0.997	7.777	0.841	0.935	0.490	1.000	0.715	1.000	0.888	19.651	0.958	SMAD/FHA domain	.	.	0.5	54	93	chr18	48584781	chr18:48584781	C	G	54	PASS	AN=2;DP=93	GT	0/1
chr18	67802446	67802502	AAATAATAGAAGACAAAATAGTGCTCCAACTTCAGTCACGACACTACAATCTTCATG	-	exonic	RTTN	.	nonframeshift deletion	RTTN:NM_001318520:exon21:c.67_123del:p.H23_F41del,RTTN:NM_173630:exon22:c.2803_2859del:p.H935_F953del	2.40E-13	0.999999994	5.97E-09	DISEASE: Polymicrogyria with seizures (PMGYS) [MIM:614833]: A disease characterized by many irregular small gyri in the brain surface and fusion of the molecular layer over multiple small gyri, which gives a festooned appearance to the cortical surface, without abnormal neuronal migration. Polymicrogyria is a heterogeneous disorder, considered to be the result of postmigratory abnormal cortical organization. PMGYS patients have moderate to severe mental retardation, poor speech, dysarthria and seizures. {ECO:0000269|PubMed:22939636}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.25498	0.10307	0.18719002	66.27742392	829.75241	5.64516	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	25.33	20	chr18	67802445	chr18:67802445	CAAATAATAGAAGACAAAATAGTGCTCCAACTTCAGTCACGACACTACAATCTTCATG	C	25.33	PASS	AN=0;DP=20	GT	0/1
chr18	76758049	76758049	A	T	UTR3	SALL3	NM_171999:c.*727A>T	.	.	0.090193129	0.90098293	0.008823941	.	0.53411	0.12093	.	.	660.65433	5.1535	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	58	72	chr18	76758049	chr18:76758049	A	T	58	PASS	AN=2;DP=72	GT	0/1
chr19	507444	507444	-	GG	upstream	TPGS1	dist=53	.	.	0.003467495	0.389170042	0.607362463	.	0.17391	0.10865	.	.	357.58608	4.0068	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	81	13	chr19	507444	chr19:507444	T	TGG	81	PASS	AN=2;DP=13	GT	1/0
chr19	900838	900838	G	A	exonic	R3HDM4	.	nonsynonymous SNV	R3HDM4:NM_138774:exon4:c.C466T:p.R156W	0.019345311	0.900324136	0.080330553	.	0.14605	0.10939	0.262810045	70.43524416	922.19623	5.89756	0.004	0.654	D	0.999	0.764	D	0.89	0.614	P	0.859	0.089	U	1	0.090	N	1.5	0.380	L	.	.	.	-2.74	0.582	D	0.248	0.303	-0.961	0.390	T	0.150	0.477	T	0.013	0.319	T	4.698	0.630	24.6	0.997	0.776	0.215	0.212	N	c	-0.391	-0.634	1.000	0.747	0.840	1.000	0	0.328	0.151	-0.142	0.102	0.824	0.337	0.064	0.217	0.119	0.196	7.657	0.274	R3H-associated N-terminal domain	.	.	0.5	.	110	chr19	900838	chr19:900838	G	A	.	PASS	AN=0;DP=110	GT	0/1
chr19	1111965	1111965	C	T	intronic	SBNO2	.	.	.	0.024423765	0.975552528	2.37E-05	.	0.41647	0.11239	-2.2729502	1.250294881	880.95739	5.7817	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	276	chr19	1111965	chr19:1111965	C	T	.	PASS	AN=0;DP=276	GT	0/1
chr19	1483042	1483044	GGT	-	intronic	PCSK4	.	.	.	6.59E-13	0.113546769	0.886453231	.	0.09952	0.1291	0.606246644	82.93229535	734.41331	5.37512	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	78	105	chr19	1483041	chr19:1483041	GGGT	G	78	PASS	AN=2;DP=105	GT	0/1
chr19	1789344	1789344	C	A	intronic	ATP8B3	.	.	.	9.19E-22	0.003624404	0.996375596	.	0.07662	.	-0.44655933	24.21561689	4172.41798	12.8315	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	30	chr19	1789344	chr19:1789344	C	A	.	PASS	AN=0;DP=30	GT	0/1
chr19	1987472	1987472	C	G	intronic	BTBD2	.	.	.	0.987678942	0.012316184	4.87E-06	.	0.16014	0.11161	-0.622676946	17.30950696	3774.01478	12.02834	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	100	340	chr19	1987472	chr19:1987472	C	G	100	PASS	AN=2;DP=340	GT	0/1
chr19	3920799	3920799	G	A	ncRNA_intronic	MIR1268A	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	42	chr19	3920799	chr19:3920799	G	A	.	PASS	AN=0;DP=42	GT	0/1
chr19	3941159	3941159	C	T	exonic	NMRK2	.	synonymous SNV	NMRK2:NM_001289117:exon7:c.C501T:p.A167A,NMRK2:NM_170678:exon7:c.C486T:p.A162A	1.17E-07	0.103948737	0.896051146	.	0.471	0.14229	0.240763792	69.36777542	244.945	3.37613	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	112	chr19	3941159	chr19:3941159	C	T	.	PASS	AN=0;DP=112	GT	0/1
chr19	4472401	4472401	C	A	exonic	HDGFL2	.	stopgain	HDGFL2:NM_001001520:exon1:c.C54A:p.Y18X,HDGFL2:NM_032631:exon1:c.C54A:p.Y18X	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.023	0.265	N	1	0.810	A	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	10.291	0.967	36	0.993	0.581	0.893	0.494	D	c	0.498	0.303	1.000	0.747	0.733	0.969	0	1.91	0.247	0.262	0.181	-0.627	0.042	0.990	0.367	0.853	0.356	9.381	0.373	PWWP domain	.	.	0.5	.	189	chr19	4472401	chr19:4472401	C	A	.	PASS	AN=0;DP=189	GT	0/1
chr19	5144222	5144222	G	A	intronic	KDM4B	.	.	.	0.999934757	6.52E-05	2.77E-12	.	0.43365	0.11421	-2.565119811	0.837461665	40.68188	1.19189	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	125	chr19	5144222	chr19:5144222	G	A	.	PASS	AN=0;DP=125	GT	0/1
chr19	7688678	7688678	T	-	exonic	XAB2	.	frameshift deletion	XAB2:NM_020196:exon8:c.1058delA:p.N353Tfs*71	0.99707026	0.00292974	2.44E-10	.	0.68409	0.19221	-1.368693559	4.482189196	119.33169	2.37747	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	40	33	chr19	7688677	chr19:7688677	GT	G	40	PASS	AN=2;DP=33	GT	0/1
chr19	7974758	7974758	G	A	exonic	MAP2K7	.	synonymous SNV	MAP2K7:NM_001297556:exon2:c.G243A:p.L81L,MAP2K7:NM_145185:exon2:c.G243A:p.L81L,MAP2K7:NM_001297555:exon3:c.G291A:p.L97L	0.985719994	0.014273006	7.00E-06	.	0.81541	.	-0.514264485	21.41424864	25.26477	0.82588	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	20	chr19	7974758	chr19:7974758	G	A	.	PASS	AN=0;DP=20	GT	0/1
chr19	7977931	7977934	CTCT	-	UTR3	MAP2K7	NM_145185:c.*615_*618delCTCT;NM_001297556:c.*615_*618delCTCT;NM_001297555:c.*615_*618delCTCT	.	.	0.985719994	0.014273006	7.00E-06	.	0.81541	.	-0.514264485	21.41424864	25.26477	0.82588	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	12.12	60	chr19	7977928	chr19:7977928	GCTCTCT	GCT,G	12.12	PASS	AN=0;DP=60	GT	0/1
chr19	7977929	7977934	CTCTCT	-	UTR3	MAP2K7	NM_145185:c.*613_*618delCTCTCT;NM_001297556:c.*613_*618delCTCTCT;NM_001297555:c.*613_*618delCTCTCT	.	.	0.985719994	0.014273006	7.00E-06	.	0.81541	.	-0.514264485	21.41424864	25.26477	0.82588	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	12.12	60	chr19	7977928	chr19:7977928	GCTCTCT	GCT,G	12.12	PASS	AN=0;DP=60	GT	0/1
chr19	9873897	9873897	C	G	intronic	ZNF846	.	.	.	3.75E-16	0.000756524	0.999243476	.	.	.	0.466683681	78.73908941	1291.14567	6.76427	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	64	62	chr19	9873897	chr19:9873897	C	G	64	PASS	AN=2;DP=62	GT	0/1
chr19	11258044	11258044	T	-	intronic	SPC24	.	.	.	0.006275544	0.741565201	0.252159254	.	0.08605	0.11889	0.413500896	76.67492333	270.60416	3.52755	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	44	31	chr19	11258043	chr19:11258043	CT	C	44	PASS	AN=2;DP=31	GT	0/1
chr19	11409676	11409676	A	C	intronic	TSPAN16	.	.	.	0.000252238	0.533132847	0.466614915	.	0.04912	0.08574	0.373041938	75.29488087	212.54112	3.14654	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	53	35	chr19	11409676	chr19:11409676	A	C	53	PASS	AN=2;DP=35	GT	0/1
chr19	12760173	12760173	G	C	exonic	MAN2B1	.	nonsynonymous SNV	MAN2B1:NM_000528:exon19:c.C2337G:p.N779K,MAN2B1:NM_001173498:exon19:c.C2334G:p.N778K	1.56E-12	0.928196832	0.071803168	DISEASE: Mannosidosis, alpha B, lysosomal (MANSA) [MIM:248500]: A lysosomal storage disease characterized by accumulation of unbranched oligosaccharide chains. This accumulation is expressed histologically as cytoplasmic vacuolation predominantly in the CNS and parenchymatous organs. Depending on the clinical findings at the age of onset, a severe infantile (type I) and a mild juvenile (type II) form of alpha-mannosidosis are recognized. There is considerable variation in the clinical expression with mental retardation, recurrent infections, impaired hearing and Hurler- like skeletal changes being the most consistent abnormalities. {ECO:0000269|PubMed:12718372, ECO:0000269|PubMed:15712269, ECO:0000269|PubMed:22161967, ECO:0000269|PubMed:9158146, ECO:0000269|PubMed:9758606, ECO:0000269|PubMed:9915946}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.06035	0.22441	0.121225147	62.22576079	2735.34889	9.86188	0.014	0.531	D	1.0	0.899	D	0.995	0.875	D	0.000	0.449	D	1.000	0.537	D	3.56	0.935	H	-1.23	0.789	T	-4.04	0.757	D	0.445	0.499	0.567	0.915	D	0.689	0.893	D	0.097	0.769	D	6.555	0.902	31	0.998	0.855	0.982	0.803	D	c	0.821	0.722	1.000	0.467	0.706	0.609	0	4.66	0.577	7.068	0.763	1.045	0.669	1.000	0.715	0.972	0.466	15.081	0.717	Galactose mutarotase-like domain|Glycosyl hydrolase family 38, C-terminal	.	.	0.5	.	28	chr19	12760173	chr19:12760173	G	C	.	PASS	AN=0;DP=28	GT	0/1
chr19	12760222	12760222	C	T	exonic	MAN2B1	.	stopgain	MAN2B1:NM_000528:exon19:c.G2288A:p.W763X,MAN2B1:NM_001173498:exon19:c.G2285A:p.W762X	1.56E-12	0.928196832	0.071803168	DISEASE: Mannosidosis, alpha B, lysosomal (MANSA) [MIM:248500]: A lysosomal storage disease characterized by accumulation of unbranched oligosaccharide chains. This accumulation is expressed histologically as cytoplasmic vacuolation predominantly in the CNS and parenchymatous organs. Depending on the clinical findings at the age of onset, a severe infantile (type I) and a mild juvenile (type II) form of alpha-mannosidosis are recognized. There is considerable variation in the clinical expression with mental retardation, recurrent infections, impaired hearing and Hurler- like skeletal changes being the most consistent abnormalities. {ECO:0000269|PubMed:12718372, ECO:0000269|PubMed:15712269, ECO:0000269|PubMed:22161967, ECO:0000269|PubMed:9158146, ECO:0000269|PubMed:9758606, ECO:0000269|PubMed:9915946}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.06035	0.22441	0.121225147	62.22576079	2735.34889	9.86188	.	.	.	.	.	.	.	.	.	0.002	0.382	N	1	0.810	A	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	13.678	0.993	43	0.996	0.744	0.981	0.798	D	c	0.777	0.604	1.000	0.747	0.706	0.609	0	4.55	0.553	7.077	0.763	0.932	0.445	1.000	0.715	0.919	0.394	14.846	0.698	Galactose mutarotase-like domain|Glycosyl hydrolase family 38, C-terminal	.	.	0.5	.	51	chr19	12760222	chr19:12760222	C	T	.	PASS	AN=0;DP=51	GT	0/1
chr19	13898936	13898936	G	T	intergenic	C19orf53;ZSWIM4	dist=9350;dist=7338	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	41	chr19	13898936	chr19:13898936	G	T	.	PASS	AN=0;DP=41	GT	0/1
chr19	14083681	14083681	G	C	exonic	RFX1	.	synonymous SNV	RFX1:NM_002918:exon9:c.C1188G:p.G396G	0.998752687	0.001247312	7.42E-10	.	0.65257	0.19379	-0.08446956	47.15145081	531.54502	4.70401	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	58	16	chr19	14083681	chr19:14083681	G	C	58	PASS	AN=2;DP=16	GT	0/1
chr19	14237026	14237026	C	T	exonic	ASF1B	.	nonsynonymous SNV	ASF1B:NM_018154:exon2:c.G133A:p.V45I	0.565696011	0.422261192	0.012042797	.	0.90878	0.12386	-0.427900189	25.14744043	14.36535	0.51875	0.001	0.784	D	0.948	0.516	P	0.984	0.745	D	0.000	0.843	D	1	0.810	D	1.985	0.540	M	.	.	.	-0.96	0.255	N	0.478	0.527	-0.067	0.809	T	0.514	0.818	D	0.009	0.250	T	6.561	0.903	31	0.999	0.936	0.934	0.579	D	c	0.848	0.831	1.000	0.747	0.732	0.924	0	5.95	0.964	7.905	0.864	0.932	0.445	1.000	0.715	0.978	0.483	17.887	0.887	.	.	.	0.5	.	34	chr19	14237026	chr19:14237026	C	T	.	PASS	AN=0;DP=34	GT	0/1
chr19	18305695	18305695	C	T	intronic	MPV17L2	.	.	.	1.67E-07	0.127199435	0.872800397	.	.	.	0.03689118	56.64071715	1728.0677	7.67188	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	58	chr19	18305695	chr19:18305695	C	T	.	PASS	AN=0;DP=58	GT	0/1
chr19	18305711	18305711	C	T	intronic	MPV17L2	.	.	.	1.67E-07	0.127199435	0.872800397	.	.	.	0.03689118	56.64071715	1728.0677	7.67188	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	65	160	chr19	18305711	chr19:18305711	C	T	65	PASS	AN=2;DP=160	GT	0/1
chr19	23158703	23158703	A	G	exonic	ZNF728	.	nonsynonymous SNV	ZNF728:NM_001267716:exon4:c.T1436C:p.L479P	1.36E-07	0.208328597	0.791671267	.	.	.	.	.	3188.19789	10.75687	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	-1.405	0.006	N	2.85	0.106	T	.	.	.	0.1	0.103	.	.	.	.	.	.	0.030	0.525	D	-1.224	0.024	0.006	0.643	0.072	0.000	0.002	N	n	-0.199	0.121	0.000	0.012	0.487	0.133	0	.	.	0.907	0.280	-5.111	0.000	0.021	0.196	0.000	0.016	6.153	0.194	Zinc finger C2H2-type/integrase DNA-binding domain|Zinc finger, C2H2	.	.	0.5	56	20	chr19	23158703	chr19:23158703	A	G	56	PASS	AN=2;DP=20	GT	0/1
chr19	23158708	23158708	C	G	exonic	ZNF728	.	nonsynonymous SNV	ZNF728:NM_001267716:exon4:c.G1431C:p.E477D	1.36E-07	0.208328597	0.791671267	.	.	.	.	.	3188.19789	10.75687	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.04	0.081	N	1.71	0.267	T	.	.	.	0.113	0.123	.	.	.	.	.	.	0.005	0.130	T	3.615	0.492	23.2	0.584	0.059	0.011	0.040	N	n	0.002	0.153	0.000	0.038	0.487	0.133	0	.	.	-0.149	0.101	0.275	0.269	0.044	0.210	0.008	0.104	8.825	0.340	Zinc finger C2H2-type/integrase DNA-binding domain|Zinc finger, C2H2	.	.	0.5	64	24	chr19	23158708	chr19:23158708	C	G	64	PASS	AN=2;DP=24	GT	0/1
chr19	35836418	35836418	T	A	ncRNA_exonic	MIR5196	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	14	chr19	35836418	chr19:35836418	T	A	.	PASS	AN=0;DP=14	GT	0/1
chr19	39948920	39948920	C	A	intronic	SUPT5H	.	.	.	0.999999735	2.65E-07	4.16E-18	.	0.64202	0.11134	-1.42004951	4.104741684	80.77096	1.89887	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	87	chr19	39948920	chr19:39948920	C	A	.	PASS	AN=0;DP=87	GT	0/1
chr19	41450754	41450755	TT	-	ncRNA_exonic	CYP2B7P	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	12.88	22	chr19	41450753	chr19:41450753	CTT	C	12.88	PASS	AN=0;DP=22	GT	0/1
chr19	41759632	41759632	C	-	intronic	AXL	.	.	.	0.766301151	0.233698224	6.25E-07	DISEASE: Note=AXL and its ligand GAS6 are highly expressed in thyroid carcinoma tissues, and might thus be involved in thyroid tumorigenesis. Overexpression of AXL and its ligand was also detected in many other cancers such as myeloproliferative disorders, prostatic carcinoma cells, or breast cancer.; 	0.31627	0.23288	-0.949752638	9.32413305	128.32814	2.46902	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	95	23	chr19	41759631	chr19:41759631	AC	A	95	PASS	AN=2;DP=23	GT	0/1
chr19	45262625	45262625	C	T	intronic	BCL3	.	.	.	0.862172685	0.137400478	0.000426837	DISEASE: Note=A chromosomal aberration involving BCL3 may be a cause of B-cell chronic lymphocytic leukemia (B-CLL). Translocation t(14;19)(q32;q13.1) with immunoglobulin gene regions. {ECO:0000269|PubMed:2180580, ECO:0000269|PubMed:7896265}.; 	0.52579	0.28802	.	.	48.07549	1.34896	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	58	101	chr19	45262625	chr19:45262625	C	T	58	PASS	AN=2;DP=101	GT	0/1
chr19	45317499	45317499	G	-	exonic	BCAM	.	frameshift deletion	BCAM:NM_001013257:exon7:c.875delG:p.D294Tfs*20,BCAM:NM_005581:exon7:c.875delG:p.D294Tfs*19	0.036851184	0.962838134	0.000310682	.	0.1514	0.15985	1.252926935	93.48313281	349.93518	3.9651	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	70	127	chr19	45317498	chr19:45317498	CG	C	70	PASS	AN=2;DP=127	GT	0/1
chr19	47342645	47342645	G	A	intronic	AP2S1	.	.	.	0.919495985	0.079989124	0.000514891	DISEASE: Hypocalciuric hypercalcemia, familial 3 (HHC3) [MIM:600740]: A form of hypocalciuric hypercalcemia, a disorder of mineral homeostasis that is transmitted as an autosomal dominant trait with a high degree of penetrance. It is characterized biochemically by lifelong elevation of serum calcium concentrations and is associated with inappropriately low urinary calcium excretion and a normal or mildly elevated circulating parathyroid hormone level. Hypermagnesemia is typically present. Affected individuals are usually asymptomatic and the disorder is considered benign. However, chondrocalcinosis and pancreatitis occur in some adults. {ECO:0000269|PubMed:23222959, ECO:0000269|PubMed:24081735}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.21863	0.16306	0.013025609	54.62962963	1.16568	0.03254	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	30	chr19	47342645	chr19:47342645	G	A	.	PASS	AN=0;DP=30	GT	0/1
chr19	47603195	47603195	G	A	intronic	ZC3H4	.	.	.	0.999999772	2.28E-07	1.41E-17	.	0.40007	.	-1.320975027	4.777070064	637.42325	5.07993	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	25	chr19	47603195	chr19:47603195	G	A	.	PASS	AN=0;DP=25	GT	0/1
chr19	50358233	50358233	C	G	exonic	PTOV1	.	nonsynonymous SNV	PTOV1:NM_001305105:exon5:c.C457G:p.L153V,PTOV1:NM_001305108:exon5:c.C361G:p.L121V,PTOV1:NM_017432:exon5:c.C457G:p.L153V	0.358456527	0.641012483	0.00053099	.	0.3692	0.11188	-0.821100135	11.88369899	836.58972	5.66639	0.006	0.614	D	0.976	0.585	D	0.851	0.659	P	0.143	0.182	N	0.998	0.445	D	1.935	0.520	L	-1.37	0.802	T	-1.01	0.266	N	0.622	0.674	-0.586	0.654	T	0.283	0.655	T	0.168	0.847	D	5.326	0.721	25.8	0.974	0.334	0.589	0.305	D	c	0.123	0.072	0.996	0.341	0.672	0.522	0	2.39	0.284	2.550	0.452	0.932	0.445	0.982	0.353	0.667	0.302	10.451	0.435	Mediator complex, subunit Med25, PTOV activation and synapsin 2	.	.	0.5	67	235	chr19	50358233	chr19:50358233	C	G	67	PASS	AN=2;DP=235	GT	0/1
chr19	51567777	51567777	C	G	intronic	KLK13	.	.	.	0.755462838	0.242478739	0.002058424	.	0.04775	0.09971	-0.159704656	41.90846898	120.56718	2.39208	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	67	139	chr19	51567777	chr19:51567777	C	G	67	PASS	AN=2;DP=139	GT	0/1
chr19	52716628	52716628	A	G	intronic	PPP2R1A	.	.	.	0.719603753	0.280370202	2.60E-05	DISEASE: Mental retardation, autosomal dominant 36 (MRD36) [MIM:616362]: A form of mental retardation, a disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. {ECO:0000269|PubMed:25533962, ECO:0000269|PubMed:26168268}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.6443	0.28104	-0.183570861	39.95046001	14.15057	0.51225	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	42	chr19	52716628	chr19:52716628	A	G	.	PASS	AN=0;DP=42	GT	0/1
chr19	52716637	52716637	G	-	intronic	PPP2R1A	.	.	.	0.719603753	0.280370202	2.60E-05	DISEASE: Mental retardation, autosomal dominant 36 (MRD36) [MIM:616362]: A form of mental retardation, a disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. {ECO:0000269|PubMed:25533962, ECO:0000269|PubMed:26168268}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.6443	0.28104	-0.183570861	39.95046001	14.15057	0.51225	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	62	106	chr19	52716636	chr19:52716636	TG	T	62	PASS	AN=2;DP=106	GT	0/1
chr19	54802461	54802461	C	A	intronic	LILRA3	.	.	.	0.002925351	0.941785239	0.055289411	.	0.06888	.	3.561548721	99.50460014	1102.81114	6.34939	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	126	chr19	54802461	chr19:54802461	C	A	.	PASS	AN=0;DP=126	GT	0/1
chr19	55452786	55452786	C	-	intronic	NLRP7	.	.	.	1.10E-12	0.150540999	0.849459001	DISEASE: Hydatidiform mole, recurrent, 1 (HYDM1) [MIM:231090]: A disorder characterized by excessive trophoblast development that produces a growing mass of tissue inside the uterus at the beginning of a pregnancy. It leads to abnormal pregnancies with no embryo, and cystic degeneration of the chorionic villi. {ECO:0000269|PubMed:16462743, ECO:0000269|PubMed:19246479}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.06942	0.12139	0.326933865	73.11866006	142.92313	2.60603	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	56	37	chr19	55452785	chr19:55452785	AC	A	56	PASS	AN=2;DP=37	GT	0/1
chr19	55795388	55795388	A	C	upstream	BRSK1	dist=146	.	.	0.993996393	0.0060036	6.95E-09	.	0.38503	0.11286	-0.80269335	12.23755603	324.11953	3.82625	.	.	.	0.017	0.163	B	0.005	0.104	B	.	.	.	0.999	0.211	N	.	.	.	-0.59	0.716	T	.	.	.	.	.	.	.	.	.	.	.	0.815	0.986	D	1.436	0.235	12.97	0.754	0.107	0.391	0.259	N	n	1.546	1.824	1.000	0.747	0.598	0.340	0	2.46	0.289	0.302	0.188	0.875	0.382	0.936	0.322	0.999	0.750	6.084	0.191	.	.	.	0.5	81	252	chr19	55795388	chr19:55795388	A	C	81	PASS	AN=2;DP=252	GT	0/1
chr19	55795451	55795451	-	G	upstream	BRSK1	dist=83	.	.	0.993996393	0.0060036	6.95E-09	.	0.38503	0.11286	-0.80269335	12.23755603	324.11953	3.82625	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	78	309	chr19	55795451	chr19:55795451	T	TG	78	PASS	AN=2;DP=309	GT	0/1
chr19	55795468	55795468	C	A	upstream	BRSK1	dist=66	.	.	0.993996393	0.0060036	6.95E-09	.	0.38503	0.11286	-0.80269335	12.23755603	324.11953	3.82625	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	104	chr19	55795468	chr19:55795468	C	A	.	PASS	AN=0;DP=104	GT	0/1
chr19	59093579	59093579	G	-	ncRNA_exonic	CENPBD1P1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	42	108	chr19	59093578	chr19:59093578	TG	T	42	PASS	AN=2;DP=108	GT	0/1
chr20	3462384	3462384	G	T	intronic	ATRN	.	.	.	0.999999976	2.42E-08	2.46E-21	.	0.27789	0.17365	0.117584698	62.19037509	3379.60468	11.13499	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	41	chr20	3462384	chr20:3462384	G	T	.	PASS	AN=0;DP=41	GT	0/1
chr20	3462432	3462432	A	G	intronic	ATRN	.	.	.	0.999999976	2.42E-08	2.46E-21	.	0.27789	0.17365	0.117584698	62.19037509	3379.60468	11.13499	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	59	92	chr20	3462432	chr20:3462432	A	G	59	PASS	AN=2;DP=92	GT	0/1
chr20	30584271	30584271	T	A	intronic	XKR7	.	.	.	0.923951243	0.075603056	0.000445701	.	0.35248	.	-0.359940251	28.93371078	645.89854	5.10288	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	37	chr20	30584271	chr20:30584271	T	A	.	PASS	AN=0;DP=37	GT	0/1
chr20	31035304	31035304	C	A	UTR3	NOL4L	NM_001256798:c.*95G>T;NM_001351680:c.*295G>T;NM_080616:c.*95G>T	.	.	.	.	.	.	0.66654	0.11152	-1.045216355	7.661004954	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	21	chr20	31035304	chr20:31035304	C	A	.	PASS	AN=0;DP=21	GT	0/1
chr20	31292194	31292198	AACCA	-	intronic	COMMD7	.	.	.	6.05E-06	0.451906293	0.54808766	.	0.07383	0.09741	-0.163345027	41.24793583	8.41662	0.30752	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	14.89	33	chr20	31292193	chr20:31292193	TAACCA	T	14.89	PASS	AN=0;DP=33	GT	0/1
chr20	31658991	31658991	C	A	intronic	BPIFB3	.	.	.	1.27E-05	0.952461122	0.047526177	.	0.14497	0.08786	1.137205722	92.32719981	8881.73483	20.36052	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	43	chr20	31658991	chr20:31658991	C	A	.	PASS	AN=0;DP=43	GT	0/1
chr20	32298349	32298349	G	A	intronic	PXMP4	.	.	.	0.604956427	0.38624188	0.008801693	.	0.1038	0.10278	0.527368849	80.73248408	67.7056	1.70224	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	60	chr20	32298349	chr20:32298349	G	A	.	PASS	AN=0;DP=60	GT	0/1
chr20	33147070	33147070	G	T	intronic	MAP1LC3A	.	.	.	0.739731535	0.249075138	0.011193327	.	0.09841	0.09617	-0.009020804	52.8544468	1.17647	0.03321	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	71	chr20	33147070	chr20:33147070	G	T	.	PASS	AN=0;DP=71	GT	0/1
chr20	33147172	33147172	G	A	exonic	MAP1LC3A	.	nonsynonymous SNV	MAP1LC3A:NM_032514:exon3:c.G118A:p.G40S,MAP1LC3A:NM_181509:exon4:c.G130A:p.G44S	0.739731535	0.249075138	0.011193327	.	0.09841	0.09617	-0.009020804	52.8544468	1.17647	0.03321	0.063	0.367	T	0.001	0.200	B	0.015	0.277	B	0.000	0.843	D	1	0.810	D	2.11	0.588	M	0.96	0.429	T	-4.22	0.758	D	0.52	0.567	-1.008	0.276	T	0.113	0.403	T	0.020	0.432	T	3.667	0.498	23.2	0.996	0.755	0.948	0.620	D	c	0.075	0.251	1.0	0.983	0.726	0.872	0	5.08	0.682	8.052	0.891	0.923	0.433	1.000	0.715	1.000	0.888	18.058	0.892	Ubiquitin-related domain	.	.	0.5	.	113	chr20	33147172	chr20:33147172	G	A	.	PASS	AN=0;DP=113	GT	0/1
chr20	33747721	33747721	G	A	intergenic	EDEM2;PROCR	dist=12560;dist=12019	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	103	chr20	33747721	chr20:33747721	G	A	.	PASS	AN=0;DP=103	GT	0/1
chr20	34134710	34134739	AGCCGGTGCAGAGGGAGAGGTGTGAGGAGA	-	intronic	ERGIC3	.	.	.	0.003859077	0.994404724	0.001736199	.	0.29981	0.10239	-0.404032746	26.53338051	12.39957	0.44974	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	12.8	24	chr20	34134709	chr20:34134709	GAGCCGGTGCAGAGGGAGAGGTGTGAGGAGA	G	12.8	PASS	AN=0;DP=24	GT	0/1
chr20	47838071	47838127	AGAAGGAGGGGACGTACGATGGCAGCTGGGCCCTGGCTGATGTCATGAGCCAACTCA	-	exonic	DDX27	.	nonframeshift deletion	DDX27:NM_001348187:exon2:c.269_325del:p.E92_K110del,DDX27:NM_017895:exon2:c.269_325del:p.E92_K110del	0.250170092	0.749829465	4.42E-07	.	0.17829	0.10926	-0.062423436	48.86765747	4157.56288	12.79754	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	41	53	chr20	47838070	chr20:47838070	GAGAAGGAGGGGACGTACGATGGCAGCTGGGCCCTGGCTGATGTCATGAGCCAACTCA	G	41	PASS	AN=2;DP=53	GT	0/1
chr20	48146780	48146780	C	A	intronic	PTGIS	.	.	.	2.42E-05	0.915593898	0.08438187	.	0.36541	0.27749	-0.352661697	29.48808681	184.44683	2.94813	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	67	chr20	48146780	chr20:48146780	C	A	.	PASS	AN=0;DP=67	GT	0/1
chr20	57613653	57613653	C	T	exonic	PRELID3B	.	synonymous SNV	PRELID3B:NM_001256403:exon2:c.G69A:p.Q23Q,PRELID3B:NM_016045:exon2:c.G69A:p.Q23Q	.	.	.	.	0.48576	.	0.281220278	71.07808445	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	36	chr20	57613653	chr20:57613653	C	T	.	PASS	AN=0;DP=36	GT	0/1
chr21	37664460	37664460	G	T	exonic	DOPEY2	.	nonsynonymous SNV	DOPEY2:NM_001320714:exon36:c.G6574T:p.V2192L,DOPEY2:NM_005128:exon36:c.G6574T:p.V2192L	9.61E-08	0.999999892	1.15E-08	.	0.29781	0.10131	-3.64623945	0.277188016	3301.99985	10.96533	0.626	0.052	T	0.0	0.026	B	0.0	0.013	B	0.304	0.145	N	1	0.090	N	-1.98	0.002	N	1.09	0.392	T	0.4	0.035	N	0.026	0.008	-0.982	0.346	T	0.018	0.077	T	0.006	0.159	T	-0.920	0.035	0.023	0.655	0.076	0.037	0.089	N	c	-1.866	-1.738	0.985	0.308	0.706	0.609	0	-0.309	0.121	-0.508	0.064	-0.442	0.057	0.000	0.063	0.822	0.344	2.821	0.051	.	.	.	0.5	.	37	chr21	37664460	chr21:37664460	G	T	.	PASS	AN=0;DP=37	GT	0/1
chr21	40759799	40759799	G	-	intronic	WRB;WRB-SH3BGR	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	53	19	chr21	40759798	chr21:40759798	AG	A	53	PASS	AN=2;DP=19	GT	0/1
chr21	46554675	46554675	G	A	intronic	ADARB1	.	.	.	0.843939347	0.155939433	0.00012122	.	0.28156	0.13431	-0.800872469	12.33191791	35.57047	1.07201	.	.	.	.	.	.	.	.	.	.	.	.	1	0.090	N	.	.	.	.	.	.	.	.	.	.	.	-0.956	0.399	T	0.097	0.365	T	.	.	.	-0.082	0.086	1.868	0.596	0.061	0.001	0.005	N	c	-0.937	-1.185	1.000	0.489	0.322	0.047	0	-1.4	0.085	-0.357	0.076	-0.551	0.047	0.000	0.063	0.001	0.043	4.253	0.101	.	.	.	0.5	.	45	chr21	46554675	chr21:46554675	G	A	.	PASS	AN=0;DP=45	GT	0/1
chr21	47845915	47845915	C	-	intronic	PCNT	.	.	.	4.18E-38	0.557429948	0.442570052	DISEASE: Microcephalic osteodysplastic primordial dwarfism 2 (MOPD2) [MIM:210720]: Adults with this rare inherited condition have an average height of 100 centimeters and a brain size comparable to that of a 3-month-old baby, but are of near-normal intelligence. {ECO:0000269|PubMed:18157127, ECO:0000269|PubMed:18174396}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.12195	0.21397	3.571342941	99.52229299	12581.30373	24.04834	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	23.57	42	chr21	47845914	chr21:47845914	TC	T	23.57	PASS	AN=0;DP=42	GT	0/1
chr22	24180781	24180781	C	T	exonic	DERL3	.	nonsynonymous SNV	DERL3:NM_001002862:exon3:c.G203A:p.G68E,DERL3:NM_001135751:exon3:c.G203A:p.G68E,DERL3:NM_198440:exon3:c.G203A:p.G68E	0.000238218	0.52095039	0.478811391	.	0.23259	0.12763	0.595326758	82.66100495	1232.36532	6.63447	0.004	0.654	D	1.0	0.899	D	0.99	0.774	D	0.000	0.843	D	1	0.810	D	3.98	0.967	H	1.45	0.325	T	-6.63	0.922	D	0.869	0.856	-0.502	0.686	T	0.248	0.618	T	0.206	0.871	D	6.210	0.857	28.7	0.998	0.902	0.971	0.725	D	c	0.806	0.699	1.000	0.747	0.726	0.872	0	4.21	0.488	7.526	0.807	0.932	0.445	1.000	0.715	1.000	0.888	8.335	0.312	.	.	.	0.5	.	88	chr22	24180781	chr22:24180781	C	T	.	PASS	AN=0;DP=88	GT	0/1
chr22	36218875	36218877	TTT	-	intronic	RBFOX2	.	.	.	0.993206875	0.006792895	2.30E-07	.	0.46697	0.0922	-0.427900189	25.14744043	30.95685	0.97922	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	23.99	64	chr22	36218874	chr22:36218874	CTTT	C	23.99	PASS	AN=0;DP=64	GT	0/1
chr22	40364389	40364389	C	-	intronic	GRAP2	.	.	.	0.101871595	0.896646827	0.001481577	.	0.87215	0.37468	0.283038099	71.26680821	81.93324	1.91955	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	19.64	27	chr22	40364388	chr22:40364388	AC	A	19.64	PASS	AN=0;DP=27	GT	0/1
chr22	41575925	41575925	C	A	UTR3	EP300	NM_001429:c.*965C>A	.	.	1	5.16E-13	1.03E-32	DISEASE: Note=Defects in EP300 may play a role in epithelial cancer.; DISEASE: Note=Chromosomal aberrations involving EP300 may be a cause of acute myeloid leukemias. Translocation t(8;22)(p11;q13) with KAT6A.; DISEASE: Rubinstein-Taybi syndrome 2 (RSTS2) [MIM:613684]: A disorder characterized by craniofacial abnormalities, postnatal growth deficiency, broad thumbs, broad big toes, mental retardation and a propensity for development of malignancies. Some individuals with RSTS2 have less severe mental impairment, more severe microcephaly, and a greater degree of changes in facial bone structure than RSTS1 patients. {ECO:0000269|PubMed:15706485}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.99999	0.91015	-3.681999375	0.259495164	1174.22905	6.51042	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	150	chr22	41575925	chr22:41575925	C	A	.	PASS	AN=0;DP=150	GT	0/1
chr22	50752070	50752070	G	A	exonic	DENND6B	.	synonymous SNV	DENND6B:NM_001001794:exon15:c.C1287T:p.I429I	0.031020348	0.966992704	0.001986948	.	0.18579	.	-0.951568548	9.271054494	2114.67479	8.46343	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	58	60	chr22	50752070	chr22:50752070	G	A	58	PASS	AN=2;DP=60	GT	0/1
chr22	50942133	50942136	GGGA	-	intronic	LMF2	.	.	.	.	.	.	.	0.14313	.	-1.293511806	5.001179523	2091.17234	8.42309	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	43	52	chr22	50942132	chr22:50942132	TGGGA	T	43	PASS	AN=2;DP=52	GT	0/1
chrX	13775823	13775823	C	T	exonic	OFD1	.	synonymous SNV	OFD1:NM_001330209:exon13:c.C1336T:p.L446L,OFD1:NM_003611:exon14:c.C1456T:p.L486L,OFD1:NM_001330210:exon15:c.C1036T:p.L346L	0.982887662	0.01711232	1.83E-08	DISEASE: Simpson-Golabi-Behmel syndrome 2 (SGBS2) [MIM:300209]: A severe variant of Simpson-Golabi-Behmel syndrome, a condition characterized by pre- and postnatal overgrowth (gigantism), facial dysmorphism and a variety of inconstant visceral and skeletal malformations. {ECO:0000269|PubMed:16783569}. Note=The disease may be caused by mutations affecting the gene represented in this entry.; DISEASE: Joubert syndrome 10 (JBTS10) [MIM:300804]: A disorder presenting with cerebellar ataxia, oculomotor apraxia, hypotonia, neonatal breathing abnormalities and psychomotor delay. Neuroradiologically, it is characterized by cerebellar vermian hypoplasia/aplasia, thickened and reoriented superior cerebellar peduncles, and an abnormally large interpeduncular fossa, giving the appearance of a molar tooth on transaxial slices (molar tooth sign). Additional variable features include retinal dystrophy and renal disease. {ECO:0000269|PubMed:19800048}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Retinitis pigmentosa 23 (RP23) [MIM:300424]: A retinal dystrophy belonging to the group of pigmentary retinopathies. Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by secondary loss of cone photoreceptors. Patients typically have night vision blindness and loss of midperipheral visual field. As their condition progresses, they lose their far peripheral visual field and eventually central vision as well. {ECO:0000269|PubMed:22619378}. Note=The disease may be caused by mutations affecting the gene represented in this entry.; 	0.1103	0.17799	-0.176292081	40.56381222	82.1386	1.92266	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	64	32	chrX	13775823	chrX:13775823	C	T	64	PASS	AN=2;DP=32	GT	0/1
chrX	17439191	17439191	T	-	intronic	NHS	.	.	.	0.999461889	0.000538109	2.34E-09	DISEASE: Cataract 40 (CTRCT40) [MIM:302200]: An opacification of the crystalline lens of the eye that frequently results in visual impairment or blindness. Opacities vary in morphology, are often confined to a portion of the lens, and may be static or progressive. CTRCT40 manifests as a congenital nuclear opacity with severe visual impairment in affected males. Heterozygous females have suture cataracts and only slight reduction in vision. In some cases, cataract is associated with microcornea without any other systemic anomaly or dysmorphism. Microcornea is defined by a corneal diameter inferior to 10 mm in both meridians in an otherwise normal eye. {ECO:0000269|PubMed:19414485}. Note=The disease is caused by mutations affecting the gene represented in this entry. Caused by copy number variations predicted to result in altered transcriptional regulation of the NHS gene: a 0.8 Mb segmental duplication-triplication encompassing the NHS, SCML1 and RAI2 genes, and an 4.8 kb intragenic deletion in NHS intron 1.; 	0.17736	0.14772	-0.725642751	14.24274593	725.51652	5.34764	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	56	32	chrX	17439190	chrX:17439190	CT	C	56	PASS	AN=2;DP=32	GT	0/1
chrX	29974743	29974743	C	T	downstream	IL1RAPL1	dist=726	.	.	0.996893678	0.003106154	1.68E-07	.	0.7883	0.22741	-0.60427181	17.74593064	15.07771	0.54108	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	83	chrX	29974743	chrX:29974743	C	T	.	PASS	AN=0;DP=83	GT	0/1
chrX	41093160	41093160	C	T	UTR3	USP9X	NM_001039591:c.*1383C>T;NM_001039590:c.*1383C>T	.	.	1	2.36E-11	2.78E-27	.	0.58131	0.10304	-1.618506764	2.925218212	35.92323	1.07855	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	36	chrX	41093160	chrX:41093160	C	T	.	PASS	AN=0;DP=36	GT	0/1
chrX	44920619	44920619	A	T	exonic	KDM6A	.	synonymous SNV	KDM6A:NM_001291421:exon12:c.A492T:p.V164V,KDM6A:NM_001291417:exon13:c.A1245T:p.V415V,KDM6A:NM_001291418:exon13:c.A1245T:p.V415V,KDM6A:NM_001291416:exon14:c.A1401T:p.V467V,KDM6A:NM_021140:exon14:c.A1380T:p.V460V,KDM6A:NM_001291415:exon15:c.A1536T:p.V512V	0.999987121	1.29E-05	1.08E-14	DISEASE: Kabuki syndrome 2 (KABUK2) [MIM:300867]: A congenital mental retardation syndrome with additional features, including postnatal dwarfism, a peculiar facies characterized by long palpebral fissures with eversion of the lateral third of the lower eyelids, a broad and depressed nasal tip, large prominent earlobes, a cleft or high-arched palate, scoliosis, short fifth finger, persistence of fingerpads, radiographic abnormalities of the vertebrae, hands, and hip joints, and recurrent otitis media in infancy. {ECO:0000269|PubMed:22197486}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.9827	0.16837	-0.066061882	48.77919321	855.17792	5.70917	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	47	chrX	44920619	chrX:44920619	A	T	.	PASS	AN=0;DP=47	GT	0/1
chrX	47039756	47039756	C	T	intronic	RBM10	.	.	.	0.999912181	8.78E-05	2.82E-11	DISEASE: TARP syndrome (TARPS) [MIM:311900]: A disorder characterized by the Robin sequence (micrognathia, glossoptosis and cleft palate), talipes equinovarus and cardiac defects. {ECO:0000269|PubMed:20451169}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.17567	0.15702	-0.66859065	15.76433121	77.16708	1.84454	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	110	chrX	47039756	chrX:47039756	C	T	.	PASS	AN=0;DP=110	GT	0/1
chrX	47488911	47488911	G	T	intronic	CFP	.	.	.	0.944168669	0.05578963	4.17E-05	DISEASE: Properdin deficiency (PFD) [MIM:312060]: Results in higher susceptibility to bacterial infections; especially to meningococcal infections. Three phenotypes have been reported: complete deficiency (type I), incomplete deficiency (type II), and dysfunction of properdin (type III). {ECO:0000269|PubMed:10909851, ECO:0000269|PubMed:8871668, ECO:0000269|PubMed:9710744}. Note=The disease is caused by mutations affecting the gene represented in this entry.; 	0.14504	0.26817	0.350995466	74.37485256	78.28928	1.86633	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	99	chrX	47488911	chrX:47488911	G	T	.	PASS	AN=0;DP=99	GT	0/1
chrX	48136516	48136516	A	-	intergenic	SSX1;SSX9	dist=9637;dist=24469	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	54	27	chrX	48136515	chrX:48136515	CA	C	54	PASS	AN=2;DP=27	GT	0/1
chrX	70794640	70794640	C	T	ncRNA_intronic	BCYRN1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	.	45	chrX	70794640	chrX:70794640	C	T	.	PASS	AN=0;DP=45	GT	0/1
chrX	104707604	104707604	A	G	intronic	IL1RAPL2	.	.	.	0.973379476	0.026613945	6.58E-06	.	0.30056	0.12272	-0.337894035	30.37272942	9.79385	0.35811	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	53	52	chrX	104707604	chrX:104707604	A	G	53	PASS	AN=2;DP=52	GT	0/1
chrX	109561058	109561060	CCG	-	exonic	AMMECR1	.	nonframeshift deletion	AMMECR1:NM_001025580:exon1:c.240_242del:p.G82del,AMMECR1:NM_015365:exon1:c.240_242del:p.G82del	0.910792997	0.088538552	0.00066845	DISEASE: Alport syndrome with mental retardation, midface hypoplasia and elliptocytosis (ATS-MR) [MIM:300194]: A X-linked contiguous gene deletion syndrome characterized by glomerulonephritis, sensorineural hearing loss, mental retardation, midface hypoplasia and elliptocytosis. {ECO:0000269|PubMed:10049589}. Note=The gene represented in this entry may be involved in disease pathogenesis.; 	0.89609	0.33817	-0.09720619	46.20193442	15.37972	0.5519	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	44	38	chrX	109561057	chrX:109561057	CCCG	C	44	PASS	AN=2;DP=38	GT	0/1
chrX	114468474	114468476	CCG	-	exonic	LRCH2	.	nonframeshift deletion	LRCH2:NM_001243963:exon1:c.129_131del:p.G44del,LRCH2:NM_020871:exon1:c.129_131del:p.G44del	0.915538079	0.08443772	2.42E-05	.	0.16063	0.09365	-0.007201372	53.19061099	42.20239	1.22827	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	120	82	chrX	114468473	chrX:114468473	CCCG	C	120	PASS	AN=2;DP=82	GT	0/1
chrX	132351041	132351046	CTGAAG	-	UTR3	TFDP3	NM_016521:c.*29_*24delCTTCAG	.	.	2.30E-06	0.085066935	0.91493076	.	0.05413	0.05691	0.729426781	86.17008728	225.71159	3.2476	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	11.93	26	chrX	132351040	chrX:132351040	CCTGAAG	C	11.93	PASS	AN=0;DP=26	GT	0/1
chrX	153068235	153068235	C	G	UTR3	PDZD4	NM_001303515:c.*573G>C;NM_001303516:c.*573G>C;NM_001303512:c.*573G>C;NM_001303513:c.*573G>C;NM_001303514:c.*573G>C;NM_032512:c.*573G>C	.	.	0.930873832	0.069054613	7.16E-05	.	0.4676	0.11257	-0.380166007	27.88393489	54.5917	1.47872	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	81	98	chrX	153068235	chrX:153068235	C	G	81	PASS	AN=2;DP=98	GT	0/1
chrX	153695719	153695720	CG	-	exonic	PLXNA3	.	frameshift deletion	PLXNA3:NM_017514:exon19:c.3346_3347del:p.R1116Lfs*7	0.983112793	0.016887207	1.47E-10	.	0.13437	0.14072	-2.494487417	0.937721161	2064.44297	8.3709	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	0.5	84	467	chrX	153695718	chrX:153695718	CCG	C	84	PASS	AN=2;DP=467	GT	0/1
